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ABSTRACT 
 
 
HasAp is a hemophore which is believed to “steal” heme from hemoglobin in 
the extracellular medium and deliver the heme to the cognate receptor, HasR for 
internalization. The mechanism of heme uptake and release mechanism of HasAp has 
not been understood. To gain insight on this mechanism, we have elucidated the 
electronic and coordination state of the heme active site, using a combination of 
bioanalytical techniques. The 13C-meso chemical shifts were primarily used as a 
straightforward probe for the coordination and electronic state of HasAp.  The results 
showed that heme-iron is hexacoordinate and in equilibrium between high-spin (S = 
5/2) and low-spin (S = ½).   The proposed explanation this unique coordination and 
spin state is the breaking and forming of hydrogen-bond between the axial ligand 
Tyr75 and His83 which could modulate the heme uptake and release in HasAp.  
The heme transfer experiments reveal that HasAp can take heme only from 
hemoglobin if the heme-iron is in the ferric state. It can not take heme from met-
myoglobin, oxyhemoglobin and HbCN. The weak aqua ligand that coordinates the 
ferric iron in met-Hb is essential to the heme transfer process since its substitution 
with a stronger ligand inhibits the heme transfer to HasAp. Moreover, the rate of 
heme transfer is relatively fast and it occurs in two steps. These observations imply 
that there appear to be a protein-protein interaction between HasAp and hemoglobin 
before HasAp take the heme from hemoglobin. Hence, the heme transfer event from 
met-Hb to apo-HasAp is a multi-step process. 
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The secondary structure of holo-HasAp was determined using X-ray 
crystallography and NMR spectroscopy. The results showed that the last 21 amino 
acid residues which composed the tail of the full-length form are highly unstructured 
and disordered.  There is no structural difference in both the holo full-length and 
truncated form of HasAp except for the tail. However, there is a conformational 
difference between the apo and holo forms of HasAp. The regions close to the heme 
active site are in different conformations in both forms which could suggests that the 
protein uses different bonding interaction to stabilize the heme.  
From the protein-protein interaction experiments the data shows that the same 
regions of the secondary structure in both holo full-length and truncated HasAp were 
perturbed upon hemoglobin binding. However, the residues in the truncated form are 
more perturbed which suggests that the truncated form is likely to be the biologically 
active form of HasAp.                               
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CHAPTER 1 
 
Introduction 
 
 
 
  The opportunistic human pathogen Pseudomonas aeruginosa is one of the 
organisms responsible for drug-resistant hospital infections and can seriously infect 
injured and immunocompromised patients as well as individuals with cystic fibrosis 
[1-6].  10% of the two million hospital-related infections each year are caused by this 
pathogen [7]. Since, P. aeruginosa needs to propagate to be pathogenic, it needs all 
the nutrients required for its growth. One of the essential nutrients needed is iron 
because it prefers an aerobic metabolism which requires respiratory enzymes that 
need iron for their function [4]. Bacteria, however, face a shortage of iron supply 
from the host organism because at aerobic and physiological conditions, insoluble 
ferric hydroxide complexes are present in solution [8, 9].  Hence, there is practically 
no free soluble iron available [10-12]. Moreover, another problem encountered by the 
bacteria is the fact that the majority of the iron in a mammalian host is intracellular 
and sequestered within heme compounds and iron-sulfur clusters in different proteins 
and storage molecules. Thus, for pathogenic bacteria to successfully propagate within 
the host animal, it must be able to utilize or steal iron from these sources [8, 13].  
To fulfill their iron requirements, P. aeruginosa and several other bacterial 
pathogens have developed various iron uptake and utilization mechanisms regulated 
by Fur (Fe uptake regulator) [3, 4, 14]  to scavenge iron from host animals. Poorly 
soluble ferric iron can be chelated by low molecular weight inorganic iron chelators, 
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called siderophores, secreted by the bacteria. The iron-containing siderophores then 
deliver the iron to the specific outer-membrane receptors in an energy-dependent 
process which allows the delivery of the iron to the bacteria via a TonB-dependent 
pathway [10, 15].  P. aeruginosa can also sequester iron from heme containing 
proteins by employing two heme-uptake systems, namely phu (Pseudomonas heme 
uptake) and  has (heme acquisition system).  
The phu system is composed of a receptor gene, phuR, and the phuSTUVW 
operon encoding an ATP-binding cassette (ABC) transporter [4]. On the other hand, 
the has operon consists of hasRADEBF genes (Figure 1) [16]. HasR is the 
hemophore-specific outer membrane receptor, HasA  is a hemophore, HasD  an ATP- 
 
 
 
 
 
 
 
Figure 1.  Organization of the has (heme acquisition system) operon. HasI and  HasS 
are the sigma and anti-sigma ECF factors, respectively. The pink square boxes are the 
consensus Fur boxes.   
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binding inner membrane protein, HasE a membrane fusion protein, HasB a TonB 
analogue,  and HasF an outer membrane protein [17, 18]. In a proteomics study [19], 
the hemophore, HasAp, of Pseudomonas aeruginosa, was identified to be a quorum-
sensing regulated protein which suggests that HasAp plays a role in the virulence 
factor of this human pathogen. The hemophore of Serratia marcescens (HasASM) has 
been structurally and biochemically characterized.  This introduction will give an 
overview on hemophores, and on the progress that has been done toward 
understanding their heme uptake and release mechanisms.  
 
HasAp and Virulence 
Twenty novel quorum-sensing (QS) regulated proteins were identified in the 
proteomics study of Arevalo-Ferro and coworker [19].  Two of the quorum-sensing 
regulated genes they identified are phuR and HasAp. As mentioned earlier, these two 
proteins are components of the two distinct heme uptake systems of Pseudomonas 
aeruginosa. This study suggests that there is a link between quorum-sensing and the 
iron regulatory system. QS enables individual bacteria to communicate and 
coordinate its behavior in a cell-density dependent manner or by cell-to-cell 
communication [20-22].  P. aeruginosa has two extensively studied quorum-sensing  
systems (lasI-lasR and rhlI-rhlR) that regulate expression of hundreds of genes that 
encode extracellular virulence factors, antibiotic resistance and biofilm development 
[3, 23-25].  It has been shown under standard laboratory conditions that the las and 
rhl systems are arranged in a hierarchic structure. The las system is on the upper level 
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of the regulation circuit. The QS systems are encoded by the synthase and the 
receptor or transcriptional regulator gene. The transcriptional regulator of the las and 
rhl systems are LasR and RhlR, respectively. While the synthase genes, LasI and the 
RhlI are specifically involved in the synthesis of the major N-acyl homoserine 
lactones (AHL) autoinducers, 3-oxo-C12-HSL and C4-HSL, respectively [23]. 
Bacteria produce these diffusible small signals molecules called autoinducers which 
diffuse in and out of bacterial cells. As the bacterial population increases to reach a 
“quorum”, so does the synthesis of the autoinducers (AHL), and as a result their 
concentration in the external medium rises [23]. When a threshold level of AHL is 
reached, it binds with the cognate transcriptional regulator (LasR or RhlR) to activate 
expression of the QS-regulated genes [24, 26-29].  
In this proteomic study [51], they employed both the wild type P. aeruginosa 
PAO1 parent strain and the isogenic lasI rhlI double mutant to determine their protein 
expression patterns in the presence and absence of AHL by two-dimensional gel 
electrophoresis (2-DE). The intracellular, extracellular, and surface fractions protein 
spots that were considered to be quorum-sensing regulated were characterized by 
MALDI-TOF peptide mapping. Moreover, the results also demonstrate that quorum-
sensing control also functions by post-transcriptional mechanisms. In fact there were 
more AHL regulated proteins than the number of up-regulated genes. This was 
supported by the fact that they observed five spots (spots SN 110, SN 168, SN 190, 
SN 191, and SN 192) due to HasAp with different intensities. On the other hand, it 
was also observed that the amount of HasAp in the surface protein fractions and in 
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the supernatant were different in the PAO1 wild type and lasl rhll double mutant. In 
the wild type strain, the most abundant HasAp spot has a molecular weight of 18 kDa 
as determined by mass spectrometry. This processed form of HasAp lacks several 
amino acid residues at the C-terminus. This form is thought to be the active form or 
the physiologically important form. Whereas, in the lasI rhlI double mutant, the most 
abundant spot has a molecular weight of 20.5 kDa which corresponds to the 
unprocessed or the full length form of the protein. In addition, spots with molecular 
weight of 18 and 19 kDa with weaker intensities were also observed.  Conversely, 
growing the lasI rhlI double mutant in medium supplemented with AHLs restored the 
wild type protein pattern. The proteomics study revealed that producing the cleaved 
HasAp form is indeed quorum sensing regulated and that protease(s) are responsible 
for the cleavage. However, the protease(s) has not been identified but it has been 
assumed that three quorum sensing regulated proteases namely, LasA, LasB and 
AprA, might be responsible for the cleavage at different sites [30]. Besides, HasAp 
has potential cleavage sites for both LasA and LasB [31, 32].   
To further prove that both phuR and HasAp are indeed quorum-sensing 
regulated, they have shown that the isogenic lasI rhlI double mutant did not grow in 
the medium as well as the wild type with hemoglobin as the only iron source. 
However, supplementation of AHL in the lasI rhlI double mutant growth medium 
showed increased growth.  Hence, the results suggest that one of the phenotypes 
controlled by quorum sensing in P. aeruginosa is hemoglobin-heme utilization. The 
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heme acquisition systems employed by this pathogen is important to sequester iron 
from the host animal.  
 
Heme Acquisition System  
 
Under iron starvation conditions, Pseudomonas aeruginosa, uses several 
strategies to sequester iron from the host animal throughout the duration of infection. 
It is remarkable how this human pathogen controls its iron acquisition and intake 
using an essential Fur regulator [33]. These Fur-regulated genes in P. aeruginosa are 
responsible for the virulence factors of the bacteria and they encode proteins which 
are involved in the iron uptake, transport and utilization [8, 33].  When the 
concentration of iron in the bacterial cell is high, the operon is repressed by the Fur 
protein. This is accomplished by the formation of a Fur protein-Fe(II) complex which 
binds DNA at the conserved Fur boxes located in the promoter region [34-36].  As 
mentioned earlier, P. aeruginosa employs two distinct Fur-regulated heme uptake 
systems to sequester iron from various heme containing proteins. One of these 
systems, the has system depends on the hemophore, HasAp, to sequester heme in the 
extracellular medium. 
 The has operon (hasRADEBF) is under negative regulation by a Fur box 
located upstream of the operon (Figure 1). Besides the negative regulation of  the has 
operon by the Fur, the has operon is also under specific autoregulation of the extra 
cytoplasmic function (ECF) sigmas or iron-starvation sigma of the has system [36].  
This process depends on the receptor, HasR and on its two upstream genes, HasI and 
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HasS. HasI is the ECF sigma factor, while HasS is the anti-sigma factor [37]. It has 
been shown that HasI and HasS genes are important elements that enable bacteria, in 
addition to the Fur-dependent mechanism, to tune the expression of the has system 
under iron limited conditions [36].  
 The has signaling cascade is induced by the heme containing HasA. 
Moreover, both the apo hemophore and heme do not induce the signaling cascade, 
which suggests that the substrate being transported (heme) and the inducer are 
different molecules [37]. When the heme containing hemophore, holo-HasA, binds to 
the cognate outer membrane receptor HasR, the sigma gene, HasI is activated and the 
anti-sigma gene, HasS is inactivated. Thus, facilitating the transcription of the has 
signaling cascade. When there are optimum iron concentrations, HasI induces 
transcription of HasS and turns off the anti-sigma of HasS which subsequently leads 
to an accumulation of inactivated HasS. This is turned on again when the heme 
concentration is low or when HasR is not bound to holo hemophore, HasA [36-39].  
 
 
Proposed Working Mechanism of the Has 
 
Heme Uptake System  
 
The proposed working mechanism of the heme acquisition system is shown in 
Figure 2. Hemophores are secreted into the extracellular medium using the type I or 
the ATP-Binding Cassette (ABC) secretion pathway. In this pathway, the hemophores 
are secreted in a Sec-independent process by the ABC transporters. Typically proteins  
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secreted by the type I secretion pathway have an α-helical C-terminal secretion signal 
that remains accessible because of the cytoplasmic chaperone, SecB,  that is  required 
for the hemophore secretion. The C-terminal secretion signal interacts with the ABC 
transport protein, regulates its ATPase activity and induces a multiprotein complex 
formation comprising the secreted protein (HasA) and the three secretion proteins 
(HasD, HasE and HasF). It has been reported by Wolff  et. al. [40] that under various 
conditions the C-terminal region displays high flexibility and is a relatively 
unstructured part of the polypeptide chain.   
Without the secretion apparatus, SecB, the hemophore cannot be secreted 
from the cytoplasm. At the same time, SecB also prevents the folding of the 
hemophore and keeps it in a secretion-competent form prior to transport. [41]. 
Properly folded hemophore in the cytoplasm can pose a problem to the bacterium 
because not only it can prevent the secretion of newly synthesized hemophores, but it 
will also be able to take heme from other cytoplasmic heme proteins [39, 40, 42, 43]. 
Thus, the tight coregulation of genes encoding the hemophore and its secretion 
components is crucial [13]. 
Once the hemophore is transported to the extracellular milleu, apo-HasA 
captures free heme and “steals” the heme from heme containing proteins such as 
hemoglobin, myoglobin and hemopexin to deliver it to the specific surface receptor 
HasR by protein-protein interaction. According to Létoffé et. al., [44], it sequesters 
heme with its iron in redox states (FeII and FeIII). These authors proposed that the 
hemophore does not capture the heme from other heme containing protein by protein-
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protein interaction. This conclusion is based on the analytical ultracentrifugation 
experiments where they did not observed a stable complex between hemoglobin and 
HasASM. Thus, they concluded that there is passive transfer of heme from the heme 
containing protein to HasA [30] because of its high affinity for heme. It is probable 
that they were not able to see the HasASM-hemoglobin complex using analytical 
ultracentrifugation technique because the binding is weak and transient. Moreover, 
their results also suggest that the heme transfer is fast and it cannot be determined by 
the technique they use.  In this research work, we attempted to determine the weak 
HasAp-hemoglobin interaction at the molecular level. We also did experiments to 
determine whether apo-HasAp can take both ferrous and ferric heme-iron and 
measured the kinetics of fast heme transfer from hemoglobin to apo-HasAp. These 
experiments are discussed in detail in Chapters 3 and 4.  
The mechanism of heme transfer from the hemophore to its receptor is also 
not well understood because the affinity of HasA for heme is higher than that of HasR 
[45, 46]. The receptor can bind apo- and holo-HasA with the same affinity and at 
unique and overlapping sites [44]. Furthermore, HasR can also take up free heme or 
heme from hemoglobin. However, the HasA-HasR heme uptake is much more 
efficient than HasR alone because it can reduce by 100-fold the minimal hemoglobin 
concentrations required for bacterial growth. This observation also supports the fact 
that HasA functions extracellularly in a soluble form [30, 39].  
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Heme Internalization  
 
Only the heme but not the apo-protein can be internalized in the cell. The 
heme is too large to diffuse through the outer membrane, thus the translocation of 
heme across the outer membrane involves the interaction of the heme with a specific 
outer membrane receptor, in this case, HasR. The heme is then translocated from the 
outer membrane to the periplasm by an energy-dependent process which in most 
cases is TonB dependent and involves the formation of an ExbB-ExbD-HasB protein 
complex. In addition, this protein complex functions in both, the release of apo-HasA 
into the extracellular medium and in heme transport into the cytoplasm [15]. The 
heme is then transported from the periplasm to the cytoplasm by a specific 
periplasmic binding protein [17, 37].  
 
Heme Utilization 
 
Once in the cytoplasm, heme is delivered to heme oxygenase (HO). Heme 
oxygenase uses heme both as a substrate and a prosthetic group. It catalyzes the 
oxidative degradation of heme to biliverdin with the concomitant release of iron, and 
CO. The degradation of heme to biliverdin is shown in (Scheme 1) [47, 48]. This 
process involves three O2 molecules and seven electrons. In the case of Pseudomonas 
aeruginosa, the seven electrons are transported from NADPH to a ferredoxin 
reductase (pa-FPR), and then to a ferredoxin (pa-Bfd) which then delivers the 
electrons to a heme oxygenase (pa-HO) [49].  
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The mechanism of heme degradation by heme oxygenase starts with the 
reduction of the ferric iron to form oxyferrous complex (FeII-O2). The oxyferrous 
complex then accepts a proton and a second electron to form a ferric hydroperoxide 
intermediate. The ferric hydroperoxide species hydroxylates the heme α-meso-carbon 
to produce α-meso-hydroxyheme. A second O2 is used to oxidize the α-meso-
hydroxyheme to verdoheme with the concomitant release of CO. Finally the third O2 
molecule is inserted into the heme macrocycle, thereby cleaving the oxygen bridge to 
verdoheme. Then verdoheme is converted to biliverdin (BV) with the release of the 
heme-iron for subsequent metabolic use of the bacteria [16, 50].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1. Oxidative heme degradation catalyzed by heme oxygenase 
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Hemophores 
 
Hemophores, constitute an independent, highly conserved family of small 
extracellular heme-binding proteins that do not share homology with any other known 
proteins. It is thought that hemophores are secreted into the extracellular medium 
during the early stages of infection when the amount of hemoglobin available is very 
low to outcompete other bacteria for the very low concentration of available heme-
iron from the host animal [30].  Aside from Pseudomonas aeruginosa, the 
hemophore, HasA, has also been found in other gram-negative bacteria such as 
Serratia marcescens (HasASM) [16] which are responsible for urinary tract and wound 
infections in hospitals [51];  Pseudomonas fluorescens (HasAPF) [52] which are found 
in blood isolates of patients who received blood transfusion [53, 54];  and Yersinia 
pestis (HasAYP) [11] which is present in bacteria responsible for the bubonic, 
pneumonic and septicemic plague [55, 56].  The sequence alignments of HasA found 
in gram-negative bacteria are shown in Figure 3.   
Hemophores lack an N-terminus secretion signal but possess secretion signal 
in the C-terminus [57].  The C-terminus signal of the hemophore is composed of a 
negatively charged amino acid followed by several hydrophobic residues (Figure 3). 
HasAp contains the motif, D-L-A-L-A-A. While, HasASM, HasAPF and HasAYP have 
E-L-L-A-A, D-W-A-L-A-A, and D-M-L-L-A-A, C-terminal motifs, respectively. In 
the extracellular medium, the hemophore undergoes proteolytic C-terminal cleavages. 
The cleavage presumably occurred due to the extracellular proteases secreted by the 
bacteria.  HasAp undergoes  multiple  C-terminal  proteolytic  cleavage  by  removing  
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Figure 3. Amino acid sequence alignment of HasA proteins from Pseudomonas 
aeruginosa (HasAp), Serratia marcescens (HasASM), Pseudomonas fluorescens 
(HasAPF) and Yersinia pestis (HasAYP).  The alignment was done using ClustalX [58]. 
The conserved heme ligands are shown in red and the C-terminus secretion signals 
are shown in blue.  
 
 
15-21 amino acid residues (Figure 4). On the other hand, HasASM and HasAPF 
undergo only single C-terminal cleavage by removing the last 12, and 21 residues, 
respectively (Figure 4) [52, 59]. Moreover, there is no mentioned in the literature if 
HasAYF also undergoes C-terminal proteolytic cleavage. It was shown [30] that both  
uncleaved forms of HasAp and HasAPF could not deliver heme to HasRSM, but the 
cleaved form could. This shows that the extra amino acid residues at the C-terminus 
could have inhibited the heme transfer by steric hindrance thus preventing a direct 
HasAP 1 MSISISYSTTYSGWTVADYLADWSAYFGDVNHRPGQVVDGSNTGGFNPGP--FDGSQYALHasASM 1 MAFSVNYDSSFGGYSIHDYLGQWASTFGDVNHTNGN-VTDANSGGFYGGS--LSGSQYALHasAPF 1 MTISVSYEAALGAYSVSDYLTDWALGFNTAGHGS------SNTGGFSNGS--LSGDQYSTHasAYP 1 MSTTIQYNSNYADYSISSYLREWANNFGDIDQAP---AETKDRGSFSGSSTLFSGTQYAL
HasAP 59 K-STASDAAFIAGG----DLHYTLFS------NPSHTLWGKLDSIALGDTLTG--GASSGHasASM 58 SSTANQVTAFVAGG----NLTYTLFN------EPAHTLYGQLDSLSFGDGLSG--GDTSPHasAPF 53 HGANNSDYAFIADSNTSNGLHYVFNPALPASHNENHYLWGNLDNVQLGTGLGG--GNGSD  HasAYP 61 GSSHSNPEGMIAEG----DLKYSFMP--------QHTFHGQIDTLQFGKDLATNAGGPSA
HasAP 106 GYALDSQEVSFSNLGLDSPIAQG------RDG-TVHKVVYGLMSGDSSALQGQIDALLKAHasASM 106 –YSIQVPDVSFGGLNLSSLQAQG------HDG-VVHQVVYGLMSGDTGALETALNGILDDHasAPF 111 -FTLDAFKVAFNGLDLSAAQGAG------RVGNDVQNVIYSLMQGNTSALETVLNNLLDDHasAYP 106 GKHLEKIDITFNELDLSGEFDSGKSMTENHQG-DMHKSVRGLMKGNPDPMLEVMKAKGIN
HasAP 159 VDPSLSINSTFDQLAAAGVAHATPAAAAAEVGVVGVQELPHDLALAAHasASM 158 YG--LSVNSTFDQVAAATA--------------VGVQHADSPELLAAHasAPF 164 FG--LSTANTFDEISAGLAAHAT--ATTTDVALVGVQDVAQDWALAAHasAYP 165 VDTAFKDLSIASQYPDSGYMSDAP-----MVDTVGVVDC-HDMLLAA
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protein-protein  interaction  between HasRSM  and HasAp.  However, it cannot be 
determined which cleaved form of HasAp is biologically relevant [30]. In this 
research work, we also studied the difference between the full-length and truncated 
form of HasAp. This is discussed in Chapters 3 and 4.   
 
 
 
 
 
 
 
Figure 4.  The C-terminal proteolytic cleavage sites of HasAp, HasASM and HasAPF 
are indicated by red arrows. HasASM and HasAPF have only one cleavage site. HasAp 
has five cleavage sites.  
 
 
 
Structure of Hemophore 
 
The first hemophore identified is from the human pathogen, Serratia 
marcescens (HasASM).  HasASM shares 50% identity with HasAp. The X-ray crystal 
structure of holo HasASM has been elucidated (Figure 5) [60]. It is a monomeric 
globular protein that binds b heme with a stoichiometry of 1 [61].  The heme-iron is 
in the ferric form with a very low redox potential (-550 mV vs. standard hydrogen 
HasAPA 1 MSISISYSTT..........QLAAAGVAHATPAAAAAEVGVVGVQELPHDLALAA 205
HasASM 1 MAFSVNYDSS..........QVAAATA--------------VGVQHADSPELLAA 188
HasAPF 1 MTISVSYEAA..........EISAGLAAHAT--ATTTDVALVGVQDVAQDWALAA 206
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electrode). This low negative redox potential value suggests that reduction of the 
heme iron is not favorable at aerobic conditions and the heme is not buried within the 
heme pocket [61].  The fact that HasASM can take heme from other heme containing 
proteins suggests that it has a very high affinity for heme. The high heme affinity of 
the hemophore makes it very efficient in taking up heme from other heme-containing 
proteins in the extracellular medium. The affininity constant (Ka) of HasASM to heme 
is 5.2 (±1.5) x 1010 M-1 which is considered as one of the highest reported for heme 
proteins [62]. 
 
The X-ray crystal structure of holo-HasASM shows a unique alpha and beta 
fold. The four α-helices and the seven anti-parallel β-strands are packed on opposite 
sides. Two loops (L1 and L2) located at the interface of the α-helices and β-strands of 
the molecules hold the heme macrocycle [60, 63].  The heme prosthetic group is 
highly exposed to the solvent with an unusual His32-Tyr75 iron coordination (Figure 
5). His32 is located in loop L1 and Tyr75 is in loop L2.  The ferric iron is coordinated 
to the Nε of His32, while it is the Oη of Tyr75 that coordinates it at the other side. In 
addition, two crystal structures at pH 4.6 and 8.0 [36] revealed that the phenolate 
group of Tyr75 forms a hydrogen-bond with the Nδ of His83, another residue close to 
the heme pocket which further stabilizes the Tyr75Oη-Fe bond. This was also 
observed in NMR studies carried out with a gallium (III)-protoporphyrin IX 
(GaPPIX) derivative of HasASM to prevent the paramagnetic relaxation and resonance 
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shifts imparted by the heme-iron. His83Nδ1, which has a pKa of 9.7 stabilized the 
Tyr75 coordinating conformation via hydrogen-bond [44]. In contrast, the structure at  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.  X-ray crystal structure of HasA of Serratia marcescens (PDB ID. 1DKO) 
highlighting the elements of secondary structure. α-helices are shown in magenta, β-
sheets in yellow, loops in green, heme in red, and  the axial ligands His32, Tyr75 and 
alternate ligand, His83 in blue.  
 
 
pH 6.5 showed that there is no H-bond between Tyr75 and His83, instead the Nδ1 of 
His83 forms a hydrogen bond with a water molecule [45]. It has been shown by 
Létoffé and coworkers [44] that in the absence of Tyr75, His83 can serve as an 
alternate ligand. It can also be observed from the sequence alignment in Figure 3 of 
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the four hemophores that Tyr75 and His83 are conserved in proteins from four 
distinct bacteria. Thus, the unusual coordination and the flexibility of the heme 
binding site might give insights on the mechanisms of heme uptake and release. In an 
effort toward an understanding of this mechanism, in this research work we studied 
the heme coordination state and electronic structure of HasAp. This is discussed in 
Chapters 2 and 3.   
 
The NMR structure of apo-HasASM in solution (Figure 6B) display the same 
overall structure as that of the holo form except that loop L1 shows a wide 
conformational rearrangement relative to its position in the holo form as shown in 
Figure 6A [64]. That loop shows a 30 Å displacement of His32 in the apo form which 
suggests that apo-HasA is in an open conformation and it closes when it binds heme 
[64, 65]. This would imply that the upper loop (L1) is more flexible than the loop 
where Tyr75 and His83 are located. Furthermore, Wolff et. al. [64] carried out 15N 
relaxation measurements to study the backbone dynamics of both the apo and holo 
forms of HasASM. They used GaPPIX as the prosthetic group of the hemophore to 
overcome the paramagnetic relaxation induced by the heme iron. The results showed 
some interesting insights on the heme binding and release mechanisms of the 
hemophore. They have proposed that heme binding occurs via an induced-fit process 
via loop L1 and they proposed that the flexibility of loop L1 is the one directing the 
heme binding and release mechanism [64].  
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The dynamics of L1 are likely necessary to form the closed form of the holo 
hemophore [64]. The heme binds primarily by the coordination of His32 to the heme 
iron and also to the  Tyr75 ligand. In addition,  the  heme is also stabilized by  the two  
 
 
 
 
 
 
 
 
 
 
Figure 6.  Comparison of the (A) Crystal structure of Holo-HasASM (PDB ID. 
1DKO); and (B) NMR structure of apo-HasASM (PDB ID. 1YBJ) showing the 
elements of secondary structure. α-helices in red, β-sheet in blue, loops in yellow, 
heme in green and ligands in cyan. The apo-HasASM is in an “open” conformation 
and the holo form is in a “close” conformation.  
 
 
hydrogen bonds formed by His32 to Asn41 and Tyr137 located close to the heme 
pocket. Another two hydrogen bonds formed by His83, also contribute to the stability 
of the loops. Moreover, the propionate groups of the heme also interact to the 
H32
Y75
H83
H32
H83
Y75
(A)
(B)L1
L1
L2
L2
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polypeptide by several hydrogen-bonds. It has been postulated by Arnoux, et. al. [45] 
that the formation of these hydrogen-bonds and the “propionate zip” is an essential 
step in the heme uptake and release mechanism of the hemophore.  
 
Heme Uptake and Release Mechanisms of Hemophore 
Work addressing the role of the distal ligands on the heme uptake and release 
mechanism of the hemophore has been reported. Caillet-Saguy et. al. [66] reported 
that the 1H NMR spectrum of holo-HasASM shows that the heme has two sets of 
resonances in a 70:30 ratio. This suggests that there are two heme orientations along 
the α-γ meso axis. The 1H and 13C NMR resonances also revealed that there is a 
chemical equilibrium between high-spin (S = 5/2) and low-spin (S = 1/2) species in 
solution. At higher temperature, the high-spin species is more populated than the low- 
spin species. The heme-iron could be pentacoordinated or hexacoordinated with an 
exogenous weak field water ligand, thus the high-spin state is favored [66].  In this 
research work, we determine the coordination state of HasAp at different 
temperatures by 13C NMR spectroscopy as discussed in Chapter 3.   
 Deniau et. al. [62] constructed single, double, and triple mutants of the heme 
ligands of HasASM  to determine the role of these residues in heme binding using ITC. 
Interestingly, the mutation of the two axial ligands did not produce the same results 
on the heme binding affinity. The H32A and Y75A mutants resulted into a five-fold 
and 400-fold decrease in heme affinity, respectively.  The results suggest that Tyr75 
is a stronger ligand than His32. On the other hand, H83Q and H83A mutants gave 
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150-fold and 260-fold decrease in heme affinity, respectively. It has been observed 
that the axial ligands make a very uneven contribution to heme binding which could 
imply that Tyr75 is located in a more flexible loop than His32 [62]. This result is in 
contrast to the apo-HasASM NMR structure and to the dynamic study [64] which 
showed that His32 is located in a more flexible loop than Tyr75.  It can also be noted 
in this thermodynamic study that there is a much greater loss of heme affinity in 
His83A than in His32A HasASM mutants. Hence, His83 is important in heme binding 
even though it is not directly coordinated to the heme iron. Therefore, it has been 
concluded that the Tyr75/His83 pair has an important implication in the heme uptake 
and release mechanism.  
 On the other hand, Raman spectroscopic studies [67] of the wild type and 
single mutants CO-complexes revealed that the His32 ligand was displaced by CO 
instead of Tyr75 unlike some proteins with His/Tyr coordination states. This 
supported the thermodynamics study [62] that Tyr75 is a stronger ligand than His32. 
The absence of hydrogen bond between His32 and CO demonstrates that there is 
another bonding interaction in the heme pocket which stabilized His32. Thus, Lukat-
Rodgers et. al. [67], proposed that a similar dissociation state happen when heme is 
captured and delivered to the receptor.  
Deniau et. al. [62] also determined that the heme affinity of the cleaved 
(without 12 C-terminal residues) and the uncleaved forms of HasASM are the same.  
The affinity of HasA for heme is higher than that of HasR. It is interesting to note that 
HasA can transfer its heme to HasR, suggesting that this mechanism is driven by 
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direct protein-protein interaction. According to Létoffé et. al. [63], two independent 
β-strands, S51-T60 and G95-S107 of the HasASM are involved in the interaction with 
its cognate receptor. In addition, Caillet-Saguy et. al. [66] proposed that during 
HasASM-HasRSM binding, HasASM might become distorted in a way that the Tyr75-
His83 hydrogen bond is broken and consequently weakened the Fe-Tyr75 bond.  
The heme-iron in HasRSM is coordinated to two histidine ligands. 
Interestingly, mutation of the two histidines abolished the heme binding and heme 
transport, but did not affect HasASM binding. Thus, it is concluded that the heme 
transfer from the hemophore to its receptor is not only driven by direct protein-
protein interaction, but also depends on the bis-histine ligands of the receptor [46].   
 
 
 
 
RESEARCH PROBLEM AND RATIONALE 
 Iron is an important nutrient for the opportunistic pathogen, Pseudomonas  
aeruginosa to efficiently colonize and infect a host animal [68, 69]. The poor 
bioavailability of iron in the host animal, however, presents a major problem. It is 
believed that in the early stages of infection when the iron concentration is very low, 
the heme acquisition system (has) available is activated and the hemophore, HasAp, 
is released into the extracellular medium to “steal” heme from heme containing 
proteins. A sensible way to prevent the colonization of the bacteria is to try to stop it 
in the early stages of infection before the host’s immune system is weakened. 
Moreover, preventing heme-iron acquisition of the bacteria is important to stop 
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infection in the host animal. Insights gained on the understanding of the mechanism 
of how HasAp scavenge heme from heme proteins would provide opportunities to 
design drugs to inhibit the heme acquisition at the early stages of infection and 
thereby controlling the diseases associated with this pathogenic bacteria. Studying the 
structure-function relationship of this protein would also serve to understand the 
hemophores in general.  Although the hemophore from Serratia marcescens has been 
structurally and biochemically characterized, there are still several questions that need 
to be addressed especially on the context of the mechanism of heme uptake.  
 In this context, this research work is aimed towards an understanding of the 
structure-function of the hemophore from Pseudomonas aeruginosa. The mechanism 
by which HasAp “steal” heme from other heme proteins is not known. Elucidation of 
this mechanism would entail studying the coordination state and electronic structure 
of the heme active site. One method that can be used to study the heme active site is 
13C NMR spectroscopy coupled with the biosynthetic preparation of 13C-labeled heme 
to overcome the low natural abundance of 13C [70, 71]. In Chapter 2, we developed a 
13C NMR spectroscopic method to differentiate the coordination state of high spin (S 
= 5/2) heme complex. Wild type sperm whale myoglobin and its H64V mutant were 
used as the   hexa- and pentacoordinate high spin (S = 5/2) model heme complexes. 
The results showed that the magnitude of the 13C chemical shifts of the core heme 
carbons can be employed as a simple diagnostic tool to determine the coordination 
state of the heme active sites, irregardless of the nature of the axial ligands. This 
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method was also used to determine the coordination state of a protein ShuT, a protein 
from Shigella dysenteriae.  
In Chapter 3, this method was applied to determine the coordination state and 
electronic structure of the HasAp protein, along with other spectroscopic techniques, 
such as electronic absorption spectroscopy, and electron paramagnetic resonance 
(EPR). In addition, we did preliminary investigation by electronic absorption 
spectroscopy to determine if HasAp can capture heme regardless of the iron oxidation 
state through passive diffusion as reported for the HasASM. The rate of heme transfer 
from hemoglobin to HasAp was measured by stopped-flow spectroscopy. This 
chapter also reports the X-ray crystal structure of the truncated holo HasAp (without 
21 C-terminal residues). Chapter 3 also reports the backbone amide assignments of 
the holo full-length and truncated HasAp as well as the truncated apo-HasAp by 
NMR. This was done by using triple resonance experiments and amino acid selective 
labeling of some residues affected by the paramagnetic relaxation of the heme-iron. 
Secondary structure assignments of the holo-HasAp full-length and truncated proteins 
were assigned using a combination of X-ray crystallography and NMR spectroscopy 
data.  In addition, the difference between the apo and holo truncated HasAp was also 
determined.  To probe the location of the tail in the structure in solution, 1H-1H NOE 
connectivities from the tail to the nearby residues were determined using 3D NOESY-
HSQC NMR experiment. Conformational dynamics study of the holo truncated 
HasAp studied using the amide hydrogen-deuterium exchange experiment monitored 
by NMR is also presented in this chapter.   
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Chapter 4 describes the attempts to study the protein-protein interaction of 
HasAp and hemoglobin at the molecular level using the chemical shift perturbation 
analysis by NMR and by mapping of the binding interactions in the X-ray structure of 
HasAp.  
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CHAPTER 2 
13C NMR Spectroscopy of Core Heme Carbons as a Simple Tool to 
Elucicate the Coordination State of Ferric High-Spin Heme Proteins   
 
INTRODUCTION 
 
Rapid elucidation of the coordination and spin state is desirable because the 
advent of genomics and proteomics has brought about the discovery of new and 
interesting heme proteins. Many of these new proteins are thought to act as heme 
transporter, heme degrading, or heme storage proteins and enzymes [1-4].  Detailed 
understanding of how these proteins acquire heme, bind it tightly, or pass it on to 
another protein, often starts with an understanding of the heme coordination state and 
heme electronic structure. Novel heme proteins exhibiting a high-spin state can be 
either five-coordinate, with only one protein-provided axial ligand, or six-coordinate, 
with one strong-field axial ligand and a weak-field sixth ligand that can be protein 
provided or exogenous.  
Spectroscopic elucidation of the coordination state of high-spin heme proteins 
as five- or six-coordinate is not straightforward. In this context, it is noteworthy that 
recent studies have shown that the study of core porphyrin carbon chemical shifts is a 
powerful approach to determine the electronic structure of model ferrihemes [5-11] 
and heme active sites [11-14]. Observation and assignment of core porphyrin carbons 
can be more challenging than the observation and assignment of their protonated 
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counterparts because the proximity of core carbons to the heme iron makes their 
resonances more strongly affected by the unpaired electron. Nevertheless, efforts to 
detect, assign, and interpret core porphyrin carbon chemical shifts can be highly 
rewarding because relatively straightforward correlations permit one to gain valuable 
insights into the coordination state and electronic structure of ferrihemes [12, 15]. In 
this report, we demonstrate that detection of core porphyrin carbon resonances from 
high-spin ferriheme active sites can be made in a relatively straightforward manner 
and the magnitude of these shifts lead to unambiguous determination of the 
coordination state.  
It has been known for quite some time that the most striking difference in the 
1H NMR spectra of five- and six-coordinate high-spin ferrihemes is the reversal in 
sign of the meso-H isotropic shift [16-18]. Thus, 6-coordinate ferrihemes exhibit 
meso-H resonances near 40 ppm, whereas the equivalent resonances in 5-coordinate 
ferrihemes occur near -25 ppm. The molecular orbital properties underlying this sign 
reversal brought about by heme coordination state are now fully understood [19] 
(discussed below). However, it is important to appreciate that perhaps the most 
important reason that this phenomenon has not been utilized to differentiate five- and 
six-coordinate high-spin ferriheme centers in proteins and enzymes is the extreme 
breadth of the meso-H resonances. This is illustrated in Figure 1 which allows 
comparison of the 1H NMR spectrum of wild-type met sperm-whale myoglobin (sw-
Mb) (Figure 1A) and that obtained from the corresponding H64V mutant (Figure 1B). 
In  the ferric oxidation state, the  heme iron of met-sw-Mb is six-coordinate high-spin,  
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Figure 1.  1H NMR spectra of hexacoordinate, wild-type sperm whale myoglobin (A) 
and pentacoordinate H64V sperm-whale myoglobin (B). The resonance assignments 
were obtained from ref. 17. Note the broad line width and consequent low intensity of 
the meso-H resonance in A. The corresponding resonance in B is buried under the 
methyl group of Val E11.  
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with proximal histidine (His-93) and a distal H2O serving as axial ligands [17].  The 
distal H2O ligand in Mb is hydrogen bonded to the Nε atom of the distal histidine 
(His64); disruption of this hydrogen bond by the replacement of His-64 for Val 
results in a five-coordinate high-spin met-Mb (H64V-sw-Mb) devoid of the sixth H2O 
ligand [20, 21].  
La Mar and coworkers demonstrated that the meso-H resonce in the 1H NMR 
spectrum of the H64V mutant (Figure 1B) is buried under the methyl resonance 
originating from Val E11, near -29 ppm. In comparison, the meso-H signal in the six- 
coordinate wild-type sw-Mb resonates near 40 ppm (Figure 1A). It is important to 
point out, however, that it is not trivial to assign meso-H resonances from high-spin 
ferrihemes because of the fast relaxation properties typical of S = 5/2 ferrihemes. 
Hence, although the magnitude of the meso-H shift is indicative of the coordination 
state in high-spin ferrihemes, the challenges associated with the assignment of very 
broad meso-H resonances render this approach impractical as an efficient method to 
establish coordination state. In this context, it is well-known that the relaxation rates 
of resonances affected by a paramagnetic center scale with the square of the 
magnitude of the gyromagnetic ratio [22, 23]. Hence, the effect of paramagnetism on 
13C relaxation is reduced ~16-fold with respect to 1H, which results in narrower and 
therefore more readily observable 13C resonances. We capitalized on this physical 
property to demonstrate that meso-carbon resonances from heme proteins are readily 
detected, thus providing a relatively straightforward spectroscopic diagnosis of the 
coordination state of high-spin ferric heme active sites. 
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EXPERIMENTAL PROCEDURES 
 
 
General Methods  
 
The recombinant pET29a plasmid harboring a gene coding for wild-type 
sperm whale myoglobin was a generous gift from Dr. Mark Hargrove, Iowa State 
University. The corresponding H64V mutation was carried out using the polymerase 
chain reaction (PCR) and the Quickchange Mutagenesis Kit from Stratagene (La 
Jolla, CA). Oligonucleotides were synthesized at the Biotechnology Support Facility, 
University of Kansas Medical Center and used without further purification. The 
mutagenic primers designed to introduce the H64V mutation are 5' – 
GCTTCTGAAGATCTGAAAAAAGTTGGTGTTACCGTGTTAACTGCC- 3' and  
5' – GGCAGTTAACACGGTAACACCAACTTTTTTCAGATCTTCAGAAGC -3'.  
The underlined codons represent mismatches introduced to generate the mutations. 
The recombinant construct was transformed into Escherichia coli XL1-Blue 
supercompetent cells for amplification. Once the mutation has been confirmed by 
sequencing, the recombinant DNA plasmid was transformed into Escherichia coli  
BL21 (DE3) GOLD cells for subsequent protein expression.  
 
 
Expression and Purification of Wild-Type and Mutant Sperm Whale Mb Proteins 
 
E. coli BL21(DE3)GOLD cells (Stratagene, La Jolla, CA) were used as the 
protein expression host. A single colony of freshly transformed cells was cultured 
overnight in 10 mL of Luria Bertani (LB) medium containing 50 μg/mL kanamycin. 
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The cells were subsequently subcultured into fresh 1 L LB-kanamycin medium and 
grown at 37 °C with continuous shaking at 225 rpm. Once the cell culture reached an 
optical density of 1.0, expression was induced by addition of isopropyl-β-D-
thiogalactopyranose (IPTG) to a final concentration of 1 mM. Approximately 10 min 
after induction of protein synthesis, 17 mg of δ-aminolevulinic acid (ALA) and 100 
mg of FeSO4•7H2O were added to each liter of cell culture. The cells were grown for 
an additional of 4-5 h at 30 °C and harvested by centrifugation. The harvested cells 
were resuspended and lysed and the soluble protein fraction was recovered using 
previously described protocols [24]. Ammonium sulfate was added to the supernatant 
(60% saturation, 2.4 M), and the resultant mixture was centrifuged at 23 500 rpm for 
1 h. The supernatant was recovered and treated with 20 mM Tris buffer (pH 8.0) to 
bring the concentration of ammonium sulfate to 1.9 M. The resultant solution was 
loaded onto a phenyl Sepharose column (2.6 cm i.d. x 30 cm length) pre-equilibrated 
with 1.9 M ammonium sulfate in 20 mM Tris buffer (pH 8.0) and eluted with a 
solution of 0.9 M ammonium sulfate in 20 mM Tris buffer (pH 8.0).  Fractions with 
an absorbance ratio (A280/A410) and (A280/A395) of <1.0 for wild type and H64V 
mutant, respectively were pooled, dialyzed extensively against phosphate buffer (μ= 
0.10, pH 6.0) at 4 °C, concentrated by ultrafiltration, and loaded onto Sephadex G-50 
column (2.6  cm i.d. x 90 cm length). Fractions with an absorbance ratio (A280/ASoret) 
of <0.5 were pooled and concentrated by ultrafiltration. Heme from Mb was extracted 
using Teale’s method [25] to make apo-protein. The apo-Mb proteins were stored at   
-80 °C.  
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Expression and Purification of ShuT 
 
The recently discovered heme protein from Shigella dysenteriae (ShuT) was 
expressed and purified as previously described [2]. Briefly, a 100 mL subculture of E. 
coli BL21 (DE3) plysS harboring pETShuT in LB-ampicillin (OD600 = 0.6) was used 
to inoculate 1 L cultures to an OD600 of 0.06. The cells were grown to an OD600 of 
0.6-0.8 and induced with 1 mM isopropyl-β-D-thiogalactopyranose (IPTG); then, 
they were grown for an additional 4 h at 30 °C. The cells were harvested by 
centrifugation for 20 min at 6000 g in a Beckman JA-20 rotor. The cells were lysed at 
4 °C by stirring in 50 mM sodium phosphate (pH 8.0) containing 100 mg of 
lysozyme/100 mL of cell lysate, 0.2 mM PMSF, and a protease inhibitor cocktail 
(Roche Diagnostics GmBH).  
The periplasmic fraction was isolated by centrifugation at 3000 g for 30 min, 
and the resulting supernatant was again centrifuged at 6800 g for 30 min. the clarified 
solution was applied to an Ni-NTA agarose column (1 x 10 cm), and the protein was 
eluted in 20 mM Tris-HCl (pH 7.8) containing 250 mM imidazole and 300 mM NaCl, 
following previous wash steps (20 column volumes) in the same buffer containing 20 
mM imidazole. The peak fractions, as judged by SDS-page, were pooled and dialyzed 
in 20 mM Tris-HCl (pH 7.5), concentrated to 10 mg/mL, and stored at -80 °C. 
 
 
Preparation of Mb and ShuT Samples Reconstituted with 13C-Labeled Heme  
  
13C-labeled δ-aminolevulinic acid (ALA) were prepared using a previously 
reported methodology [26] and were used as precursors for the biosynthetic 
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preparation of 13C-labeled protoheme IX (heme) [12, 24, 27].  [5-13C]-ALA was used 
to label heme at the meso (Cm) and α-pyrrole (Cα) positions, and [4-13C]-ALA was 
used to label heme at the Cα and β pyrrole (Cβ) carbons (see Figure 2). 13C labeled 
heme  is  prepared  by  capitalizing on the  fact  that  the first committed  precursor  in  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.   Heme labeled at the Cα and Cβ positions was obtained using [4-13C]-ALA 
as a precursor and heme labeled at the Cα and Cm positions was obtained from         
[5-13C]-ALA.  
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heme biosynthesis is δ-aminolevulinic acid (ALA) [28, 29].  Hence, 13C-labeled heme 
is biosynthesized in E. coli upon the addition of suitably 13C-labeled ALA and 
trapped in the outer mitochondrial membrane cytochrome b5 (OM cyt b5) which is 
overexpressed in the bacterial host. The details of the biosynthetic protocol, which 
entails the expression and purification of OM cyt b5  harboring 13C-labeled heme, 
have been presented previously [24]. Reconstitution of the target protein with 13C-
labeled heme entails the removal of isotopically labeled macrocycle from OM cyt b5, 
followed by the formation of the heme-target protein complex. 13C-labeled heme is 
extracted from OM cyt b5 with the methods reported previously [12, 30, 31]. In short, 
the addition of 15 mL of pyridine to 2.5 mL of 1 mM OM cyt b5 in phosphate buffer 
(μ = 0.10, pH 7.0), followed by the slow addition of chloroform, typically 10-15 mL, 
results in the precipitation of the polypeptide, leaving the pyridine hemochrome in 
solution.  The latter is separated from the denatured polypeptide by centrifugation, 
allowed to equilibrate at room temperature, and then dried over anhydrous MgSO4. 
The desiccant is separated by filtration, and the filtered pyridine/chloroform solution 
transferred to a round-bottom flask, where it is concentrated to dryness on a rotary 
evaporator. The solid is redissolved in 1.5 mL of DMSO, and the resultant solution is 
immediately used to reconstitute the target protein. In this study, ~2 μmol of Mb, 
H64V Mb or ShuT was reconstituted with a freshly prepared solution of 13C-labeled 
heme until the A280/ASoret ratio no longer changed. The resultant solution was 
incubated at 4 °C overnight and then purified by size exclusion chromatography at the 
same temperature. The Mb-13C-labeled heme complexes were purified in a Sephadex 
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G50 column (2.6 cm i.d. x 90 cm length), equilibrated and eluted with 10 mM 
phosphate buffer (pH 6.0). The ShuT-13C labeled heme complex was purified in a 
Sephacryl S-100 column (2.6 cm i.d. x 90 cm length) also equilibrated and eluted 
with 10 mM phosphate buffer (pH 8.0). Fractions containing pure protein were 
concentrated in Amicon centrifugal concentrators to ~1 mL and transferred to smaller 
Centricon concentrators to exchange protein into deuterated buffer.  
 
NMR Spectroscopy 
 
1H and 13C spectra were acquired on a Varian Unity Inova spectrometer 
operating at a 599.74 MHz 1H frequency and a 150.92 MHz 13C frequency. The 1H 
spectra were referenced to a residual water peak at 4.8 ppm and the 13C spectra were 
referenced to an external solution of dioxane (60% v/v in D20) at 66.66 ppm. Proton 
spectra were acquired with presaturation of the residual water peak over 49 k data 
points, a spectral width of 125 kHz, a 200 ms acquisition time, no relaxation delay, 
and 1024 scans. The acquisition parameters used to obtain 13C NMR spectra were 
given in the appropriate figure captions.  
 
 
 
RESULTS AND DISCUSSION 
 
 
Chemical Shift Characteristics of the High-Spin Core Heme Carbons 
 
Wild type sperm whale Mb was reconstituted with hemin labeled with 13C at 
the Cα and Cβ positions (insert of Figure 3A) and with hemin labeled at the Cα and Cm  
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Figure 3.  13C NMR spectra of wild type sperm whale myoglobin, pH 6.0, 
reconstituted with (A) heme labeled at the Cα and Cβ positions and (B) heme labeled 
at the Cα and Cm positions. The spectra were obtained at 30 °C over 213 kHz, with 
100 ms acquisition time, 20 ms relaxation delay, and 450 000 scans. 
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positions (insert of Figure 3B). The 13C NMR spectrum in Figure 3A displays the 
paramagnetically  affected  resonances  between  1100  and  1500  ppm,  whereas  the                               
spectrum in Figure 3B shows a set of peaks centered near 1500 ppm and a second set 
of resonances (enclosed in a box) near -80 ppm. The 13C labeling patterns in Figure 
3A and B have in common the isotopic enrichment of Cα.  It is therefore 
straightforward to conclude that resonances centered near 1500 ppm originate from 
Cα, resonances centered at ~1200 ppm originate from Cβ and resonances near -80 
ppm correspond to meso carbons.  
A similar set of experiments was conducted with the H64V mutant, which is 
know to be pentacoordinated and high-spin [20, 21]. The spectrum shown in Figure 
4A, obtained from a sample of H64V Mb reconstituted with heme labeled at the Cα 
and Cβ positions, was acquired with a spectral window covering from -200 to 1200 
ppm. This spectrum shows two sets of peaks originating from the heme: one near 800 
ppm and the second at ~1000  ppm. The spectrum of H64V sw-Mb reconstituted with 
heme labeled at the Cα and Cm positions is shown in Figure 4B. In this spectrum, 
which was acquired with a spectral window covering from -200 to 1200 ppm, a set of 
peaks (enclosed in a box) centered near 250 ppm is apparent. However, when the 
spectrum was acquired using the same sample with a smaller spectral window (700-
1400 ppm), a set of broad peaks centered near 1000 ppm became evident. These 
observations permit the straightforward assignment of the resonances at ~800 ppm to 
Cβ , those near 1000 ppm to Cα , and the ones near 250 ppm to Cm.  
The  above-described  observations  indicate that hexa-  and  pentacoordinated                      
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Figure 4.  13C NMR spectra of the H64V mutant of sperm whale myoglobin at pH 6.0 
reconstituted with (A) heme labeled at the Cα and Cβ positions and (B) heme labeled 
at the Cα  and Cm positions. The spectra were obtained at 30 °C over 213 kHz, with 
100 ms acquisition time, 20 ms relaxation delay, and 450 000 scans.  
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Mb’s exhibit distinct differences in the chemical shifts of their corresponding core 
carbons. Among these differences, those corresponding to Cm shifts stand out: Cm 
resonances from hexacoordinated Mb are centered at approximately -80 ppm (Figure 
5A), whereas, the Cm resonances from pentacoordinated H64V sw-Mb occur near 250 
ppm (Figure 5B). We propose that these chemical shift differences can be used as a 
diagnostic tool for the relatively straightforward determination of the coordination 
state of high-spin heme proteins. Two important properties make this approach 
readily applicable to this task: (i) Cm resonances from penta- and hexacoordinated 
heme active sites are relatively sharp and resonate relatively close to the typical 
diamagnetic range of 13C resonances, which accounts for their relatively simple 
detection. This is in stark contrast with the difficult detection and assignment of the 
corresponding meso-1H resonances, as has been illustrated in Figure 1. (ii) The 
electronic properties that give rise to the distinct Cm shifts are now well understood 
[19] and therefore provide a firm basis for consistent correlations between Cm shifts 
and heme coordination state. In short, five-coordinate ferrihemes place the metal out 
of the porphyrin plane, whereas in six-coordinate ferrihemes, the metal sits within the 
porphyrin plane. In high-spin ferrihemes (five- or six-coordinate), spin delocalization 
through σ-bonding interactions with the iron dx2-y2 orbital is dominant [19] and results 
in very high spin densities at the Cα and Cβ positions and therefore in large downfield 
Cα    and    Cβ   shifts  [32, 33]   (Figures 3  and  4).    In    addition,   the   out-of-plane 
displacement of the metal in five-coordinate ferrihemes promotes interactions 
between the metal dz2 orbital  and the porphyrin  a2u obital that are not possible in six- 
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Figure 5.  13C NMR spectra demonstrating the difference in the magnitude of meso-
carbon chemical shifts obtained from (A) hexacoordinate high-spin sw-Mb and (B) 
pentacoordinate high-spin H64V-sw-Mb. The spectra were obtained at 30 °C over 84 
kHz, with 100 ms acquisition time, 20 ms relaxation delay, and 110 000 scans. 
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coordinate high-spin ferrihemes [19]. These orbital interactions in five-coordinate 
ferrihemes allow delocalization of spin density from the porphyrin a2u orbital into the 
metal dz2 orbital, thus placing positive unpaired electron density at Cm, which results 
in downfield Cm shifts. In this context, it is noteworthy that the Cm positions are 
located at the nodes of the σ-bonding system and therefore are insulated from direct 
σ-delocalization. Hence, interactions between the dz2 and a2u orbitals in five-
coordinate ferrihemes result in positive spin density at the meso positions and 
therefore downfield shifts ranging from 250 to 600 ppm (Figure 5B). In contrast, the 
placement of the iron in porphyrin plane in six coordinate ferrihemes prevents similar 
orbital interactions, thus leaving the Cm positions insulated from direct spin 
delocalization. The negative Cm shifts, -30 to -100 ppm (Figure 5A), are therefore a 
consequence of polarization from large spin density at the Cα position, which places 
negative spin density at the meso carbons.  
Results from the DFT calculations also suggest that the porphyrin to iron-dπ 
(dxz and dyz) spin delocalization is more efficient in six- than in five-coordinate 
ferrihemes [33]. This phenomenon should be manifested in larger Cα and Cβ shifts in 
six-coordinate complexes relative to the equivalent shifts in their five-coordinate 
counterparts. Indeed, spectra obtained from the six-coordinate Mb and from the five-
coordinate H64V Mb (Figures 3 and  4) show that the Cα and Cβ  shifts corresponding 
to Mb are larger than those obtained from the the H64V mutant. This would suggest 
that the relative magnitude of the Cα and Cβ  shifts can be used to determine the 
coordination state of a ferriheme in an active site. However, the large chemical shifts 
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and broader lines of the Cα and Cβ  shifts makes this approach less practical than 
simply measuring the magnitude of the Cm shifts, which are significantly easier to 
observe. In the following discussion, we apply this concept to the determination of 
the coordination state of a recently discovered heme protein implicated in the heme 
uptake system of S. dysenteriae (ShuT) [2].  
 
13C NMR Analysis of the Coordination State of the Heme in ShuT.  
ShuT is a 28.5 kDa monomeric periplasmic heme protein thought to be 
involved in transporting exogenously acquired heme across the periplasm of S. 
dysenteriae [4]. Exhaustive mutagenesis and spectroscopic (MCD and resonance 
Raman) studies have suggested that the ferriheme center in ShuT is five-coordinate, 
with Tyr-94 serving as the axial ligand [2]. We have used this recently discovered 
protein to illustrate the simplicity with which the coordination state of high-spin heme 
proteins can be elucidated using 13C NMR spectroscopy. 
 A sample of ShuT was purified to homogeneity as described in the 
Experimental Methods. After purification, the sample of ShuT consisted of a mixture 
of molecules with and without heme in an approximate 1:1 ratio. A solution 
containing heme labeled at the meso carbons was added to a solution of ShuT to 
reconstitute labeled heme into those molecules devoid of heme. The resultant solution 
was  purified  from excess  free  heme  and  then  concentrated  for  subsequent  NMR 
analysis. A set of Cm resonances centered near 350 ppm in the 13C NMR spectrum of 
this  protein (Figure 6)  demonstrates that  ShuT harbors a five-coordinate ferric heme  
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Figure 6. 13C NMR spectrum of ShuT at pH 8.0 reconstituted with heme labeled at 
the Cα and Cm positions. The Cm chemical shifts centered at ~350 ppm 
unambiguously demonstrate that the ferriheme center in ShuT is pentacoordinate and 
high-spin. The spectrum was obtained with the aid of a cryoprobe in a Bruker 
instrument operating at 125.76 MHz (13C-frequency) and 30 °C over 88 kHz, with 
100 ms acquisition time, 20 ms relaxation delay, and 50 000 scans.  
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center. The spectrum was obtained in ~2 h from a 250 μL solution (2.0 mM) of ShuT 
using a cryoprobe. The relatively short analysis time required for the ShuT sample, 
which was labeled with 13C heme to approximately a 50% enrichment level, 
underscores the simplicity and the potential of utilizing the Cm shift in the 
determination of coordination state of ferric heme centers in novel proteins. In 
comparison, spectroscopic methods commonly used to determine the coordination 
state of high-spin ferriproteins (MCD and resonance Raman) rely strongly on the 
availability of suitable model complexes for assignment and interpretation of the 
pertinent signals [2]. 
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CHAPTER 3 
Structural and Spectroscopic Characterization of HasAp  
 
INTRODUCTION 
 
 
Many pathogenic bacteria have evolved specific heme uptake systems to 
acquire heme-iron from mammalian hosts. Heme uptake and utilization is a 
mechanism utilized by some pathogenic bacteria to overcome the highly restricted 
iron conditions encountered in the process of colonizing a mammalian host. Some 
pathogenic bacteria, such as the opportunistic bacteria, Pseudomonas aeruginosa are 
thought to overcome these challenging conditions by deploying multiple systems for 
iron uptake that are regulated by Fur, the Fe uptake regulator [1]. These include the 
secretion of siderophores to bind and uptake Fe3+ via specific receptors [2, 3]. When 
iron is limited more severely, however, the global iron response associated with Fur-
regulated genes includes the heme uptake systems phu (Pseudomonas heme uptake) 
and has (heme acquisition system). The phu locus consists of a receptor gene (phuR) 
and the phuSTUVW operon encoding a typical ABC transporter. The second uptake 
system, has, consists of a heme receptor (hasR) and a protein that binds heme with 
high affinity, also known as the hemophore, HasAp [2]. In fact, it is thought that in 
the early stages of infection, before inflammation and damage ensues, the very low 
concentration of hemoglobin is overcome by the secretion of hemophores, which can 
“steal” heme from hemoglobin for subsequent delivery to HasR previous to 
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internalization. Once internalized to the cytoplasm heme is delivered to a heme 
oxygenase (pa-HO) for its degradation to biliverdin, thus facilitating release of the 
heme-iron for subsequent metabolic use [4]. 
To date, the only structurally characterized hemophore is that of Serratia 
marcescens (HasASM), which captures heme and delivers it to the receptor HasRSM 
[5]. In this organism HasRSM alone is able to take heme from hemoglobin but 
synergism with HasASM increases the efficiency of heme uptake from hemoglobin at 
least 100-fold [6]. A gene encoding a similar protein (HasAp) in P. aeruginosa is 
upregulated under iron-limiting conditions [7]. HasAp, which shares approximately 
50% identity with HasASM, is essential for P. aeruginosa uptake and utilization of 
hemoglobin iron [7]. Amino acid sequence alignment of HasAp and HasASM is shown 
in Figure 1. Like HasASM, HasAp is secreted to the extracellular milieu where it 
undergoes C-terminal proteolytic cleavage [8], presumably by proteases also secreted 
by P. aeruginosa. However, whereas the growth of HasASM mutants can be 
sufficiently rescued by addition of full-length or cleaved forms of the S. marcescens 
HasA to media where the only source of iron is hemoglobin, the growth of P. 
aeruginosa HasAp mutants can only be rescued by addition of truncated HasAp when 
hemoglobin is the sole source of iron [7]. These observations suggest that proteolytic 
cleavage of HasAp is important to activate this protein for heme uptake. In this 
context, it is also important to note that expression of most virulence factors in P. 
aeruginosa is not constitutive but is regulated in a cell density-dependent manner, i. e. 
quorum-sensing.  This ensures that P. aeruginosa does not  express  pathogenic  traits 
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Figure 1.  Amino acid sequence alignment of HasA in Pseudomonas aeruginosa 
(HasAp) (A) and Serratia marcescens (HasASM) (B). Identical residues are shown in 
red. This alignment was prepared using ClustalW [9].  
 
 
until the population has reached the critical density necessary to overwhelm the host 
defenses and establish an infection. It is therefore significant that a recent proteomics 
study revealed that among quorum-sensing regulated proteins in P. aeruginosa, 
several are involved in iron utilization, thus suggesting a link between quorum-
sensing and the iron regulatory system [8]. Two of the up-regulatred proteins are the 
receptor phuR and the hemophore HasAp, which are components of each of the two 
heme uptake systems in P. aeruginosa (phu and has). Consequently, these 
observations indicate that hemoglobin utilization is one of the phenotypes controlled 
through quorum-sensing [8]. The same authors reported that a mass spectrometric 
proteomics analysis of the wild type P. aeruginosa (strain PAO1) revealed that the 
most abundant form of secreted HasAp is the processed form (wild type minus 21 
HasAp 1 MSISISYSTTYSGWTVADYLADWSAYFGDVNHRPGQVVDGSNTGGFNPGPFDGSQYALKSHasASM 1 MAFSVNYDSSFGGYSIHDYLGQWASTFGDVNHTNGNVTD-ANSGGFYGGSLSGSQYAISS
HasAP 61 TASDA-AFIAGGDLHYTLFSNPSHTLWGKLDSIALGDTLTGGASSGGYALDSQEVSFSNLHasASM 60 TANQVTAFVAGGNLTYTLFNEPAHTLYGQLDSLSFGDGLSGGDTSP-YSIQVPDVSFGGL
HasAP 120 GLDSPIAQGRDGTVHKVVYGLMSGDSSALQGQIDALLKAVDPSLSINSTFDQLAAA---G
HasASM 119 NLSSLQAQGHDGVVHQVVYGLMSGDTGALETALNGILD- -DYGLSVNSTFDQVAAATAVG
HasAP 177 VAHA-TPAAAAAEVGVVGVQELPHDLALAAHasASM 177 VQHADSPELLAA
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amino acids). The multiple C-terminal cleavage sites of HasAp are shown in Figure 2. 
In contrast, similar analyses of quorum-sensing impaired mutants indicate that the 
most abundant form of HasAp is the full-length protein [8].  
 
 
 
 
 
 
 
 
Figure 2.  Multiple C-terminal cleavage sites of HasAp as indicated by the arrows.   
 
 
Moreover, quorum-sensing impaired mutants show significantly reduced 
growth relative to wild type P. aeruginosa PAO1 in medium containing hemoglobin 
as the only source of iron. Growth, however, is rescued by supplementation with the 
quorum-sensing signal molecule N-acyl homoserine lactone (AHL), which indicates 
that the ability to utilize hemoglobin in P. aeruginosa is quorum-sensing controlled. It 
is therefore clear that genetic and proteomic studies converge on the idea that HasAp 
must be processed to function properly. These findings are significant because they 
indicate that production of functional (truncated) HasAp by P. aeruginosa is quorum- 
MSISISYSTTYS………..AAAAAEVGVVGVQELPHDLALAA
1 205
a
b  
c
d
e
15 residues
18 residues
19 residues
20 residues
21 residues
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sensing regulated [8]. These observations indicate that efforts aimed toward a 
molecular level understanding of hemoglobin utilization by the opportunistic P. 
aeruginosa should include the structural and biochemical characterization of the full-
length and proteolyzed (truncated) forms of HasAp. In this work we have undertaken 
this task as a stepping stone to enhance current understanding of how this resilient 
microorganism can overcome the challenging low levels of iron encountered in the 
early stages of colonization (infection). An understanding of hemophore and 
hemoglobin interaction could give insights on the mechanism of heme uptake.  
Analytical centrifugations methods were used to investigate the formation of a 
complex between HasASM and hemoglobin [5]. These investigations led to the 
conclusion that a stable complex is not formed, although the formation of a transient 
complex could not be ruled out. Nevertheless, it was postulated that heme capture by 
HasASM is thought to occur by passive transfer from hemoglobin to the hemophore, 
rather than by protein-protein interactions [5]. In this investigations leading to this 
report we used electronic absorption spectroscopy to assess the timescale of heme 
transfer. Secreted full-length HasAp is a 205 amino acid protein. Proteases also 
secreted by P. aeruginosa cleave its carboxy terminus at five different sites. It has 
been shown that the most abundant form of HasAp observed in the secretome of 
quorum-sensing impaired mutants of P. aeruginosa is the full-length protein. In 
contrast, the cleaved forms are more abundant in the secretome of wild type PAO1, 
with the most abundant form being that cleaved between residues 184 and 185 (full-
length minus 21 C-terminal residues). Hence full-length HasAp and the species 
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consisting only of 184 residues, hereafter referred to as truncated HasAp, are the 
subjects of these studies. In this study, we attempt to understand the heme uptake and 
release mechanism of HasAp by using various techniques. This was primarily 
accomplished by elucidating the structure of HasAp both by X-ray crystallography 
and nuclear magnetic resonance (NMR) spectroscopy. The three-dimensional 
structure of holo truncated HasAp was determined by X-ray crystallography.  The 
coordination and electronic structure of the heme active site is an important 
modulator of the physical, chemical and biochemical properties of heme proteins 
[10]. Various well-established techniques are widely used to study paramagnetic 
proteins [11].  Among these techniques, NMR spectroscopy has been proven to be a 
powerful tool to study heme proteins [11-14]. In this study we primarily use 13C 
NMR spectroscopy coupled with the use of isotopically labeled-heme to study the 
heme active site to gain more insights on the heme uptake and release mechanisms. 
Besides 13C NMR, complementary techniques such as electronic absorption 
spectroscopy, and electron paramagnetic resonance (EPR) were also employed to 
study the spin state and coordination of heme iron in HasAp. Moreover, to better 
understand the heme release and uptake mechanism of HasAp, it is also important to 
study its structure and dynamics in solution.  In an attempt toward this goal, we report 
here the amide backbone amide resonance assignments of holo full-length, holo 
truncated and apo truncated forms of HasAp. These assignments were done on 
uniformly isotopic labeled HasAp using a combination of 2D and 3D NMR 
experiments [15], and amino acid selective labeled protein.  
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EXPERIMENTAL PROCEDURES 
 
General Methods  
 
The HasAp (PA3407) gene was synthesized and subcloned into pET11a 
vector by Celtek Genes (Nashville, TN). The genes were engineered with silent 
mutations introducing codons favored by Escherichia coli [16].  The restriction sites 
NdeI and BamHI were constructed at the 5' and 3' ends of  HasAp gene, respectively 
(Figure 3).  The recombinant DNA plasmid harboring the HasAp gene was then 
transformed into E. coli BL21-GOLD (DE3) expression host cell (Stratagene, La 
Jolla, CA) for subsequent expression.  
 
Site-Directed Mutagenesis  
 
The truncated HasAp gene was contructed using the recombinant pET11a 
plasmid harboring the gene coding for HasAp (full-length form), polymerase chain 
reaction (PCR) and QuickChangeTM mutagenesis kit from Stratagene (La Jolla, CA). 
The oligonucleotides were synthesized by Integrated DNA Technologies, Inc. and 
used without further purification. The primers were designed to have a melting 
temperature (Tm) greater than or equal to 78 °C. The sequences corresponding to the 
primers used are 5'-GCGACCCCGGCGGCGTAAGCGGCGGAAGTGGGC - 3' and 
5'-GCCCACTTCCGCCGCTTACGCCGCCGGGGTCGC-3'. The underlined codons 
represent mismatches designed to introduce a stop codon where the protein cleavage 
was  desired.  The  recombinant  construct  was  transformed  into   E. coli  XL1-Blue 
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Figure 3.  DNA and amino acid sequence of HasAp. The Nde I and BamHI 
restriction endonuclease sites were constructed at the 5' and 3' ends, respectively, for 
subcloning.  
 
 
5' Nde I
GGGCATATG AGC ATT AGC ATT AGC TAT AGC ACC ACC TAT AGC GGC TGG ACC
M        S       I       S        I       S Y       S        T       T      Y       S         G      W T
GTG GCG GAT TAT CTG GCG GAT TGG AGC GCG TAT TTT GGC GAT GTG AAC CAT
V        A       D      Y      L        A       D      W     S       A       Y      F        G       D      V       N      H
CGT CCG GGC CAG GTG GTG GAT GGC AGC AAC ACC GGC GGC TTT AAC CCG GGC
R      P       G       Q       V       V       D       G   S      N        T      G       G       F       N       P    G
CCG TTT GAT GGC AGC CAG TAT GCG CTG AAC AGC ACC GCG AGC GAT GCG GCG
P      F       D       G       S       Q      F        A    L       K       S       T        A       S       D       A   A
TTT ATT GCG GGC GGC GAT CTG CAT TAT ACC CTG TTT AGC AAC CCG AGC CAT
F       I        A       G       G       D       L       H   Y      T       L       F       S       N       P        S    H
ACC CTG TGG GGC AAA CTG GAT AGC ATT GCG CTG GGC GAT ACC CTG ACC GGC
T        L      W      G       K      L        D      S      I        A       L       G       D       T       L       T    G
GGC GCG AGC AGC GGC GGC TAT GCG CTG GAT AGC CAG GAA GTG AGC TTT AGC
G       A       S       S        G       G      Y        A  L       D       S       Q      E       V        S       F  S
AAC CTG GGC CTG GAT AGC CCG ATT GCG CAG GGC CGT GAT GGC ACC GTG CAT
N       L       G       L        D      S        P       I   A       Q       G       R       D       G       T       V  H
AAA GTG GTG TAT GGC CTG ATG AGC GGC GAT AGC AGC GCG CTG CAG GGC CAG
K      V        V      Y        G      L      M        S     G       D       S       S        A       L       Q       G    Q
ATT GAT GCG CTG CTG AAA GCG GTT GAT CCG AGC CTG AGC ATT AAC AGC ACC 
I       D       A       L       L       K       A       V   D        P       S       L        S       I       N       S  T
TTT GAT CAG CTG GCG GCG GCG GGC GTG GCG CAT GCG ACC CCG GCG GCG GCG
F       D      Q       L        A       A       A        G   V        A      H       A        T       P       A       A   A
GCG GCG GAA GTG GGC GTG GTG GGC GTG CAG GAA CTG CCG CAT GAT CTG GCG
A        A      E       V       G       V       V       G   V       Q       E       L       P       H       D       L   A
BamH I
CTG GCG GCG TAA GGATCCGGG
L       A       A       -
3'
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supercompetent cells for amplification. Once the mutation had been confirmed by 
sequencing, the recombinant DNA plasmid was transformed into E.  coli BL21 (DE3) 
GOLD cells for subsequent protein expression.  
 
Protein Expression and Purification of Full-Length and Truncated HasAp  
Protein Expression and Purification of Unlabeled Proteins 
 Protein samples were expressed using the recombinant pET11a plasmids 
harboring genes coding for the full-length (205 amino acids residues) and truncated 
(184 amino acid residues) HasAp.  A single colony of freshly transformed cells was 
cultured for 12 h in 10 mL of Luria-Bertani (LB) medium containing 200 μg/mL of 
ampicillin. This culture was used to inoculate 1.0 L of M9 minimal medium (200 
μg/mL ampicillin), which was then incubated with continuous shaking at 225 rpm.  
When the OD600 reached 0.80 – 0.90, the cells were centrifuged at 4000 rpm for 10 
min. The cells were then resuspended and subcultured into 1.0 L of fresh minimal 
M9-ampicillin medium. After the OD600 reached 1.0, biosynthesis of the polypeptide 
was induced by addition of isopropyl-β-D-thiogalactopyranoside (IPTG) to a final 
concentration of 1 mM and the cells were cultured for 5 h at 30 °C,  before  they  
were  harvested   by centrifugation at 4000 rpm for 10 min.  The cells were lysed by 
sonication as previously described [17] in 50 mM Tris-HCl (pH 7.8) containing 1 mM 
EDTA, and 1 mM phenylmethysulfonyl fluoride (PMSF). The cell suspension was 
then centrifuged at 23 500 rpm for 2 h.  The cell debris was separated by 
ultracentrifugation and the soluble fraction was dialyzed against 20 mM Tris-HCl (pH 
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7.8) (3 x 4 L) at 4 °C. The protein was loaded into a Sepharose-Q Fast Flow column 
(2.6 cm  i.d. x 15 cm length) pre-equilibrated with 20 mM Tris-HCl (pH 7.6). The 
protein was eluted with the same buffer with a linear gradient (50-500 mM) NaCl. 
Purity of the protein fractions were determined by SDS-PAGE and the best fractions 
were pooled. The apo-protein was subsequently reconstituted with hemin dissolved in 
DMSO. To this end, heme was added gradually to the protein solution until the 
absorbance ratio (A280/A407) no longer changed. The resultant solution was incubated 
at 4 °C and concentrated to a final volume of 2 - 3 mL using Amicon ultracentrifuge 
filter and further purified by size-exclusion chromatography in a Sephacryl S-200 
column (2.6 cm i.d. x 90 cm length), equilibrated with 100 mM Tris-HCl and 100 
mM NaCl (pH 7.6). Fractions with an absorbance ratio (A280/A407) < 0.35 were 
pooled, dialyzed against phosphate buffer (μ = 0.1, pH 7.0), concentrated by 
ultrafiltration, and stored at -20 °C.  
 
Protein Expression and Purification of Labeled Proteins 
 
Singly-(15N) and doubly-labeled (15N, 13C) samples were expressed using the 
same procedure as the unlabeled proteins. When the OD600 reached 0.80 – 0.90, the 
cells were centrifuged at 4000 rpm for 10 min. The cells were then resuspended and 
subcultured in 1.0 L of fresh minimal M9-ampicillin medium that did not contain any 
nitrogen or carbon sources. After the OD600 reached 1.0, biosynthesis of the 
polypeptide was induced by addition of isopropyl-β-D-thiogalactopyranoside (IPTG) 
to a final concentration of 1 mM and 1 g of 15NH4Cl for producing [U-15N]-HasAp. 
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For the [U-13C, U-15N]-HasAp labeled samples, 1 g of 15NH4Cl and 1.5 g of 13C-
labeled glucose were added during induction with IPTG.   The cells were then grown 
further for 5 h at 30 °C and harvested by centrifugation at 4000 rpm for 10 min. The 
harvested cells were resuspended and lysed by sonification. Cell lysis, protein 
purification and heme reconstitution of the singly (15N) and doubly-labeled (15N, 13C)-  
samples were carried out using the same protocol for the unlabeled proteins described 
above.   
 
Protein Expression and Purification of Selectively Labeled Proteins 
 
The protocol used to prepare selectively labeled amino acid truncated HasAp 
was as previously described in [13, 18, 19] but with some minor changes. The M9 
minimal medium was supplemented with the synthetic amino acids (g/L) prior to 
autoclaving, except for L-Trp (0.05) : L-Ala (0.5), L-Arg (0.4), L-Asn (0.4), L-Asp 
(0.4), L-Cys (0.05), L-Gln (0.4), L-Glu (0.65), Gly (0.55), L-His (0.1), L-Ile (0.23), 
L-Leu (0.23), L-Lys hydrochloride (0.42), L-Met (0.25), L-Phe (0.13), L-Pro (0.1), L-
Ser (2.10), L-Thr (0.23), L-Tyr (0.17), and L-Val (0.23). 
 
Expression of [15N-Val] 
In brief, 1.0 L of M9 minimal medium supplemented with all the amino acids 
except L-Val, was inoculated with 10 mL of the above mentioned E. coli BL21 
GOLD (DE3) culture grown overnight. When the OD600 reached a value of 1.0, 
biosynthesis of polypeptide was induced by adding isopropyl-β-D-
thiogalactopyranoside (IPTG) to a final concentration of 1 mM, followed by the 
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addition of 0.23g [15N-L-Val]. The cells were incubated for 5 h at 30 °C. Cell 
harvesting, lysis, protein purification and heme reconstitution were done as described 
above.  
 
       Expression of [15N-Leu]  
       Expression of [15N-Leu] truncated HasAp was carried out using the protocol 
similar to [15N-Val] truncated HasAp except that the medium was devoid of L-Leu 
amino acid instead of L-Val.  Moreover, 3 g of glucose instead of 2 g was used in the 
M9 medium.  In addition, when the OD600 reached 1.0, IPTG was added to induce the 
biosynthesis of the polypeptide followed by 55 mg of [15N-L-Leu], 0.23g L-Ile, and 
0.23g L-Val. It was observed in the previous expressions that both Ile and Val were 
also labeled together with Leu. Hence, these two amino acids were added to prevent 
isotopic scrambling. The cells were incubated for 5 h at 30 °C. Cell harvesting, lysis, 
protein purification and heme reconstitution were done as described above.  
 
Expression of [15N-Thr] 
 
Expression of [15N-Thr] truncated HasAp was carried out using the protocol 
similar to [15N-Leu] except that the medium was devoid of L-Thr instead of L-Leu. 
During induction, IPTG was added followed by the addition of 55 mg [15N-Thr], 
0.55g Gly, and 2.10g L-Ser. It was necessary to supplement the medium with Gly and 
L-Ser to prevent the incorporation of 15N labeled Gly and Ser residues as observed in 
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the previous expressions. Cell harvesting, lysis, protein purification and heme 
reconstitution were done as described above.  
 
Expression of [15N-Tyr] 
Expression of [15N-Tyr] truncated HasAp was carried out using the protocol 
similar to [15N-Val] truncated HasAp except that the medium was devoid of 15N-Tyr 
amino acid. In addition, when the OD600 reached 1.0, IPTG was added to induce the 
biosynthesis of the polypeptide followed by 0.17g of [15N-L-Tyr]. The cells were 
incubated for 5 h at 30 °C. Cell harvesting, lysis, protein purification and heme 
reconstitution were done as described above.  
 
UV-Visible Absorption Spectroscopy 
 
The electronic absorption spectra of both holo full-length and truncated 
HasAp were recorded in phosphate buffer (μ = 0.1, pH 7.0) using an Ocean Optics 
UV-Vis spectrophotometer. Extinction coefficients of the proteins at 407 nm (ε407) 
were measured as described previously [20].  In brief, a 100 μL of pyridine was 
added to a pure sample (900 μL) of holo HasAp in phosphate buffer (μ = 0.1, pH 7.0) 
with an absorbance of 1.0. The pyridine will denature the protein and coordinate to 
the displaced heme. An excess of sodium dithionite was added to the solution to 
reduce the iron, after which the spectrum of the pyridine hemochrome was recorded. 
The protein concentration was calculated the using the reported extinction coefficient 
of the reduced ferrous pyridine-hemochrome and the Beer-Lambert Law. The average 
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protein concentration was calculated using extinction coefficients at the absorbance 
maxima of 418 nm, 555 nm and 525 nm are 170, 34.4, and 17.5 mM-1 cm-1, 
respectively. The average protein concentration values were used to calculate the 
extinction coefficient of the protein at 407 nm. Three trials were performed per 
protein sample.   
 
 Sample Preparation 
Preparation of Apo-protein 
 
The extraction of heme was carried out using the cold-acid acetone treatment 
[6].  A 1.5 mL of 2.5 mM holo HasAp was added drop by drop with stirring into a 
100 mL acid-acetone solution (0.2% V/V of 12M HCl) previously stored in -20 °C.  
The resultant solution turned red with the concomitant formation of white precipitate. 
The suspension was stirred for an additinal 10 min and then centrifuged at 2500 rpm 
for 1 min at 4 °C.  The procedure was repeated again if the precipitate has some 
reddish color.  The final precipitate was dissolved in 100 mL of 100 mM Tris-HCl 
buffer (pH 7.8) containing 7.0 M urea.  The solution was then dialyzed against 100 
mM Tris-HCl with 100 mM NaCl buffer (pH 7.8) (1 x 4 L) and then against 
phosphate buffer (μ = 0.1, pH 7.0) (3 x 4 L) at 4 °C. After dialysis the protein was 
concentrated to 3 mL and loaded into a G50 size exclusion column pre-equilibrated 
with phosphate buffer (μ = 0.1, pH 7.0). Protein fractions with > 90% apoprotein, as 
determined by the absence of the Soret peak at 407nm, were pooled and concentrated.  
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Preparation of Protein Harboring 13C-Labeled Heme 
 
13C-labeled δ-aminolevulinic acid (ALA) was used as the biosynthetic 
precursor for the preparation of 13C-labeled protoporphyrin IX (heme) [21-23] . The 
13C-labeled hemes were synthesized and subsequently extracted from outer 
mitochondrial (OM) cytochrome b5 using the methodology described in Chapter 2. 
Synthesis of [1,2-13C]-ALA, [4-13C]-ALA and [5-13C]-ALA were previously 
described [21, 22]. [1,2-13C]-ALA was used as precursor to label heme at the methyl, 
β-vinyls, propionate-β, and carbonyls (Figure 4A), while [4-13C]- and [5-13C]-ALA 
were used to label the core carbons: Cα and Cβ, and Cα and Cm, positions, respectively 
(Figure 4B and C). After truncated apo-HasAp was reconstituted with a freshly 
prepared solution of 13C-labeled heme, the resultant solution was incubated at 4 °C 
overnight and then purified in Sephacryl S-200 size exclusion column (2.6 i.d. cm x 
90 cm. length). The fractions with high purity (A280/A407) ratio of < 0.35 were pooled 
and dialyzed in phosphate buffer (μ = 0.1, pH 7.0). Fractions containing pure protein 
were concentrated in Amicon centrifugal concentrators to ~1 mL and transferred to 
smaller concentrators to exchange protein into deuterated buffer.  
 
X-Ray Crystallography 
 
Initial crystal growth screening conditions were carried out in the High 
Throughput Crystallization Screening Laboratory of Hauptman-Woodward Medical 
Research Institute (Buffalo, NY) [24].  This facility uses an automated liquid-
handling system to set up 1536 microbatch-under-oil crystallization experiments and 
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plates are imaged before and after addition of the protein solution to the cocktails and 
every week thereafter for six weeks. The cocktail conditions and the images of the 
crystals are shown in Appendix 1. Twenty nine wells showed crystal growth after six 
weeks  and 15 crystal growth conditions  were optimized  in our laboratory  to  obtain  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.   13C-labeling patterns obtained when protoporphyrin IX is biosynthesized 
from (A) [1,2-13C]-ALA, (B) [4-13C]-ALA, and (C) [5-13C]-ALA.  
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good quality crystals suitable for X-ray diffraction. Crystals were grown using the 
hanging drop vapor diffusion method by mixing 5 μL of a 120 mg/mL solution holo 
HasAp with an equal volume of reservoir solution, containing 100 mM MES buffer 
(pH 6.5), 100 mM NH4Cl, and 80% PEG 400. Under these conditions, holo truncated 
HasAp crystallizes as brown colored crystals (Figure 5) at 23 °C and takes 3 days to 
reach a size (1 mm length x 1 mm width  x 1 mm depth) suitable for X-ray analysis.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.  Crystals of truncated holo-HasAp grown using the hanging drop method  
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NMR Spectroscopy 
 
One-Dimensional NMR Spectroscopy 
 
1H NMR spectra were collected on a Varian Unity Inova spectrometer 
equipped with a triple resonance probe operating at a 599.74 MHz 1H frequency.  
Proton spectra were acquired with presaturation of the residual water peak over 40 k 
data points, a spectral width of 100 kHz, a 200 ms acquisition time, 20 ms relaxation 
delay, and 1024 scans; spectra were  referenced to a residual water peak at 4.80 ppm. 
The 13C spectra were obtained on a Varian Unity Inova spectrometer equipped with a 
5 mm broadband probe and operating at a frequency of 60.781 MHz 13C frequency. 
The 13C spectra were referenced to an external solution of dioxane (60% V/V in D2O) 
at 66.66 ppm. The acquisition parameters used to obtain 13C NMR spectra are given 
in the appropriate figure captions. One-dimensional 1H and 13C spectra were 
processed and analyzed with VNMRJ.  
 
Two- and Three-Dimensional NMR Spectroscopy 
The protein samples used for two- and three-dimensional NMR data collection 
were in phosphate buffer (μ  = 0.1, 95% H2O, 5% D2O, pH 7.0). The protein 
concentrations were approximately 2.5 mM.  All NMR experiments were performed 
at 32 °C unless otherwise noted in the figure captions. 2D and 3D NMR experiments 
[1H-15N-HSQC, HN(CO)CA, HNCA, CBCA(CO)NH, HNCACB and NOESY-
HSQC] used to carry out the backbone assignment of  holo HasAp, full-length and 
truncated,  were carried out using Bruker Avance 800 spectrometer equipped with a 5 
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mm TXI 1H-13C/15N/D xyz-gradient probe. The backbone assignments of truncated 
apo-HasAp were carried out using the same set of 2D and 3D NMR experiments 
obtained in the Varian Unity INOVA 600 spectrometer equipped with a triple-
resonance z-axis gradient probe. While the three dimensional NMR experiments 
HNCO and (HCA)CO(CA)NH used for the sequential backbone assignment of holo 
proteins were carried out in the Varian Unity INOVA 600 spectrometer. Three-
dimensional 15N-separated NOESY-HSQC (110 ms mixing time) of the holo full-
length HasAp was obtained at 305 K in a Bruker Avance 800 spectrometer. Specific 
parameters used for the NMR experiments are shown in the corresponding figure 
captions. The data were processed using NMRPipe [25] and analyzed with the 
program Sparky [26]. The chemical shifts were referenced directly and indirectly 
using the proton frequency of the DSS resonance at 0.00 ppm.  
 
H/D Exchange Studies 
 Amide hydrogen-deuterium exchange experiments were carried out in the 
Varian Unity INOVA 600 spectrometer at 32 °C. Prior to the start of an H/D 
exchange experiment the [U-15N]-holo truncated HasAp sample (2.5 mM) was 
exchanged in aqueous sodium phosphate buffer (μ = 0.10, pH 7.0).  The aqueous 
solvent was eliminated by freeze-drying using Savant® Speed Vac Lyophilizer 
(Farmingdale, N. Y.) then resuspended in D2O. The volume of D2O added is equal to 
the volume of the protein sample prior to lyophilization. Sample prepared in this way 
showed identical UV-Vis and NMR spectroscopic characteristics to the sample shown 
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before lyophilization. The H/D exchange process was monitored immediately after 
the lyophilized protein was redissolved in D2O. The exchange was followed as a 
function of time by following the time-dependent decrease of the amide cross-peaks 
with the aid of 2D 1H-15N HSQC [27].  The dead time between addition of D2O to the 
lyophilized protein and the beginning of data acquisition was about 10 min.  Total 
acquisition time for each HSQC spectrum was 20 min and spectra were taken every 
20 min for 18 h, and every hour thereafter for a total of 32 h. Each HSQC spectrum 
was acquired at 32 °C using the Varian Unity INOVA 600 spectrometer. The HSQC 
spectra were taken over  8.4 kHz (1H) and 2.2 kHz (15N) spectral widths, with 4 scans 
per increment, 0.085 s acquisition time, 1.0 s relaxation delay and 1428 and 128 
complex points for the 1H, and 15N dimensions, respectively.  Exchange rate constants  
per residue (kex)  were determined as described previously [28] by fitting the time-
dependent decay of cross-peak intensities to a three parameter single exponential 
decay function using the program Sigma Plot version 2001, v.7.0. Sequence-specific 
intrinsic rate constants (kch), Gibbs free energy of exchange (ΔGHX) and protection 
factors per residue were calculated using the spreadsheet provided in Dr. S. Walter 
Englander’s website at http://hx2.med.upenn.edu/download.html.  The spreadsheets 
were used with pD corrected values at 32 °C. The pH of the D2O solution was 
measured immediately after data acquisition and corrected for the isotope effect using 
equation 1 [29]. 
(pDcorrected = pDread + 0.4)                                                                                (1) 
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Heme Transfer Experiments 
 
Preparation of Hb, Mb and HbO2 Samples 
Horse heart myoglobin and human hemoglobin were purchased from Sigma-
Aldrich. Lyophilized myoglobin and hemoglobin were dissolved in phosphate buffer 
(μ = 0.10, pH 7.0). The insoluble part was removed by centrifugation and the 
solutions were purified in a Sephadex G-50 (2.6 i.d. cm x 90 cm. length) size 
exclusion column. Protein fractions with purity ratio < 0.25 at (A280/A405) and 
(A280/A409) for hemoglobin and myoglobin, respectively, were pooled and 
concentrated using Amicon ultracentrifuge filters to a final concentration of ~1.0 mL.  
Oxyhemoglobin (HbO2) was prepared by adding molar excess of sodium dithionite to 
hemoglobin to reduce the ferric heme-iron to ferrous. This reaction was done inside a 
glove box. The sodium dithionite was then removed by passing the protein solution in 
a desalting column and the HbO2 complex formed by subsequent exposure to air.  
Freshly prepared myoglobin, hemoglobin and oxyhemoglobin were used in the heme 
transfer experiments. 
 
Heme Transfer Assay 
The heme transfer assay was carried out at 37 °C using UV-Visible 
spectrophotometer. In brief, heme transfer experiments were carried out by mixing an 
excess of truncated apo-HasAp with respect to Hb, Mb and HbO2  in phosphate buffer 
(μ = 0.1, pH 7.0) with stirring in a cuvette. The transfer of heme from  holo-proteins 
 76
(Hb, Mb and HbO2)  to apo-HasAp were monitored by the emergence of the high-
spin charge transfer band of holo HasAp at 616 nm as a function of time.  
 
RESULTS AND DISCUSSION 
 
Overexpression and Purification of HasAp  
Both full-length and truncated apo-HasAp proteins were expressed under the 
same conditions. Luria-Bertani (LB) medium was first used to express the proteins. 
However, the expressed proteins contained > 50% heme content. The full length 
HasAp expressed using this medium have multiple C-terminal cleavages as 
determined by SDS-PAGE gel and mass spectrometry. Moreover, the cleaved and 
uncleaved forms were not separated by size exclusion chromatography. To 
circumvent this problem, M9 minimal medium not supplemented with FeSO4 was 
used to grow the culture so as to inhibit the formation of heme containing HasAp.  
With the absence of iron in the culture medium, it took 12 h for the OD600 to reach 
1.0. After lysis, all the proteins were found in the supernatant. The proteins were 
purified using an anion exchange chromatography column. HasAp protein fractions 
were only 80% pure after ion exchange and they came out with 30% heme content. 
The fractions with the protein of interest as determined by SDS-PAGE gel were 
pooled and reconstituted with hemin. In the SDS-PAGE gel, the full-length and the 
truncated protein gave a band a little bit above and below 20 kDa, respectively 
(Figure 6). The protein was passed through a size exclusion column. The protein 
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purity was monitored by the ratio of A280/A407. The molecular weight of the full- 
length and the truncated HasAp forms were 20 773 and 18 761 kDa, respectively, as 
determined by mass spectrometry. The molecular weight also showed that both the 
full-length and truncated HasAp proteins were expressed without the start methionine 
residue.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.  SDS PAGE of purified full-length and truncated HasAp. The molecular 
weight of full-length and truncated HasAp are 20 773 and 18 761 KDa, respectively.  
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X-ray Crystallography 
 
Protein Crystallization  
 
Protein crystallization is a trial-and-error process in which the protein is 
precipitated from its solution [30]. This process is characterized by a reversible 
equilibrium phenomenon driven toward the minimization of the free energy of the 
system [31]. This method aims to produce crystals free of contaminants and large 
enough to provide X-ray diffraction pattern. This diffraction pattern is then analyzed 
to solve the three-dimensional structure of the protein. Formation of crystals can be 
explained using the two-dimensional solubility diagram illustrating the protein 
concentration against the concentration of the precipitating agent as shown in Figure 
7.  The solubility curve separates the concentration space into two areas, the 
undersaturated and supersaturated state of a protein solution [30, 32, 33]. The area 
under the solubility curve is the undersaturation phase where crystals will not grow. 
The supersaturation phase is the area above the solubility curve and it is divided into 
three areas and this is where the protein crystallizes. In the metastable area, the rate of 
nucleation is slow that no crystal grows for a long time unless seed crystals are 
introduced.  In the nucleation zone, supersaturation is large enough that crystal 
growth is observed. Lastly in the precipitation zone, supersaturation is large enough 
that protein molecules separates from the solution to form amorphous aggregates [34, 
35].  
Several methods are used to bring the protein solution into a supersaturation 
phase [32, 36]. In this work, the hanging drop diffusion method was used for protein 
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Figure 7.  Schematic representation of a two-dimensional crystallization phase 
diagram.  
 
 
 
crystallization (Figure 8).  This  technique  uses  vapor  diffusion  to  promote  crystal  
growth. A droplet containing the pure protein, buffer and precipitant solution is 
suspended over a reservoir like a hanging drop which contains higher concentrations 
of buffer and precipitants similar to the droplet [33]. The droplet contains a 1:1 ratio 
of the protein and the precipitants.  Vapor equilibration between the droplet and 
reservoir is the driving force which causes the protein solution to reach the nucleation 
level to promote crystal growth.  
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Figure 8.  Schematic representation of the hanging drop diffusion vapor diffusion 
technique used in growing protein crystals.  
 
 
 
 
 
X-ray Diffraction Analysis 
Three-day old crystals of truncated holo-HasAp are shown in Figure 5. The 
truncated holo-HasAp protein crystallized with two monomers per asymmetric unit in 
space group P3(1). The overall structure was refined by Dr. Ernst Schönbrunn and 
coworkers to 1.7 Å resolution with a current Rfree of 19.5%.  The crystal is hexagonal, 
with unit cell a = b = 47.7 Å, and   c=141.29 Å; alpha = beta = 90 degrees, gamma = 
120 degrees.  
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Secondary Structure of Truncated HasAp 
The X-ray crystal structures of the two monomers of holo truncated HasAp is 
shown in Figure 9. Close inspection of the two crystals determined using the stride 
program [37] show that they both have the same secondary structure composition 
(Table 1).  Analysis of the secondary structure content of the protein reveals that it is 
a member of the family of αβ proteins, with 29% of the structure involved in α-
helices and 34% in β-strands. The secondary structure (Figure 10) shows four α-
helices and eight anti-parallel β-sheets, three 310 –helix and 16 β-turns (types I, II, II’, 
IV, VIb and VIII).  The first  β-sheet is connected to a three-residue 310-helix  and α- 
helix 1, and interestingly, the following six antiparallel β-strands (β2 to β7) are  
adjacent   in  sequence  and   are  connected by   hairpins.  The four α-helices (α1-α4) 
are packed against the aforementioned β-sheets, thus forming an “α-helix wall” 
opposite to the “β-sheet wall”.  The two 310-helices in the structure are 310-helix 1 
(residues Thr9-Tyr11) which connects the first β-strand to the first α-helix.  The 
second 310-helix (I125-D130) connects α-helix 2 and β-strand 6. 310-helices are only 
three or four residues long, compared with a mean of ten residues in a typical α-helix 
[38, 39], and are found at the N- or C-terminus of α-helices [40]. It is the fourth most 
common secondary motif in proteins and it is believed to be an intermediate in the α- 
helix folding and melting processes [40-43].  
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Figure 9.  X-ray crystal structures of truncated HasAp (A) monomer A and (B) 
monomer B showing four α-helices (cyan), eight anti-parallel β-strands (magenta), 
loops (green), loop with high B-factor values (yellow), heme (red), and axial ligands 
(blue).  
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Table 1.  Secondary Structure Comparison of Monomer A and B of Holo-HasAp  
               X-ray Crystal Structure Using The Program Stride [37]. 
Residue Monomer A Monomer B
Val16 - Phe27 Alpha Helix I Alpha Helix I
Thr132 - Ser142 Alpha Helix II Alpha Helix II
Ser145 - Val159 Alpha Helix III Alpha Helix III
Phe169 - Ala175 Alpha Helix IV Alpha Helix IV
Thr9 - Tyr11 310 - Helix 310 - Helix
Ile125 - Asp130 310 - Helix 310 - Helix
Ser4 - Ser8 Beta Sheet I Beta Sheet I
Gly45 - Pro48 Beta Sheet II Beta Sheet II
Asp52 - Lys59 Beta Sheet III Beta Sheet III
Ala65 - Tyr75 Beta Sheet IV Beta Sheet IV
Leu85 - Gly100 Beta Sheet V Beta Sheet V
Tyr107 - Ser117 Beta Sheet VI Beta Sheet VI
Leu121 - Ser123 Beta Sheet VII Beta Sheet VII
Ala178 - Thr181 Beta Sheet VIII Beta Sheet VIII
Tyr11 - Trp14 Turn I Turn I
Arg33 - Gln36 Turn II Turn II
Pro34 - Val37 Turn IV Turn IV
Gly140 - Thr43 Turn IV Turn IV
Phe46 - Gly49 Turn VI b Turn VI b
Gly49 - Asp52 Turn I Turn I
Gly53 - Tyr56 Turn VIII Turn VIII
Ser60 - Ser63 Turn IV Turn IV
Thr76 - Ser79 Turn II' Turn II'
Ser79 - Ser82 Turn IV Turn IV
Pro81 - Thr84 Turn IV Turn IV
Gly100 - Ser103 Turn IV Turn IV
Ala102 - Gly105 Turn IV Turn IV
Leu109 - Gln112 Turn VIII Turn VIII
Asp160 - Leu163 Turn I Turn I
Ser164 - Ser167 Turn I Turn I  
 84
 
 
 
 
 
Figure 10.  Secondary structure assignment of truncated HasAp using Stride [37]. 
The α-helices are in red, β-sheets in yellow, 310-helix in magenta and loops in green.  
 
The X-ray crystal structure of HasAp looks very similar to that of HasASM 
[44], which also looks like a fish with the heme pocket resembling a mouth biting the 
heme.  These two proteins share > 50% sequence identity. A superimposed   X-ray  
crystal  structures of  holo-HasASM  and  HasAp (Figure 11) show that the 
polypeptide of truncated HasAp folds into the same αβ fold characteristic of HasASM 
[44]. The heme is highly exposed to the solvent and it is contained within two 
extended loops: Loop 1 is located between α1 and β2 and contains one of the heme 
axial ligands, His32. The second extended loop is located between strands β5 and β6, 
and contains the other heme axial ligand, Tyr75. The carboxyl end of the second 
extended loop continues onto the bulk of the “β-sheet wall”, thus the loops containing 
the heme can be thought of as flexible jaws hinged to the rigid β-sheet and α-helix 
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walls.  In the structure of HasASM electron density can be seen only to residue 174. In 
the structure of HasAp, electron density is seen for all 184 residues, which reveals a 
strand (β8, residues 178-181) parallel  to β-1,  thus  extending the  β-sheet wall by  
one strand,  relative  to  the structure of HasASM. 
 
 
 
 
 
 
 
 
Figure 11.  Superimposed X-ray crystals structures of Holo-HasAp (red) and Holo- 
HasASM (green) (PDB ID. 1DKO).  
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As pointed out above, the heme is axially coordinated by a His32 and Tyr75, a 
coordination motif that is identical to that seen in the structure of HasASM, and in 
agreement with the conserved nature of these residues in hemophore sequences from 
distinct organisms [45].  The heme propionate groups interact with the polypeptide 
via hydrogen bonding and electrostatic interactions; the oxygen atoms of propionate 
A interact to form a salt bridge with the guanidinium group of Arg129, whereas the 
O1 atom of heme propionate D is hydrogen bonded to the NH of Gly35 on the 
opposite side of the heme plane. The heme prosthetic group in heme proteins binds to 
the polypeptide in two orientations that differ by a 180° rotation about the α-γ-meso 
axis, a phenomenon common to proteins when the heme is not bound covalently, i.e. 
cytochrome b5 [46, 47] and heme oxygenase [17]; these two heme isomeric forms of 
HasASM, which exist in 70:30 ratio have been observed in electron density maps of a 
1.77 Å resolution structure [48] and solution NMR spectroscopic studies [49].  
Analysis of heme electron density in HasAp, on the other hand, indicates that the 
heme is bound in only one orientation as shown in Figure 12. This conclusion is 
supported by observations made in the solution NMR spectroscopic studies described 
later in this chapter.  
The hydrogen bonding network in the vicinity of the heme is also very similar 
in the HasASM and HasAp structures. Notably, the orientation of the side chain of 
His83 places its Nδ within hydrogen bonding distance of the coordinated phenolate 
oxygen in Tyr75, a situation identical to that observed in the crystal structure of 
HasASM [44], which was crystallized at pH 4.6. It is interesting that in a subsequent 
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investigation, crystals of HasASM were grown at pH 4.6, 6.5, and 8.0 [48]. The 
structure  of  HasASM obtained  at pH 6.5  showed that  the  His83 side chain  attains a 
 
 
 
 
 
 
 
Figure 12.  Electron density map of the heme active site of truncated HasAp crystal 
structure in (A) monomer A, and (B) monomer B. There is only one heme isomer in 
HasAp.  
 
different conformation and is not hydrogen bonded to Tyr75. B factors for the heme 
in this structure were very high, thus the observation was interpreted to suggest that 
the loss of hydrogen bond between His83 Nδ and the phenolate of Tyr75 may 
facilitate heme acquisition and/or release [48]. It is therefore interesting that the 
structure of HasAp, obtained from crystals grown at pH 6.0, show low B-factors for 
the heme and a hydrogen bond between the coordinated Tyr75 phenolate oxygen and 
Nδ of His83. Thus a pH switch controlling the protonation state and concomitant 
(A) (B)
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heme affinity in the hemophores does not seen to be operative when comparing the 
structures of HasAp and HasASM obtained from crystals grown at similar pH values.  
The internal order of the protein is reflected from B-factor values. The B-
factors show thermal vibration, conformational disorder or static lattice disorder, or 
misorientation of the protein molecules [50]. This suggests that residues which 
exhibit high B-factor values are located in highly flexible and disordered loops. The 
calculated Cα B-factors of both HasAp monomers (Figure 13) show that residues 100-
106 (GGASSGG) have B-factor values ranging from 29.42 to 51.58 A2, while the 
average Cα B factor value is only 15.60 A2.  Ser103 shows the largest B-factor (51.58 
A2) among the residues in the protein. Inspection of the structure reveals that the loop 
containing residues 100-106 is a hairpin loop connecting β5 with β6 and is highly 
exposed to the solvent. This loop, which is colored yellow in Figure 9, faces outward 
and looks like the gills of the fish. Using the structural alignment in Figure 1, residues 
Gly100-Gly106 of HasAp correspond to Gly100-Pro105 of HasASM.  It was observed 
by   Létoffé et. al. [51] that these residues were involved in the interaction of HasASM 
with HasRSM.  It is possible that the high flexibility of this loop allows it to change its 
conformation to bind with the cognate receptor to deliver the heme. In addition, 
residues A183 and A184 also have high B-factor values. This could also suggest that 
the tail is also a highly unstructured part of the protein. The flexibility of the tail 
could make HasAp easily accessible for: (1) binding with the ABC-transporter before 
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being secreted to the extracellular medium, and (2) proteases to cleave the C-terminal 
residues.  
 
 
 
 
 
 
 
 
 
 
Figure 13.  Per-residue plot of the Cα B-factor values of monomer A (red) and 
monomer B (blue). The average B-factor values of both monomers are shown in 
black dotted line. Residues 100 to 106 show high B-factor values.  
 
 
Spin State of the Heme-Iron in HasAp 
Electronic  Absorption  Spectroscopy 
 The electronic absorbance spectra of the holo full-length and truncated HasAp 
proteins show a Soret maximum at 407 nm with visible bands at 495, 540, 577, and 
618 nm (inset of  Figure 14).  Their extinction  coefficients at  407  nm (ε407)  is 77.67  
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mM-1 cm-1.  Typically, heme proteins exhibit characteristic electronic absorption 
bands in the visible region [52]. Moreover, high-spin species (S = 5/2) have Soret 
maxima between 405 to 410 nm while low-spin species (S = 1/2) have Soret maxima 
at longer wavelengths, between 415 to 425 nm. The electronic absorption spectrum of 
HasAp suggests that it is a high-spin species [53]. However, its alpha, beta and charge 
transfer bands do not show either fully high-spin or fully low-spin character.  The 
alpha and beta bands at 577 and 540 nm, respectively, which are indicative of a fully 
low-spin species are not very prominent.  Moreover, the bands at 495 and 616 nm 
correspond to a high-spin charge transfer band [52, 53]. The Soret peak and the 
visible bands strongly suggest that HasAp have both high-spin (S = 5/2) and low-spin 
(S = 1/2) characters. 
 
 
 
 
 
 
 
Figure 14.  Electronic absorption spectrum of HasAp 
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1H  NMR Spectroscopy 
 
The 1H NMR spectra of both the holo full length and truncated HasAp are 
identical (Figure 15). The presence of only one set of resonances shows that there is 
only one heme conformation of HasAp in solution. This result also agrees with the X- 
ray crystal structure data (see above). The mean hyperfine shifts of the four methyl 
peaks in heme proteins has been used as an indicator of the spin state of the heme-
iron [54, 55]. Heme methyl resonances of purely high-spin and low-spin species 
differ very dramatically from each other [54, 56-58]. The heme methyl resonances 
were  identified as the three intense  downfield  resonances at 42.90, 38.40 and  29.64   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15.  1H NMR spectrum of HasAp. 
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ppm. The most intense peak at 42.90 ppm contains two overlapping heme methyl 
resonances at 32 °C. The average 1H chemical shift of the heme methyl resonances of  
high-spin (S = 5/2) met-myoglobin wild type and H64V mutants is ~80 ppm [59]. In 
comparison, the average chemical shift of the heme methyl resonances of HasAp is 
only 36.98 ppm. This average methyl chemical shift is too large for a low-spin 
species (S = 1/2). Thus, the 1H NMR spectrum suggests an intermediate spin species 
(S = 3/2) or a mixture of high-spin (S = 5/2) and low spin (S = 1/2) species in fast 
exchange relative to the NMR timescale. These observations agree with the electronic 
absorption spectra of these proteins. From these results, we can conclude there is an 
equilibrium of high-spin (S = 5/2) and low-spin (S = 1/2) of HasAp in solution. It has 
been known that for a high-spin species, the meso-H isotropic shift [60-62] can be 
used as a probe to determine its coordination state. The meso-H for a penta- and 
hexacoordinate high-spin species resonates at ~ 40 ppm and -25 ppm, respectively. 
As shown in Chapter 2, broad meso-H peak render this approach inefficient. From the 
1H NMR data of HasAp shown in Figure 15, there is no way to determine its 
coordination state. There is no peak at approximately 40 ppm or -28 ppm. It has been 
reported [59, 63-68] that the chemical shift characteristics of the core heme carbons 
(Cα, Cβ and Cm), more importantly the meso-carbons, can be used as a probe to 
determine the coordination state of heme iron. As mentioned in Chapter 2, the 13C 
NMR approach is more practical in determining the coordination state of the heme-
iron because the effect of paramagnetism of the relaxation of 13C is ~ 16-fold lower 
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than the 1H relaxation and this results in narrower and readily observable 13C 
resonances.   
 
13C NMR Spectroscopy 
           To overcome the low natural abundance inherent to 13C spectroscopy, heme-
labeled with 13C at appropriate positions was used to reconstitute truncated apo-
HasAp.  Heme derived from [1,2-13C-ALA] was  used to reconstitute apo-HasAp so 
the  heme is labeled at the four methyls, two β-vinyls, two carbonyls, and  two β-
propionates (insert of  Figure 16) [21].   The peaks with blue arterisks correspond to 
polypeptide peaks, which were determined from a sample of HasAp reconstituted 
with unlabeled heme. The [1,2-13C]-ALA precursor should label 10 carbons in the 
heme macrocycle. However, in the spectrum (Figure 16) there are only 8 peaks 
originating from 13C labeled carbons.  Assignment of the 13C peaks could not be 
accomplished using 1H-13C HMQC experiment because no signal was detected in the 
spectrum due to the fast relaxation of the 1H resonances.  However, La Mar and 
coworkers [69] reported that the 2,4 Cβ-vinyls of met-aquo myoglobin resonate 
between  270  and  350 ppm.  Hence, the peaks at 225 and 254 ppm were assigned as 
the 2, 4 Cβ-vinyls.  A closer look at the spectrum shows that the intense peak at ~200 
ppm consists of two equivalent resonances, which have been assigned to the two 
carbonyls. The three peaks clustered between 30 and 45 ppm are due to the four 
methyls. The peak at 33 ppm has two overlapping methyl peaks. This leaves the two 
β-propionates unassigned. Hence, the two remaining peaks at 130 and 170 ppm are 
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assigned as the two β-propionates. Moreover, from Figure 16, it can be noted that 
there is only one heme isomer in HasAp.  This result agrees with information 
obtained from X-ray crystallography and 1H NMR.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16.  13C NMR spectrum of HasAp reconstituted with heme derived from [1,2-
13C]-ALA. The spectrum was obtained from a sample (2.5 mM) in phosphate buffer 
(pH 7.0) at 32 °C over 125 kHz, with 150 ms acquisition time, 20 ms relaxation delay 
and  100 000 scans at 150.821 MHz 13C frequency. The polypeptide peaks are 
indicated by blue asterisks. 
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The protonated carbons of the heme would not be able to give much 
information on the electronic structure and coordination state of the heme-iron as 
much as the core porphyrin carbons. As mentioned earlier, the characteristic chemical 
shifts of the core carbons can be used as a probe to determine the coordination state 
and electronic structure of the heme. However, the close proximity of the core 
porphyrin carbons (Cα, Cβ, and Cmeso) to the heme iron makes them more strongly 
affected by the unpaired electron, which makes assigning them more challenging than 
assigning the protonated heme carbons [10].  Moreover, detection and assignment of 
core porphyrin carbons has provided straightforward correlations between 13C-core  
chemical shifts and electronic structure of the heme [59, 68]. Several studies by NMR 
and density functional calculations (DFT) were reported to determine the electronic 
structure and coordination of the heme active sites [10, 22, 63, 70]. A method 
developed [59] and described  in Chapter 2 on determining the coordination state of 
the high spin heme protein was developed to provide some insights on the electronic 
structure and coordination state of HasAp. 
The meso-13C chemical shifts have been shown to be a simple and reliable 
diagnostic tool to determine the coordination state of high-spin (S = 5/2) heme protein 
regardless of the axial ligands as described in Chapter 2. This method was also used 
to determine the coordination state of a heme transport protein, ShuT [20]. A 
summary of the 13C chemical shift characteristics of the core carbons of the high-spin 
(S = 5/2) hexacoordinate and pentacoordinate sperm whale myoglobin complexes and 
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also the characteristic chemical shifts of the core carbons of low-spin species [10] are 
shown in Figure 17.  
 To determine the core porphyrin carbons chemical shifts, truncated HasAp 
samples were reconstituted with hemin labeled  with 13C  at  the Cα  and  Cβ  positions 
(insert of Figure 18A) and with hemin labeled at the Cα and Cm positions (insert of 
Figure 18B). The 13C NMR spectrum in Figure 18A shows downfield 
paramagnetically affected resonances between 800 and 1100 ppm. While the 
spectrum in Figure 18B shows peaks between 1000 and 1100 ppm and another peak 
(enclosed in red box) at approximately -6 ppm.  The common isotopic enrichment for 
both samples (Figures 18A and B) is Cα. Thus, the broad peaks centered at 
approximately 1050 ppm in Figures 18A and B can be straightforwardly assigned as 
the pyrrole Cα resonances.  The four peaks between 900 to 950 ppm in Figure 18A 
are the four Cβ resonances. Therefore, it is straightforward to conclude that the peak 
at -6.10 ppm in Figure 18B originates from the Cmeso resonances. The downfield 
shifted Cα and Cβ resonances indicate that the dx2-y2 orbital of the iron is half-filled 
and this places a positive sigma spin density at the core carbons (Cα and Cβ) [71-73].   
The high spin density at the Cα and Cβ positions leads to a conclusion that HasAp has 
more high-spin (S = 5/2) than low spin (S = 1/2) characteristics.  It was also noted in 
Chapter 2 that pyrrole Cα  and  Cβ  chemical shifts (Figure 17) can also be used to 
differentiate the hexacoordinate from the pentacoordinate heme complex.  
Hexacoordinate complexes have Cα and Cβ peaks at 1500 and 1250 ppm, 
respectively,  whereas in pentacoordinate complexes  they resonate at  1250  and  900  
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Figure 17.  13C NMR chemical shift characteristics of the core carbons of  (A) high-
spin (S = 5/2) hexacoordinate;  (B) high-spin (S = 5/2) pentacoordinate and (C) low-
spin (S = ½) heme complexes. Adapted from [10, 59]. 
 
 
1800 1400 600 400 200 0 -2001200 1000 8001600
Cα CmesoCβ
1800 1400 600 400 200 0 -2001200 1000 8001600
CmesoCα Cβ
13C Chemical shift (ppm)
Cα CmCβ
1800 1400 600 400 200 0 -2001200 1000 8001600
A
C
B
 98
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18.   13C NMR spectra of HasAp, pH 7.0, reconstituted with (A) heme labeled 
at the Cα and Cβ positions and (B) heme labeled at the Cα and Cm positions. The 
spectra were obtained at 32 °C over 213 kHz, with 100 ms acquisition time, 20 ms  
relaxation delay and 500 000 scans at  150.821 MHz 13C frequency. 
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ppm, respectively, i. e.  the pyrrole Cα and Cβ chemical shifts of  hexacoordinate 
heme complexes are more downfield shifted than their pentacoordinate counterparts.  
The pyrrole Cα and Cβ   chemical shifts  of   HasAp   resonate  at  1050  and  900   
ppm, respectively. The Cα chemical shifts of HasAp are more upfield shifted 
compared to the Cα of the hexa- and pentacoordinate high-spin model heme 
complexes and the Cβ has the same chemical shift as the pentacoordinate complex.  
However, from the methodology developed in Chapter 2, it was emphasized 
that the magnitude of the 13C-meso chemical shifts can provide a straightforward 
diagnostic tool to elucidate the coordination of the heme-iron. Hexacoordinate and 
pentacoordinate complexes exhibit 13C-meso chemical shifts at approximately -80 
and 250 ppm, respectively (Figure 17). The Cmeso resonance at -6.10 ppm shows that 
the heme-iron in HasAp is hexacoordinate. However, the resonance is not as upfield 
as the purely high-spin hexacoordinate complex of sperm whale metmyoglobin (~80 
ppm). An expanded spectrum of the Cmeso resonance at 32 °C is shown in Figure 19. 
At closer inspection, the expanded spectrum shows that the single broad peak (-6.10 
ppm) corresponding to the Cmeso consists of several peaks. 13C NMR spectra of 
HasAp reconstituted with heme labeled at the Cmeso positions were also obtained at 
different temperatures. In Figure 19, it can be seen that at 37 ˚C, only one meso-
carbon broad peak (-3.97 ppm) is observed. As the temperature is lowered, this peak 
moves upfield (indicated by red arrow) and new peaks show up. At 25 °C, the Cmeso 
resonates at -6.95 ppm and a new small peak shows up at -15.53 ppm. As the 
temperature is lowered to 15, 10 and 5 °C, the Cmeso peak shifts even more upfield.  In  
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Figure 19.  Expanded 13C NMR spectra of HasAp in phosphate buffer ( μ = 0.10, pH 
7.0 in D2O) reconstituted with heme labeled at the Cm positions. The spectra were 
obtained at different temperatures indicated above over 125 kHz, with 100 ms 
acquisition time, 20 ms relaxation delay, and 200 000 scans at 150.821 MHz 13C 
frequency. The high-spin and low-spin 13C-mesos are indicated with red arrows and 
blue asterisks, respectively.  
- 6 0- 4 0- 2 002 04 06 08 01 0 01 2 01 4 0140 0120 80100 -6060 40 -40-2020
13C Chemical Shift (ppm)
5 °C
25 °C
10 °C
15 °C
32 °C
37 °C
unlabeled, 37 °C
unlabeled, 5 °C
* *
**
 101
addition, at 15 °C, there are two new small peaks and at 10 °C and 5 °C, there are 
three new peaks. The small peaks also shift upfield as the temperature is lowered and 
become more intense.  This could imply that the species attains higher hexacoordinate 
character. Decreasing the temperature, however, shifts the meso-carbon resonances 
toward more negative values, which are characteristic of hexacoordinate high-spin 
heme centers. Comparison of spectra obtained with HasAp reconstituted with heme 
derived from 5-13C-ALA spectra at different temperatures and spectra of HasAp 
reconstituted with unlabeled heme and identical acquisition parameters reveals that 
there are two sharp peaks resonating between 80-100 ppm which are not present in 
the unlabeled samples. As shown schematically in Figure 17C, the meso-carbon 
chemical shifts of low-spin hemes resonate near their diamagnetic region of 80 ppm 
[10]. Hence, the results suggest equilibrium of hexacoordinate high-spin and low-spin 
populations in slow exchange relative to the NMR time scale. We postulated that this 
hexacoordinate high-spin and low-spin equilibrium is due to the breaking and 
forming of the hydrogen-bond between the phenolate group of Tyr75 and Nδ of 
His83. To further prove the hydrogen-bond postulate, 13C NMR spectra of HasAp 
with heme-labeled at the meso-carbon were obtained at different temperatures in 95% 
H2O and 5% D2O in order to compare them with the spectra in Figure 19, which were 
obtained in 100% D2O.  In principle, the hydrogen-bond between Tyr75 and His83 
should be stronger in water solution than in D2O because the hydrogen bond between 
His83 and Tyr75 would be abolished if hydrogen is replaced by deuterium. The 13C 
NMR data obtained in H2O solution are shown is Figure 20.   
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Figure 20.  Expanded 13C NMR spectra of HasAp in phosphate buffer ( μ = 0.10, pH 
7.0 in 95% H2O, 5% D2O) reconstituted with heme labeled at the Cm positions. The 
spectra were obtained at different temperatures indicated above over 125 kHz, with 
100 ms acquisition time, 20 ms relaxation delay, and 200 000 scans at 150.821 MHz 
13C frequency. The high-spin and low-spin 13C-mesos are indicated with red arrows 
and blue asterisks, respectively.  
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The 13C resonances of HasAp in H2O are sharper and more intense than those 
in D2O.  It can also be observed that as temperature is lowered, new peaks show up, 
however, in H2O new peaks start to show up at 37 ˚C. The meso-carbon resonances of 
both low-spin and high-spin species also move upfield as the temperature is lowered.  
The chemical shifts of the meso-carbons corresponding to the low-spin and high-spin 
species have been tabulated in Table 2.  For the high-spin species, there are two 
meso-carbon chemical shifts in Table 2, one for the broad meso peak and the other for 
the most upfield shifted meso-carbon resonance.  The meso-carbon chemical shift 
corresponding to the low-spin species is an average of the two observable meso 
peaks.  It is noteworthy that the chemical shifts of the meso-carbon resonances from 
the low-spin species at different temperatures are identical in H2O and in D2O, despite 
the fact that they move upfield as the temperature is lowered. In striking contrast, the 
resonances corresponding to high-spin meso-carbons behave differently.  From 25-37 
°C, the broad meso-carbon is more upfield shifted in H2O solution, but at 5 °C, it is 
more upfield shifted in D2O. However, the chemical shifts of the most upfield shifted 
small peak in both solutions are more upfield shifted in H2O solution.  In fact, they  
start to show up  at  higher  temperature and  at  5 °C, the most upfield shifted meso-
peak  resonates at -40.19 ppm,  which clearly suggests that there is a stronger 
hexacoordinate species at lower temperature  in H2O solution.  The equilibrium of 
hexacoordinate high-spin and low-spin species in solution is likely brought about by 
the breaking and forming of the hydrogen-bond between Tyr75 and His83, as shown 
in  Figure 21.  The higher temperature could promote  the breaking  of  the  hydrogen- 
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Table 2.   Chemical Shift Characteristics of Meso-Carbons at Different Temperatures 
 
Low-Spin Low-Spin 
5 -13.04 -39.82 72.11 -13.24 -40.19 72.37
10 -11.9 -33.44 75.23 -13.01 -35.18 75.28
15 -11.73 -28.19 78.55 -12.52 -29.89 78.65
25 -6.95 -15.53 84.64 -8.63 -16.18 84.64
32 -4.55 89.97 -6.95 -13.13 89.89
37 -3.97 93.64 -5.31 -12.75 93.62
Temp. 
(ºC)
D2O H2O
High-Spin High-Spin 
 
 
bond between Tyr75 and His83 which makes Tyr75 a stronger field ligand and thus 
have a low-spin character. Whereas the formation of hydrogen-bond between Tyr75 
and His83 makes Tyr75 a weaker field ligand, and weakens the field strength of the 
Tyr ligand, thus introducing high-spin character to the hexacoordinate complex.  The 
changes in population of the two spin states in equilibrium serves as a sensitive probe 
of the effective axial field strength.  The breaking and forming of hydrogen-bond 
which contributes to the two spin states of HasAp is in slow exchange relative to the 
NMR time scale.  
 The 13C NMR spectra (Figure 22) of HasAp with heme labeled at the Cα and 
Cβ positions were also taken at different temperatures to further prove the presence of 
equilibrium between hexacoordinate high-spin and low-spin species in solution. It 
should be expected that the Cα and Cβ resonances should shift downfield as the 
temperature is lowered if a high-spin hexacoordinate species is populated. In contrast 
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to this expectation, the Cα (indicated by red arrows) and Cβ (indicated by blue arrows) 
resonances are shifting upfield at lower temperatures. However, their chemical shift 
characteristics do not correspond to a fully low spin species [10]. Even at lower 
temperatures, the Cα and Cβ resonances suggest that low spin species are being 
populated. The 13C NMR results agree with the electronic absorbance spectrum that 
there is equilibrium of high-spin and low-spin species of HasAp in solution.  At lower 
temperature,  the  high-spin  species are  still  dominant  as  observed by  the chemical 
 
 
 
 
 
 
 
 
 
 
Figure 21.   Illustration of the equilibrium of high-spin (S = 5/2) and low-spin (S = 
½) hexacoordinate species of HasAp. The hydrogen bond between Tyr75 and His83 
is shown in black dotted lines.  
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Figure 22. Expanded 13C NMR spectra of HasAp at pH 7.0 reconstituted with heme 
labeled at the Cα and Cβ positions. The Cα and Cβ resonances are indicated with red 
and blue arrows, respectively. The spectra were obtained at different temperatures 
indicated above over 125  kHz, with 100 ms acquisition time, 20 ms relaxation delay, 
and 200 000 scans at at 150.821 MHz 13C frequency. 
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shift characteristics of the Cα and Cβ resonances, but the low spin species are being 
populated.  These results could lead to an understanding how HasAp takes up heme 
from hemoglobin and how it transfer heme to the cognate receptor.   The axial ligand 
and/or His83 might  play important roles in  this  process. The hydrogen-bond 
between Tyr75-His83 could make HasAp bind strongly with heme while the breaking 
of this bond might facilitate the release of heme to HasR.  Hence, this hydrogen-bond 
may functionally be relevant in the context of uptake and release of heme in 
hemophores.   
 
Electron Paramagnetic Resonance 
 The EPR spectra of HasAp at different pH is shown in Figure 23. At pH 5.8 
and 7.0, it exhibits a rhombic low-spin signal with g values of 2.83, 2.20 and 1.71. In 
addition, it has a very weak high-spin signal (g  = ~ 6)  which is about ~10% with 
some distinguishing rhombicity. The EPR data also agree with the electronic 
absorption spectroscopy, 1H and 13C NMR results that there is a low-spin and high-
spin equilibrium of HasAp in solution.  
 
Heme Transfer Experiments 
The heme transfer experiments aim to determine if apo-HasAp can capture 
heme from hemoglobin and myoglobin regardless of the heme iron redox state. Both 
methemoglobin and metmyoglobin have ferric heme iron, while oxyhemoglobin has a 
ferrous heme-iron. As shown in Figure 24, the Soret band of holo-HasAp, 
 108
methemoglobin, metmyoglobin and oxyhemoglobin are 407, 405 and 409, 415 nm, 
respectively. The difference in the Soret band of HasAp to the above-mentioned holo- 
 
 
 
 
 
 
 
 
 
 
 
 
 
                              Figure 23 . EPR spectra of HasAp at different pH. 
 
proteins is too small and it is hard to monitor the heme transfer using the Soret band. 
However, the high-spin charge transfer band of holo-HasAp at 616 nm (inset of 
Figure 24) is the only intense band which differs from the other proteins. Thus, the 
absorbance at this peak was used as a marker to monitor the heme transfer from holo- 
proteins to apo-HasAp.  
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Figure 24. Electronic absorption spectra of oxyhemoglobin (red), methemoglobin 
(black), metmyoglobin (blue) and HasAp (green).  The inset shows their visible 
bands. The high-spin charge transfer band of HasAp at 616 nm was used to monitor 
the heme transfer.  
 
 
The heme transfer experiment from oxyhemoglobin to apo-HasAp is shown in 
Figure 25A. The black dotted line in the family of spectra in Figure 25A-C are the 
spectra of oxyhemoglobin, methemoglobin and metmyoglobin, respectively, before 
mixing with apo-HasAp.   While, the red lines are the spectra taken 30 seconds after 
mixing of apo-HasAp with oxyhemoglobin, methemoglobin and metmyoglobin, 
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respectively. In Figure 25A, there is no noticeable change in visible spectra 
absorbances at 540 and 570 nm (inset of Figure 25A) as well as in the Soret bands at 
415 nm. A 7 nm difference in the Soret band of HasAp and oxyhemoglobin would be 
slightly noticeable. The small decrease in the Soret absorbance is due to dilution after 
mixing of HasAp and oxyhemoglobin solution. The reaction was monitored for 2 
hours. But the reaction was incubated for overnight. After 15 hours, the visible region 
shows bands characteristic of holo-HasAp and absence of low-spin marker bands of 
oxyhemoglobin. This could imply that heme is transferred to apo-HasAp when the 
heme is in the oxidized state. The autooxidation of methemoglobin would have 
facilitated the transfer.  
There was also no heme transfer from metmyoglobin to apo-HasAp as 
observed in Figure 25B. The absorbances at the visible region did not change in 2 
hours. However, after overnight incubation, heme transfer was observed as indicated 
by the change in the high-spin charge transfer bands. While in Figure 25C, it can 
clearly be observed that there is a fast heme transfer from methemoglobin to apo- 
HasAp.   After 30 seconds of mixing apo-HasAp with methemoglobin, the high-spin 
charge  transfer  band  shifts from  630 nm  to  622 nm.   Subsequent spectra show a 
complete shift to 616 nm.  There is definitely a fast transfer of heme from 
methemoglobin to apo HasAp. The change at 616 nm in the heme transfer 
experiments is shown in Figure 26.  From the results, it can be observed that both oxy 
hemoglobin and metmyoglobin did not show heme transfer to apo-HasAp or if there 
is any  heme transfer, it is very slow.  These  experiments tell us that  apo-HasAp  can  
 111
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25.  Heme transfer experiments from (A) oxyhemoglobin, (B) metmyoglobin                   
and (C) methemoglobin to apo-HasAp. 
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capture heme from methemoglobin and not from oxyhemoglobin and metmyoglobin. 
In addition, the experiments also suggest that apo-HasAp can only take heme in the 
oxidized form as manifested in the oxyhemoglobin heme transfer experiment. It can 
take heme from metmyoglobin but very slow. This could lead us to conclude that 
apo-HasAp can “steal” heme from hemoglobin in the oxidized state by protein-
protein interaction and not by passive diffusion. The protein-protein interaction of 
HasAp and methemoglobin is discussed in Chapter 4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. Heme transfer experiment from holo proteins (indicated above) to apo- 
HasAp. The heme transfer was monitored using the change in intensity at 616 nm 
with time. 
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 However, the fast rate of heme transfer from hemoglobin to apo-HasAp 
cannot be monitored by UV-Visible spectroscopy. The kinetics of heme transfer 
experiments were done using stopped-flow spectroscopy at 37 °C with a 16:1 apo-
HasAp to met-Hb ratio. The result showed a rapid formation of holo HasAp (Figure 
27A). The time course at 616 nm appears to be biphasic with observed pseudo-first-
order rate constants of 0.02 s-1 and 0.002 s-1 at 10 μM met-hHb (Figure 27B). The 
0.02 s-1 observed rate is approximately two-orders of magnitude faster than the 
dissociation rate constant of met-Hb alone. The control experiments with equivalent 
amounts of  bovine  serum  albumin show  no significant spectra changes in  the  time  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27.  Heme transfer from hemoglobin to apo-HasAp monitored at 616 nm as a 
function of time (A) and the stopped flow experiment to determine the kinetics of 
heme transfer (B).  
 
 
 
0 200 400 600 800
 
ΔΑ616nm
Time (s)
k1 = 0.02 s
-1
k
2
 = 0.002 s-1
500 550 600 650 700
0.00
0.05
0.10
0.15
 
Ab
so
rb
an
ce
Wavelength (nm)
    50-s steps
from 0.5s to 768s
616 nm
A B
  
Ab
so
rb
an
ce
 114
frame examined. These heme transfer experiments strongly suggests that apo-HasAp, 
can take heme only from methemoglobin and it takes the heme from hemoglobin 
before met-Hb dissociates in solutions. Thus, there is a likelihood of protein-protein 
interaction between apo-HasAp and met-Hb.  
 
Amide Backbone Resonance Assignments 
The 1H-15N HSQC spectra of holo full-length and truncated forms of HasAp 
(pH 7.0) taken at 32 °C are shown in Figures 28 and 29, respectively.  The intensity 
of the cross-peaks and signal dispersion in both spectra are similar to each other. This 
is an indication that both the full-length and truncated 15N-labeled samples are of 
good quality and labeling with deuterium is unnecessary for these samples. The full-
length form is consists of 205 amino acid residues, while the truncated form has 184 
residues. As observed in Figures 28 and 29, the cross-peaks corresponding  to Gly35,  
Phe78 and  Tyr138  (enclosed in  black boxes) are not as intense as the rest of the 
residues. They are very weak but were assigned because correlations were found to 
the residues before and after them in the sequence. Overlayed spectra of holo full-
length and truncated HasAp are shown in Figure 30.  Not counting Pro198, 20 of the 
21 residues in the carboxy tail of the full-length form exhibit cross-peaks. The 20 
residues corresponding to the tail are located in a crowded region (enclosed in blue 
boxes).  The two glycine residues (Gly191 and Gly193) are located upfield in the 15N 
region. These assignments and the similarity in the spectra of full-length and 
truncated forms greatly  simplified  the assignment of resonances from the  full-length 
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Figure 28. Fast 1H{15N} HSQC spectrum of holo full-length HasAp (2.8 mM in 
phosphate buffer, μ = 0.1, pH 7.0, 5% D2O)  Weak resonances originating from G35,  
F78 and Y138 are enclosed in boxes. Spectrum was obtained at 305 K using a Bruker 
Avance 800 NMR spectrometer  (see  Experimental  Procedures). Complex  points,  
256 (t1) x  2048 (t2); spectral  width 3.4  kHz  (t1) x 19.2 kHz  (t2); 16  scans  per  
increment; acquisition time 100 ms; recycle delay 1s. 
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Figure 29. Fast 1H{15N} HSQC spectrum of holo truncated HasAp (2.8 mM in 
phosphate buffer, μ = 0.1, pH 7.0, 5% D2O)  Weak resonances originating from G35,  
F78 and Y138 are enclosed in boxes. Spectrum was obtained at 305 K using a Bruker 
Avance 800 NMR spectrometer  (see  Experimental  Procedures). Complex  points,  
256 (t1) x  2048 (t2); spectral  width 3.4  kHz  (t1) x 19.2 kHz  (t2); 16  scans  per  
increment; acquisition time 100 ms; recycle delay 1s. 
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form once the assignments for the truncated form had been obtained. The absence of 
heme isomerism in both forms of HasAp proteins as observed in the X-ray crystal 
structure and in the 1H and 13C NMR means that there should be only one cross-peak 
per residue. Interestingly Asp29, Asn47, and Asn80 display two cross-peaks each.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30.  Fast 1H{15N} HSQC Spectra of (A) full-length (green) and (B) truncated 
(red) HasAp.  
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Conventional heteronuclear 2D and 3D NMR experiments performed with a 
sample of holo truncated [U-13C, U-15N]-HasAp allowed resonance assignment of a 
large majority of non-proline residues, with the exception of residues listed in Table 
3. Most of these residues except for Ser2 and Ser103 are located < 9 Å from the heme 
iron, thus they are expected to be strongly influenced by the iron paramagnetism, 
which is manifested in weak or undetectable cross-peaks in the HSQC spectrum. 
These residues have been mapped on the X-ray crystal structure shown in Figure 31.  
No amide correlation connection was present to Ser2 because it is the first residue in 
the N-terminus, because, the start methionine codon was cleaved during expression. 
S103 is located in a loop and this residue has the highest B-factor value in the 
structure as determined by X-ray crystallography as discussed above. Thus, this 
residue was not seen because of its conformational disorder.  The assignment of the 
above-mentioned residues in close proximity to the heme active site except for His32, 
Arg33,  Thr76, and  His83 were  assigned  with the  aid of  samples selectively 
labeled with 15N-Leu, 15N-Val, 15N-Tyr or 15N-Thr and 2D 1H-15N HSQC 
experiments  tailored to detect fast relaxing signals [18, 74],  in a manner similar that 
used for the assignment of fast relaxing signals in heme oxygenase from 
Pseudomonas aeruginosa [18].  The method was modified to prevent isotopic 
scrambling.  Thus, 98% of the non-proline residues in both holo full-length and 
truncated HasAp forms were assigned using the combination of 3D NMR 
experiments and the selective labeling technique coupled with fast recycling 1H-15N 
HSQC.   It should be noted that a  cross-peak originating  from axial ligand  His32  or  
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Table 3.  Distances of the Unassigned Residues from the Heme-Iron 
Residue Distance from heme-iron (Å)
His32 7.70
Arg33 6.92
Val37 8.10
Val38 9.29
Thr43 7.36
Thr76 8.01
Leu77 6.71
His83 6.52
Thr84 6.81
Leu85 7.92  
 
 
 
 
 
 
 
 
 
Figure 31.  Unassigned residues using triple resonance NMR experiments are 
shown in blue. The heme is in red. 
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from His83, which in the crystal structure of HasASM and HasAp forms a hydrogen 
bond to the phenolate oxygen of Tyr75, have not been identified. Selective labeling 
with His was not attempted due to cost considerations, thus it is not known whether 
the strategy would have facilitated the identification and sequential assignment of 
cross-peaks originating from these residues. Selective labeling with 15N-Arg was not 
also attempted because it is not commercially available, hence Arg33 was not 
assigned. The backbone assignment of the truncated apo-HasAp was also assigned 
using the conventional 3D NMR experiments and only 89% of the non-proline 
residues were assigned. The 1H-15N spectrum is shown in Figure 32. Most of the 
residues not assigned are close to the N-terminus. Moreover, those residues in close 
proximity to the heme-iron were all assigned.  
 
Triple Resonance NMR Assignments 
 The triple-resonance (3D) NMR experiments for sequential backbone 
assignments of proteins (See Table 4) are based on the ability to transfer 
magnetization through NMR active nuclei using J-couplings. The nomenclature of 
3D NMR experiments is very descriptive. Names of nuclei used for magnetization 
transfer during the indirect evolution periods are listed in the order of their use. The 
nuclei whose frequency are not detected but are used in magnetization transfer are 
shown in parenthesis [75]. The signals in triple resonance experiments are dispersed 
in three dimensions so the spectra are distributed in a cube instead of a plane. 2D 
slices are taken  from the  3D  cube  along  the 15N  dimension.   This is  illustrated  in  
 121
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32.  Fast 1H{15N} HSQC spectrum of apo truncated HasAp. Spectra were 
recorded on a Varian Unity INOVA 600 NMR Spectrometer. Acquisition parameters 
were as follows: (A) Complex points, 128 (t1) x 1632 (t2); spectral width, 2.4 kHz (t1) 
x 9.60  kHz (t2); acquisition time, 85 ms; recycle delay, 1 s; 32 scans.   
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 Table 4, the nuclei whose frequencies are detected are encircled in blue and nuclei 
whose frequencies are used for magnetization transfer are encircled in red. A 
summary of the 3D NMR experiments and their correlations is shown in Table 5.   
The HNCA experiment is the prototype of all triple resonance experiments. This 
experiment employs out-and-back coherence transfer. This experiment correlates the 
amide 1H and 15N with the aid of the intraresidue 13Cα through a single bond (1JNCα = 
7-11 Hz). The magnetization is first transferred from the amide proton to the directly 
attached nitrogen atom. Then the magnetization is transferred to the 13Cα. This 
experiment also gives sequential connectivities by transferring magnetization to the 
preceding 13Cα via two interresidue bonds (2JNCα) [75-78]. Hence, in the HNCA 
experiment the 13Cα  of any given residue and that of its preceding residue can be 
assigned. It may be possible to assign the protein backbone exclusively with an 
HNCA experiment. However, sometimes sequential assignments with HNCA are 
ambiguous because of the frequency overlap or the degeneracies of the intraresidue 
and interresidue Cα.   
To overcome this ambiguity, a complementary experiment to HNCA was 
employed. This 3D experiment, HN(CO)CA, provides assignments only for the 13Cα 
of the preceding residue (See Table 4). The HN(CO)CA experiment is specifically 
designed for sequential correlations between the  15N and 1H chemical shifts of a 
given residue and the preceding 13Cα shifts via the intervening 13CO nucleus by 
means  of  the  1J(NH), 1J(N,CO)  and    1J(CA,CO)  coupling  constants  [76, 79, 80].  
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 Table 4.  Magnetization Transfer Observed in 3D NMR Experiments 
Experiment
HNCA
HN(CO)CA
CBCA(CO)NH
HNCACB
HNCO
Magnetization Transfer
Residue iResidue i-1
Residue iResidue i-1
Residue i-1 Residue i
Residue i-1 Residue i
Residue iResidue i-1
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Table 5.  Triple Resonance Experiments Used for Sequential Backbone Assignment 
Experiment Observed Correlations J  Couplings
HNCA 1HNi – 
15Ni – 
13Cαi 
1J NH
1HNi – 
15Ni – 
13Cαi-1 1J NC
α
2J NC
α
HN(CO)CA 1HNi – 
15Ni – 13C
α
i-1 
1J NH
1J NCO
1J C
α
CO
CBCA(CO)NH 1HNi – 
15Ni – 
13Cβi-1 
1J CH
1J C
α
C
β
1J C
α
CO
1J NCO
1J NH
HNCACB 1HNi – 
15Ni – 
13Cαi/C
α
i-1 
1J NH
1HNi – 
15Ni – 
13Cβi/C
β
i-1
1J C
α
N
1J CC
2J C
α
N
HNCO 1HNi
 – 15Ni
 – 13COi-1 1J NH
1J NCO  
 
 
 
 125
Moreover, ambiguity from the 13Cα resonances can be further resolved by looking at 
the beta carbons (13Cβ). Basically, most of the 13Cα of most in HasAp were assigned 
by the combination of HN(CO)CA and HNCA experiments.  
 The 13Cβ were assigned using CBCA(CO)NH and HNCACB experiments. 
These experiments are considered to be the workhorse for backbone assignments. 
Both experiments provide similar set of data. The HNCACB experiment provides 
both intra- and interresidue connections, whereas, CBCA(CO)NH provides only 
interresidue connections (See Table 4). HNCACB correlates the 1H and 15N amide 
resonances with those of the interresidue 13Cα and 13Cβ resonances by means of the 
1J(NH), 1,2J(N,CA) and optional 1J(CA,CB) coupling constants [81, 82]. In the 
HNCACB spectrum, at any given amide proton frequency, four peaks can be 
observed: two positive 13Cα cross-peaks and two negative 13Cβ cross-peaks, which 
correspond to the 13Cα and 13Cβ of a given residue and its preceding residue.  Proline 
residues can interrupt the chain because they do not have amide protons. In principle, 
HNCACB can provide the assignments for both 13Cα and 13Cβ, but frequency overlap 
and degeneracies of resonances can also be a problem like in HNCA.  CBCA(CO)NH 
can help overcome this ambiguity by providing assignments of the 13Cα and 13Cβ 
peaks of the preceding residue (See Table 4). This experiment correlates the 1H and 
15N resonances of a given residue to both 13Cα and 13Cβ of the preceding residue [75, 
76].  In this spectrum, positive and negative peaks can be observed due to the 13Cα 
and 13Cβ resonances, respectively.  
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Overall, the amide backbone assignments were accomplished with the use of 
the above described triple resonance NMR experiments. However, there were still 
some ambiguities in the assignment. Two more experiments were done to resolve 
these ambiguities. These two experiments are HNCO and (HCA)CO(CA)NH.  The 
HNCO experiment correlates crucial sequence backbone connectivities between the 
amide 1H and 15N of a given amino acid to the carbonyl (13CO)  resonance of the 
preceding residue by means of  1J(NH) and 1J(N,CO) coupling constants 1J(NH) and 
1J(N,CO) coupling constants [75, 78, 79].  The HNCO provides the assignment of the 
13CO of the previous residues while (HCA)CO(CA)NH provides the connectivity to 
both intra- and interresidue 13CO. Majority of the resonances were assigned using the 
above-mentioned 3D NMR experiments. The chemical shifts for N-H, 15N, 13Cα, 13Cβ, 
and 13C' of full-length and truncated holo HasAp and truncated apo-HasAp are 
summarized in Appendix 2, 3 and 4, respectively.   
 
Assignment of Leu 77 and Leu85 
Leu77 and Leu85 could not be assigned with the aid of the 3D spectra 
described above. Leu77 and Leu85 are located 6.71 and 7.92 Å, respectively from the 
heme-iron. The 1H-15N HSQC spectrum of 15N-Leu-HasAp acquired with conditions 
typically utilized to study diamagnetic proteins (Figure 33A), shows 16 cross peaks, 
that is, one less cross-peak than the number of Leu residues in the sequence. All these 
cross-peaks, except the weak signal at δ (1H) = 7.3 ppm δ (15N) = 123 ppm (enclosed 
in circle) had been previously assigned with the aid of 3D heteronuclear experiments.  
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In comparison, an HSQC spectrum acquired with rapid pulse repetition from the same 
15N-Leu-HasAp sample (Figure  33B) exhibits a cross-peak with a large downfield 1H 
and 15N shifts, at δ (1H) = 10.4 ppm and δ (15N) = 133 ppm, respectively.  This cross-
peak was sequentially assigned to Leu85 using information obtained from the suite of 
3D spectra collected to obtain sequential assignments. Thus, the fact that strip plots 
taken from 1H-13C slices at the 15N frequencies of the amide N-H cross-peak in 
question and the N-H cross-peak of W86 share a Cβ correlation (Figure 34) in the 
CBCA(CO)NH and HNCACB assigns the N-H cross-peak in question to Leu85. It is 
important to note that in retrospect the Leu85 cross-peak can also be observed as a 
very weak signal in a HSQC spectrum acquired with standard conditions and a 
sample of uniformly 15N-labeled HasAp. In absence of the information provided by 
the HSQC spectrum acquired with a sample of [15N-Leu]-HasAp and  fast  pulse 
recycling,  however, this cross-peak could  have been easily overlooked. It is also 
noteworthy that the non-assigned weak signal at δ (1H) = 7.2 ppm and δ (15N) = 125 
ppm in the HSQC spectrum acquired with standard conditions (Figure 33A) is a well-
defined  cross-peak in  the spectrum  acquired with fast repetition. In fact, this signal, 
which is attributed by default to Leu77, is a double cross-peak, indicating that Leu-77 
is present in at least two conformations in HasAp.  
 
Assignment of Val 37 and Val 38 
Valine 37 and 38 are located 8.10 and 9.29 Å, respectively from the heme-
iron. The HSQC spectrum of 15N-Val-HasAp acquired with standard conditions 
 129
(Figure 35A) displays 8 cross-peaks corresponding to previously assigned Val 
residues. All the alanines were also labeled. However, the intensities of the 15N-Ala 
are lower compared to 15N-Val. Moreover, all alanine amide resonances were 
assigned, so new peaks observed can be safely assigned as valine residues. In 
comparison,  the HSQC  spectrum  acquired  with the same sample but with fast pulse 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34.  Strip plots taken at 1HN amide resonance frequencies corresponding to 
residues Leu85 and Trp86. The panels shown are sections of HN(CO)CA (a), HNCA 
(b), CBCA(CO)NH (c) and HNCACB (d) spectra collected with holo truncated 
HasAp sample. Straight lines connect resonances exhibiting sequential intra- (13Ci) 
and/or inter-residue (13Ci-1) correlations with the corresponding amide 1HN.  Cross-
peaks in HNCACB spectra shown in red were phased positive (13Cαs) and exhibit a 
180° phase difference relative to those shown in blue (13Cβs). 
 130
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A
)
(B
)
(A
)
(B
)
Fi
gu
re
 3
5.
  1
H
{1
5 N
} 
H
SQ
C
 sp
ec
tra
 o
f [
15
N
-V
al
]-
H
as
A
p.
 S
pe
ct
ra
 w
er
e 
re
co
rd
ed
 o
n 
a 
B
ru
ke
r A
va
nc
e 
80
0 
(A
) a
nd
 V
ar
ia
n 
U
ni
ty
 IN
O
V
A
 6
00
 (B
) N
M
R
 S
pe
ct
ro
m
et
er
s. 
A
cq
ui
si
tio
n 
pa
ra
m
et
er
s w
er
e 
as
 fo
llo
w
s:
 (A
) 
C
om
pl
ex
 p
oi
nt
s 
25
6 
(t1
) x
 2
04
8 
(t2
); 
sp
ec
tra
l w
id
th
, 3
.4
 k
H
z 
(t1
) x
 1
9.
2 
 k
H
z 
(t2
); 
ac
qu
is
iti
on
 ti
m
e,
 1
00
 
m
s;
 re
cy
cl
e 
de
la
y,
 1
 s;
 1
6 
sc
an
s. 
 (B
) C
om
pl
ex
 p
oi
nt
s, 
12
8 
(t1
) x
 1
05
0 
(t2
); 
sp
ec
tra
l w
id
th
, 3
.6
 k
H
z 
(t1
) x
 
15
  k
H
z 
(t2
); 
ac
qu
is
iti
on
 ti
m
e,
 3
5 
m
s;
 re
cy
cl
e 
de
la
y,
 5
0 
m
s;
 2
56
 sc
an
s. 
  
 131
repetition exhibits 10 cross-peaks corresponding to valine resonances (Figure 35B); 
the signal at δ (1H) = 7.8 ppm and δ (15N) = 122 ppm corresponds to Val37 because it 
has Cα and Cβ correlations to the preceding residue, Gln36, with the aid of 
CBCA(CO)NH and HNCACB data, as described above. Thus, the broad peak in 
Figure 35B at δ (1H) = 8.6 ppm and δ (15N) = 131 ppm corresponds to Val38.   
 
Assignment of Thr 43 and Thr84 
The three unassigned threonines, Thr43, 76 and 84 are located 7.36, 8.01 and 
6.81 Å from the heme-iron.  Isotopic scrambling with glycine and serine was 
overcome by supplementing the medium with those 15N-Gly and 15N-Ser together 
with the 15N-Thr during induction with IPTG. In the normal HSQC spectrum (Figure 
36A), only one new cross-peak corresponding to Thr shows up. This peak is at δ (1H) 
= 7.5 ppm and δ (15N) = 114 ppm besides Thr61. It is a fairly intense cross-peak and 
it is not surprising that it was not observed in the HSQC spectrum of the fully labeled 
15N-sample because this cross-peak overlapped with Asp30.  This peak beside Thr61 
was assigned as Thr84 because in its HN(CO)CA and HNCA spectra, it has Cα  
which corresponds to a histidine. Moreover, the HNCACB also has Cα and Cβ 
corresponding to a histidine. It cannot be Thr43 or Thr76 because it does not have 
correlations with Asn42 or Tyr75. Moreover, it was hard to assign this cross-peak 
without the aid of selective labeling because the preceding residue, His83 was not 
assigned and no correlation was observed with Leu85. In the fast pulse recycling 
HSQC (Figure 36B), one very broad peak located δ (1H) = 6.8 ppm and δ (15N) = 106  
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ppm can be observed. This peak has Cα correlations to Asn42 and Cα and Cβ 
correlations to Gly44.  Therefore, it is assigned as Thr43. However, this leaves Thr76 
unassigned.   
 
Assignment of Tyr 75  
HasAp was also labeled with 15N-Tyr in an effort to confirm the sequential 
assignment of the Tyr75 axial ligand. It is located 9.15 Å from the heme-iron. 
Isotopic scrambling with phenylalanine, glutamine and aspartate residues was 
observed when HasAp was expressed with 15N-labeled Tyr. However, their intensities 
are lower compared to   the tyrosine   residues.    Results  from these experiments 
confirmed the assignment of Tyr75 and drew attention to the fact that several residues 
near the heme are conformationally disordered, as indicated by the presence of more 
than one cross-peak per residue in HSQC spectra. For example, the HSQC spectrum 
of 15N-Tyr HasAp suggested the presence of two cross-peaks originating from Tyr138 
(Figure 37A-B). The peak at δ (1H) = 10 ppm and δ (15N) = 123 ppm had been 
assigned to Tyr138 but the smaller peak with very weak intensity had been 
overlooked. Upon additional analysis, it was shown that the lower intensity cross-
peak can be sequentially assigned to Tyr138, thus demonstrating that this residue is 
conformationally disordered. The HSQC spectra (Figure 37A-B) also suggest that the 
axial ligand Tyr75 exhibits two cross-peaks. The most intense peak had been assigned 
sequentially, whereas the low intensity signal had been previously overlooked. The 
clear presence of more than one cross-peak in Tyr75, Leu77 and Tyr138 prompted  us  
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to investigate and find the presence of conformational disorder in a number of 
residues in HasAp.   
 
Fast Recycling HSQC of HasAp 
It can be observed in the fast recycling HSQC spectra of both full-length and 
truncated fully labeled 15N-HasAp samples shown in Figure 38 and 39, respectively, 
that there are several residues that exhibit two cross-peaks. The results which are 
summarized in tabular form in Appendix 5 and in pictorial form in Figure 40  indicate  
that most  of  these residues  which  have  double peaks are located in the extended 
loop containing His32, in  the hairpin containing Tyr75 and in helix α2 and strand  
β2, both  of which  form  the  “back wall” of  the heme  pocket, are disordered 
conformationally. This conformational agility may contribute to endow HasAp with 
its ability to capture heme from hemoglobin and then deliver it to the HasR receptor.  
On the other hand, Gly35, Phe78 and Tyr138 (enclosed in black boxes) which 
where pointed out to be very weak in the HSQC spectra in Figures 28 and 29 are now 
more intense and broad.  Morever, two new peaks were observed in the fast recycling 
1H-15N-HSQC spectrum of both full-length and truncated HasAp as seen in Figures 
38 and 39 enclosed in green boxes. These peaks could be His32 and His83, however, 
no cross-peak can be found in all the 3D NMR spectra to sequentially assign these 
cross-peaks.  Comparison of the full-length and truncated HasAp acquired with 
normal and fast recycling HSQC also revealed that there are some peaks that are 
benefited by the short acquisition time which means that these residues relax faster 
than  the rest of the residues.   Mapping these residues in the X-ray crystal structure of  
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Figure 38. Fast recycling 1H{15N} HSQC spectrum of holo full-length HasAp (2.8 
mM in phosphate buffer, μ = 0.1, pH 7.0, 5% D2O). G35, F78 and Y138 resonances 
are enclosed in boxes. They are broader and more intense in the fast recycling HSQC 
shown above compared to the HSQC spectrum obtained in Figure 28. Spectrum was 
recorded on a Varian Unity INOVA 600 NMR Complex points, 128 (t1) x 1632 (t2); 
spectral width, 2.4 kHz (t1) x 9.60  kHz (t2); acquisition time, 35 ms; recycle delay, 1 
s; 128 scans.   
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Figure 39. Fast recycling 1H{15N} HSQC spectrum of holo truncated HasAp (2.8 
mM in phosphate buffer, μ = 0.1, pH 7.0, 5% D2O). G35, F78 and Y138 resonances 
are enclosed in boxes. They are broader and more intense in the fast recycling HSQC 
shown above compared to the HSQC spectrum obtained in Figure 28. Spectrum was 
recorded on a Varian Unity INOVA 600 NMR Complex points, 128 (t1) x 1632 (t2); 
spectral width, 2.4 kHz (t1) x 9.60  kHz (t2); acquisition time, 35 ms; recycle delay, 1 
s; 128 scans.   
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HasAp (Figure 41) shows that these residues are located less than 11 Å from the 
heme-iron. Clearly resonances from these residues are affected by the paramagnetic 
heme-iron which enhances relaxation and causes broadening of the signals.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 40.  Residues which exhibit double cross-peaks in the fast recycling HSQC 
are highlighted in marine. The heme is in red.  
 
 
 
Secondary Structure Identification of HasAp by NMR  
 The elements of secondary structure of HasAp can be identified by using the 
Chemical  Shift Index  (CSI) method of  Wishart et. al. [83, 84].   Chemical  shifts  of  
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Figure 41. Residues which are affected by the paramagnetic relaxation of the heme 
iron as observed in the fast recycling HSQC are highlighted in blue and magenta. The 
residues in magenta show double resonance in the spectrum. Residues not affected by 
heme paramagnetism are shown in green. The heme is in red.   
 
 
NMR active nuclei depend on several factors such as proximity to polar groups, 
presence of aromatic rings, bond hybridization states, local electronic distributions 
and magnetic anisotropies. Thus, chemical shifts depend on the structural 
environment and they can give structural information [84]. Wishart et. al. [83] 
developed useful empirical rules, called CSI, which is based on the observation that 
there is a relationship between 1Hα, 13Cα, 13Cβ or 13C' chemical shifts and protein 
secondary structure. The CSI approach has become a standard procedure in the NMR 
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based structural characterization of proteins and is considered as a quick and reliable 
method for determining the elements of secondary structure in proteins [85-89]. It has 
been observed in essentially all 20 amino acids that the Cα and the carbonyls 
chemical shifts are downfield and upfield shifted, respectively, when they are located 
in the α-helices and in β-strands, relative to their positions in random coil.  While, the 
Cβ resonances are upfield and downfield shifted when located in the α-helices and β-
strands, respectively [83, 88, 90, 91].   Strong correlation between protein secondary 
structure and Cα, Cβ and C' chemical shifts suggests that these can be used for 
determining the secondary structure of the protein [83].  From these observations, the 
chemical shift approach was developed as a tool for assigning the secondary structure 
of the protein [83, 92].  
The CSI concept consists of two parts. In the first part, chemical-shift index 
values (-1, 0, 1) are assigned to each residues based on their chemical shifts. Wishart 
et. al. [83] tabulated the 13Cα, 13Cβ and 13C' chemical shift reference values for each 
amino acid.  If the observed chemical shift for 13Cα and 13C' is higher than the range 
for that amino acid in random coils, it is marked as “+1”. In the same way, if the 
value is within the range or below the range for that amino acid, it is marked as “0” or 
“-1”, respectively. The same chemical index values are also applied for 13Cβ, but the 
shifts are opposite from those observed in 13Cα and 13C’.  In the second part, the 
secondary structures are assigned based on the values and local “densities” of these 
chemical-shift indices. For both 13Cα and 13C', a consecutive group of four or more 
“+1’s” not interrupted by a “0” or “-1” is considered a helix. A consecutive group of 
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three or more “-1’s” not interrupted by “1” and “0” is considered a β-strand. All other 
regions not assigned as α-helix or β-strand is considered to be “coils”. For the 13Cβ 
index values, a consecutive group of four or more “1’s” not interrupted by “1” or “0” 
is considered a β-strand. The 13Cβ chemical shift index can only be used to identify β-
sheets [83].  
The chemical shift index (13Cα, 13Cβ and 13C’) versus the residue number of 
holo full-length and truncated HasAp are shown in Figures 42 and 43.   The CSI were 
analyzed using the tool designed by Wishart et. al. [83] described above.  The 
consensus chemical shift index of 13Cα, 13Cβ and 13C' for both proteins was calculated 
using the Chemical Shift Index software version 2.0 downloaded from the website of 
PENCE/CIHR-Group Joint Software Center of the University of Alberta at 
http://www.bionmr.ualberta.ca/bds/software/csi/latest/csi.html.   The consensus CSI 
calculated using the software reveals four α-helices and 5 β-strands in the structure of 
holo full-length and truncated HasAp. Comparison of the secondary structures 
calculated using the consensus CSI and the X-ray structure are tabulated in Table 6. 
From Table 6, it can be noted that the α-helices for both the X-ray and CSI data are 
almost the same. However, in the X-ray structure there are 8 β-strands, while in the 
CSI there are only 5 β-strands. Closer inspection of the CSI based from the 13Cβ data 
which give more information about the β-strands in the structures revealed that there 
are 8 β-strands in the structure of both holo full-length and truncated HasAp. 
Moreover,  since the X-ray  crystal structure of the  full-length HasAp does  not  show  
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Figure 42. Chemical shift index (CSI) of holo full-length HasAp determined using 
(A) 13Cα, (B) 13Cβ, and (C) 13C' chemical shifts.   
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Figure 43.   Chemical shift index (CSI) of holo truncated HasAp determined using 
(A) 13Cα, (B) 13Cβ, and (C) 13C' chemical shifts.   
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the last 21 carboxy residues, it can be concluded that this part of the protein is highly 
dynamic and disordered. These residues were assigned using the triple resonance 
experiments and based from the CSI results shown in Figure 42, this part of the 
protein is not classified as α-helix or β-strands. It is a loop or a random coil. Thus, it 
can be concluded that both the X-ray and CSI results agree with each other. 
 
 
 
 
Table 6. Comparison of the Elements of Secondary Structures of HasAp by X-Ray 
and NMR 
Secondary Residues
Structure X-Raya Full-Length CSIb Truncated CSIb
Helix Val16-Phe27 Val16-Tyr26 Val16-Tyr26
Thr132-Ser142 Lys135-Leu140 His134-Leu140
Ser145-Val159 Ser146-Gly150 Ala147-Gln151
Ala154-Ala158 Ala154-Ala158
Phe169-Ala175 Phe169-Ala174 Phe169-Gly176
Strand Ser4-Ser8 Ser2-Ser8 Ile3-Ser8
Gly45-Pro48
Asp52-Lys59 Gln55-Lys59 Gln55-Lys59
Ala65-Tyr75 Phe67-Gly70 Ile68-Gly70
Leu85-Gly100 Leu85-Lys89 Leu85-Leu94
Ser91-Leu94
Tyr107-Ser117 Val114-Ser117 Val114-Phe116
Leu121-Ser123
Ala178-Thr181
 
a Secondary structure as determined by the Stride program [37] 
b Secondary structure as determined by the consensus CSI program  
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Structure of the Carboxy Tail of Full-Length HasAp 
 
As observed in the 1H-15N HSQC of the full-length HasAp shown in Figure 
44A, the peaks corresponding to the 21 C-terminal residues of the tail (enclosed in 
black boxes) are more intense than the rest of the residues in the protein. A closer 
inspection of the 1D slices shown at the right-hand side and bottom of the spectrum in 
Figure  44A taken at cross-peak originating from Ala187 δ (1H) = 8.20 ppm and δ 
(15N) = 123 ppm,   it can be observed that the 1D 1H  and  15N peaks originating  from  
Ala187 are sharper and more intense than those observed for the other residues with 
15N frequency also at 123 ppm. The 1D peaks of Ala187 as well as the other residues 
of the tails have narrower linewidths and more intense peaks compared to rest of the 
residues of the protein. This suggests that the resonances coming from those NHs are 
relaxing much faster compared to the rest of the residues thereby resulting in sharper 
peaks. In other words, the residues in the tail have different relaxation property than 
the rest of the protein. These resonances appear to be in slow exchange in the NMR 
time scale compared to the rest of the protein, which results in more intense and 
sharper peaks.  While the rest of the residues in the protein have broader linewidths 
and shorter relaxation time, T2, compared to the tail.  The line width of an NMR 
signal depends on the transverse relaxation time, T2, which is the inverse of the 
relaxation time (R = 1/T2). T2 relaxation is measured by the half-height linewidth of 
the Lorentzian lineshaped peak,  (Δν½ = 1/πT2*) [93].  
The spin relaxation times, T1 and T2 are related to the Nuclear Overhauser 
Effect (NOE) [94].  NOE is used for structural studies because  it can provide data  on 
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internuclear distances which is directly correlated to the molecular conformation of 
the protein.  The NOE intensity is directly propotional to 1/r6, with r being the 
distance between the protons.  NOE correlation between two hydrogen atoms depends 
on the distance between them, typically, approximately 5 Å or less from one another.  
The NOE correlates hydrogen atoms of proteins which are close in space due to 
tertiary structure but not necessarily close in amino acid sequence. In globular 
proteins, large numbers of NOEs are observed due to several pairs of hydrogen atoms 
in close proximity in space from each other. This is one of the most important 
information NOE can provide for structure determination [93, 94]. 
In 3D NOESY-HSQC experiment, the NOESY experiment is extended by an 
HSQC step. The signals are dispersed into three dimensions (1H-15N-1H). Data 
acquisition starts after the HSQC step instead of at the end of the NOESY mixing 
time. Magnetization is transferred from the first nucleus to the next one during the 
mixing time. Mixing time employs two magnetization transfer processes: dipolar 
interaction (NOE) and scalar coupling [94]. Figure 44B shows the 1H-1H 2D slice at δ 
(15N) = 123 ppm out of the 3D NOESY-HSQC spectrum taken with 110 ms mixing 
time. In the two dimensional spectrum, the diagonal signals divide the spectrum in 
two equal halves. There are several symmetrical cross signals observed along the 
diagonal line.  These cross signals originate from nuclei that exchanged 
magnetization during the mixing time. Hence, they are indicative of the interaction 
between nuclei and give important NOE information. From Figure 44B, Ala187 peak 
which is marked with the cross lines shows fewer cross-peak signals (shown in black 
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box) which suggests that it does not have many NOE correlations with other residues 
in the protein.  This could be because the NH of Ala187 is far in space from the rest 
of the residues or it could be because the NH is very dynamic and the NOE cannot be 
build during the mixing time. As observed in Figure 44A, Ala187 also relaxes slower 
compared to the other residues at the same 15N frequency. Moreover, few or no NOEs 
were also observed for the other non-proline residues in the tail. The few NOE cross- 
peaks observed could be attributed the intramolecular proton or to the protons 
preceding or after Ala187. It can be concluded that these part of the full-length 
protein is highly dynamic and disordered. This result also agrees with the X-ray and 
CSI data reported above.  
To further show that there are indeed few NOEs observed in the carboxy 
terminus of the protein, we compared the NOE cross peaks observed in Leu73 which 
is also along the same 15N frequency as Ala187. In the 1H-15N HSQC shown in Figure 
45A, the 1H and 15N slices of Leu73 are shown in the bottom and right-hand side, 
respectively. The 1D peaks are broader and less intense compared to Ala187. In 
addition, the 1H-1H 2D slice from the 3D NOESY-HSQC spectrum is shown in 
Figure 45B.  Several NOE cross peaks originating from Leu73 are observed (enclosed 
in black box), suggesting that this residue is close in space to a number of residues in 
the protein structure compared to Ala187. In fact, this is also observed for a majority 
of residues, except those located in the carboxy tail.  Thus, the NOESY-HSQC 
experiment tells us that the 21 residues which composed the carboxy tail are indeed 
far  in distance  to the rest of the residues in the tail or that they are  very dynamic and 
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cannot be detected in the NOE correlations.   
 
Difference Between Apo and Holo Truncated HasAp  
It is important to determine if there is conformational difference between the 
physiologically relevant truncated apo-HasAp and its heme loaded counterpart. The 
1H-15N HSQC spectrum of apo truncated HasAp is shown in Figure 32. The presence 
and absence of heme in the protein could promote structural and conformational 
differences that could provide insights on the heme uptake and release mechanism of 
HasAp. The conformational difference between the apo and holo truncated HasAp 
were determined using the chemical shift perturbation analysis.  This is commonly 
used to determine residues in the protein which undergo change in chemical 
environment as a result of protein-protein interaction [95]. The magnitude of the 
amide chemical shift perturbation that occur upon binding of heme in the protein was 
used as an indicator to identify the regions of the protein experiencing change in 
chemical environment as a result of the presence of heme. The magnitude of the 
chemical shift perturbation was calculated using the weighted average chemical shift 
difference of the 15N nuclei and amide 1H. The per-residue chemical shift perturbation 
is plotted in Figure 46A.  The arithmetic mean of all perturbations is 0.25 ppm.  The 
region between Gly28 to Thr43 showed large perturbations. Among the residues in 
the protein, Asp39 showed the highest chemical shift perturbation (1.69 ppm). These 
perturbations are mapped in the holo truncated HasAp structure shown in Figure 46B; 
regions  of   the  protein   which  exhibit  chemical shift  perturbation  larger  than  the  
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Figure 46.  (A) Per-residue plot of the  chemical shift difference between apo and 
holo truncated HasAp calculated using the weighted average amide chemical shift , 
Δδave = {[(Δδ1H)2 + (Δδ15N/5)2]/2}½. The horizontal line represents the average 
difference of all residues (0.25). (B) The weighted average amide chemical shift 
differences are mapped onto the structure of holo truncated HasAp. Residues which 
exhibit differences in the range of   0.25 < Δδave < 0.80 are highlighted in cyan, and 
those which exhibit the largest difference (Δδave  > 0.80) are highlighted in red.  
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arithmetic mean of all perturbation (0.25 ppm) but ≤ 0.80 are colored in cyan. While, 
residues exhibiting largest chemical shift perturbation (> 0.80) are colored in red. 
Residues with chemical shift perturbation lower than the arithmetic mean are colored 
in white.  
It can be observed from Figure 46B that residues which are perturbed are 
located in α1, α2, β2, β3, β4, and in the two extended loops where the heme ligands 
are located. Interestingly, residues which exhibit chemical shift perturbation are 
concentrated on one part of the protein, close to the heme pocket. Residues with the 
largest chemical shift perturbations shown in red are located in the long extended 
loop which connects α1 and β2 and this is the loop where His32 is located.  These 
results suggest that this region of the protein experiences different conformations in 
both apo and holo state, but the other regions of the protein far from the active site are 
the same in both forms. The results also agree with the NMR structure of apo- 
HasASM [96]. The NMR structure of apo-HasASM is in an open conformation and its 
holo structure is in closed conformation. Hence, in HasAp it could also be the same 
since these two proteins share 50% identity. This open conformation may make 
HasAp more active in taking the heme from hemoglobin and when it takes the heme, 
the loops closed to secure the heme inside. This open and close conformation could 
also suggest that there is a different dynamics in both apo and holo HasAp. The 
dynamic property of holo truncated HasAp was studied by H/D exchange 
experiments.  
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Hydrogen-Deuterium Exchange Experiment of HasAp  
Hydrogen/Deuterium (H/D) exchange experiment is a phenomenon wherein 
the amide backbone protons in the peptide bond of a protein are exchanged by 
deuterium. By changing the solvent from H2O to D2O, the exchange process can be 
followed. The H/D exchange in holo-HasAp was followed by HSQC as a function of 
time. As the amide protons exchange with deuterium, the signals in the HSQC 
spectrum decay with time. This experiment gives information of all the residues in the 
protein at the same time. Basically, the H/D exchange experiment gives information 
on the exchange rate of hydrogen with deuterium and this reflects the accessibility of 
the particular amide to the solvent [28, 97, 98] as well as the dynamics of the 
protein[18]. Hence, amide protons forming hydrogen bonding interactions with other 
residues and those that are buried within the hydrophobic core will exchange slowly 
than the residues not forming hydrogen bonding interaction and exposed to the 
solvent.  The rate constants for H/D exchanged for each residue were calculated by 
fitting the time-dependent decay of the cross-peak intensity to a three-parameter 
single exponential decay (Figure 47) using eq 2 [99]. 
 
I(t)   =  I∞ +A exp(-kext)                 (2)  
              
 
where I(t) is the intensity of the cross-peak at time t, I∞ is the cross-peak intensity at 
infinite time, A is the amplitude of the exchange curve, and kex is the experimental N-
H exchange rate constant of each residue in the protein. Protection factors (P) allow 
the quantitative comparison of the H/D exchange rate of the residues in the protein. 
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Protection factors were calculated using eq 3 [97, 98] where kch is the sequence-
specific intrinsic rate constants of each residues and kex is described above.  
P = kch/kex                                (3) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 47. H/D exchange rate constant determination for residue Asp52 in holo 
truncated HasAp at pD 7.58. The line represents the fit of equation 2 to the 
experimental data. 
 
 
 
The H/D experiment was monitored for 32 hours. Exchange rates (kex) for 
30% of the residues were not obtained because rates are too fast to observe 
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experimentally.  Per-residue plot of the logarithm of the protection factors is shown in 
Figure 48 and the results are mapped on the structure of HasAp shown in Figures 
49A-D. As observed in Figures 49A and C, the residues with kex too fast to measure 
(yellow) are mostly concentrated in the loops:  loops where the heme axial ligands 
(His32 and Tyr75) are located; hairpin loops which connect the antiparallel beta 
sheets,  β3 and β4, and β6 and β7;  extended loop connecting 310-helix 2 and β7 and 
in the last 5 C-terminal residues  (ATPAA).  Those residues with high B-factor values 
mentioned earlier have kex too fast to measure.  Moreover, α3, α4, 310-helix 2, β7 and 
β8  were susceptible  to  H/D exchange as shown in  Figures  49A  and  C  colored  in 
 
 
 
 
 
 
 
 
 
Figure 48. Per-residue protection factors obtained from amide H/D exchange 
experiment of truncated holo HasAp. A value of log P = 1 was given to residues not 
included in the analysis due to either lack of assignment or peak overlap and a value 
of log P = 2 was arbitrarily given to residues exhibiting exchange rates too fast to be 
measure. The horizontal line represents the average log P of all residues.  
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yellow and cyan.  This result suggests that this region of the protein is dynamic.  β4-
β6 have lower protection factors values and α1, α2 and β3 have combination of 
residues which are less and highly protected by deuterium exchange.  A closer look at 
the surface structures of the protein in Figures 49B and D shows overall the protein is 
highly dynamic as suggested by the results that there are more residues with kex too 
fast  too  measure (yellow) and  with lower protection  factor values (cyan)  combined 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 49.  Stereoview (A and C) and surface structure (B and D) of holo truncated 
HasAp highlighting residues with high protection factor values in red, with low 
protection values in cyan, residues with kex too fast to measure in yellow, residues not 
included in the analysis due to lack of assignment or peak overlap in white and the 
heme in magenta.  
A
D
C
B
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than residues which are highly protected (red). Interestingly, most of these fast 
exchanging residues are located close to the heme active site, in the loops and C-
terminus.  In comparison, in general the α-helices are more protected than the β-
sheets and majority of the residues which are protected are glycine. Overall, the 
residues which were susceptible to hydrogen-deuterium exchange are located in the 
surface of the protein. The H/D exchange experiment suggests HasAp is a highly 
dynamic protein.  
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APPENDICES 
 
Appendix 1.  Protein Crystallization conditions 
 
Crystal Plate # Salt Conc. Buffer Conc. pH Solvent Conc.
40% W/VTris 0.1M 8 PEG4000664 RbCl 0.1M
20% W/V
644 KC2H3O2 0.1M Tris 0.1M 8 PEG4000 40% W/V
Tris 0.1M 8 PEG4000602 NaNO3 0.1M
0.1M 8 PEG4000 20% W/V587 KCl 0.1M
582 KBr 0.1M Tris 0.1M 8 PEG4000 20% W/V
Tris
PEG4000 20% W/V551 NH4NO3 0.1M Tris 0.1M 8
0.1M 8 PEG8000 40% W/V520 KSCN 0.1M Tris
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Crystal Plate # Salt Conc. Buffer Conc. pH Solvent Conc.
0.1M 8 PEG1000 20% W/V745 Na2S2O3 0.1M Tris
20% W/V
40% W/V
40% V/V
PEG1000
PEG1000
PEG400
8
8
8
0.1M
0.1M
0.1M
0.1M
0.1M
0.1M
761
818
840
NH4SCN
NaCl
NH4Br
Tris
Tris
Tris
20% W/VTris 0.1M 8 PEG1000743 NaNO3 0.1M
20% W/V
735 RbCl 0.1M MES 0.1M 6 PEG1000 20% W/V
Tris 0.1M 8 PEG1000734 KSCN 0.1M
699 NH4Cl 0.1M Tris 0.1M 8 PEG1000 20% W/V
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Crystal Plate # Salt Conc. Buffer Conc. pH Solvent Conc.
Sodium 
acetate
40% V/VMES6MES 0.1MNH4Cl 0.1M842
0.1M 5 PEG400 20% V/V951 KH2PO4 0.1M
80%V/VTris 0.1M 8 PEG400947 KCl 0.1M
40% V/V
918 NH4Cl 0.1M Tris 0.1M 8 PEG400 80% V/V
Tris 0.1M 8 PEG400911 NH4SCN 0.1M
40% V/V
893 NaNO3 0.1M Tris 0.1M 8 PEG400 40% W/V
Tris 0.1M 8 PEG400888 NaBr 0.1M
849 (NH4)2SO4 0.1M MOPS 0.1M 7 PEG400 40% V/V
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Crystal Plate # Salt Conc. Buffer Conc. pH Solvent Conc.
1425 0.20M Tris 0.1M 8.5 PEG3350
976 Li2SO4.H2O 0.1M Tris 0.1M 8 PEG400
25% W/V
25% W/V
30% W/V
1389 Tris 0.1M 8.5 PEG3350
20% W/V
1199 Tris 0.1M 8 PEG6000
10% W/V
1193 Tris 0.1M 8 PEG6000
1187 Tris 0.1M 9 PEG6000
60% V/V
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Appendix 2. Backbone Assignment of Holo Full-Length HasAp 
 
Residue 1HN
15NH
13Cα 13Cβ 13CO
Met1
Ser2 57.80 64.51 171.20
Ile3 8.57 122.24 61.61 38.74 171.89
Ser4 8.08 118.76 56.67 65.08 174.15
Ile5 8.62 127.37 60.01 42.84 174.88
Ser6 8.82 124.36 56.42 65.24 172.63
Tyr7 7.98 120.15 55.07 41.32 172.54
Ser8 8.14 115.73 57.02 63.68 177.45
Thr9 8.46 118.71 65.61 68.68 176.06
Thr10 7.66 119.88 65.82 69.48 174.64
Tyr11 7.87 117.66 58.73 38.18 175.09
Ser12 7.66 115.81 63.47 64.34 175.25
Gly13 7.99 105.33 45.07 175.00
Trp14 8.65 122.90 57.44 29.15 176.21
Thr15 8.82 109.40 60.19 70.93 175.52
Val16 7.33 120.77 66.64 30.80 178.40
Ala17 8.50 119.92 55.63 18.98 179.51
Asp18 8.22 118.38 57.41 39.70 179.97
Tyr19 8.85 121.46 63.59 39.09 176.85
Leu20 8.78 118.72 58.18 41.76 179.45
Ala21 8.44 122.50 55.55 18.79 180.32
Asp22 7.92 120.77 58.04 42.78 178.33
Trp23 9.12 122.13 63.41 28.76 178.56
Ser24 8.61 113.34 63.04 64.02 176.88
Ala25 7.45 124.26 54.53 18.18 178.78
Tyr26 7.42 120.43 58.40 38.55 177.86
Phe27 8.50 123.35 61.47 39.20 176.64
Gly28 8.27 108.27 44.99 176.72
Asp29 7.28 116.33 51.54 42.84 177.96
Asp29' 7.21 116.21 51.43 42.95 177.86
Val30 7.96 118.55 61.51 31.00 176.31
Asn31 8.93 123.86 53.33 36.07 172.58
His32
Arg33
Pro34 65.94 32.43 177.42  
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Residue 1HN
15NH
13Cα 13Cβ 13CO
Gly35 9.60 113.92 46.05 174.95
Gln36 8.22 116.73 54.18 30.95 175.08
Val37 7.81 122.27 65.40 29.49 173.92
Val38 8.60 131.25 65.67 29.69 176.61
Asp39 7.79 118.25 52.37 41.93 177.20
Gly40 8.11 112.50 45.63 173.86
Ser41 8.04 115.00 58.92 63.28 174.11
Asn42 7.49 114.77 51.12 36.31 176.28
Thr43 6.85 105.65 58.20 71.88
Gly44 8.41 111.92 45.97 173.75
Gly45 8.17 107.36 45.97 170.42
Phe46 9.46 117.54 57.58 44.22 176.12
Asn47 8.96 116.31 49.00 43.02 175.20
Asn47' 9.02 116.02 49.00 43.02 175.19
Pro48 65.72 34.60 179.70
Gly49 8.03 105.74 46.46 176.28
Pro50 64.67 34.38 177.66
Phe51 8.89 117.22 56.80 40.74 170.85
Asp52 6.64 113.56 51.98 45.95 174.82
Gly53 8.67 106.84 47.35 171.28
Ser54 8.90 114.08 58.17 63.98 176.77
Gln55 8.11 117.14 54.67 37.30 175.22
Tyr56 9.46 122.81 57.51 42.40 172.15
Ala57 8.18 129.09 49.54 24.04 174.32
Leu58 7.09 121.01 54.17 45.27 174.39
Lys59 7.82 124.95 53.88 34.82 174.31
Ser60 8.22 117.56 57.64 63.30 174.77
Thr61 7.61 114.47 62.17 68.50 174.75
Ala62 8.40 125.95 52.45 21.18 176.53
Ser63 7.80 116.00 56.94 66.37 172.39
Asp64 8.01 114.94 54.67 41.33 175.78
Ala65 7.63 124.14 52.87 19.88 175.26
Ala66 9.26 120.57 52.24 25.21 174.16
Phe67 8.22 112.85 55.30 44.27 172.88
Ile68 8.68 115.00 60.78 42.31 176.28  
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Residue 1HN
15NH
13Cα 13Cβ 13CO
Ala69 10.43 135.57 50.42 20.88 175.13
Gly70 9.49 110.91 43.63 173.75
Gly71 8.67 111.20 46.71 171.60
Asp72 9.59 129.59 54.64 41.64 173.68
Leu73 8.50 123.35 54.52 47.11 176.09
His74 8.17 118.44 56.49 31.57 173.66
Tyr75 8.41 125.14 53.22 34.06 173.65
Thr76 64.91 176.31
Leu77 7.32 123.00 58.42 41.80 179.14
Phe78 6.51 120.57 57.82 38.59 175.30
Ser79 7.03 118.60 57.86 63.03 170.58
Asn80 7.69 117.98 51.47 39.40 173.73
Asn80' 7.56 117.91 51.31 39.40 173.62
Pro81 62.53 32.85 176.40
Ser82 8.17 124.71 58.09 63.27 174.83
His83 57.94 174.83
Thr84 7.57 113.86 62.27 68.61 176.29
Leu85 10.42 133.39 54.68 46.18 174.29
Trp86 9.57 125.82 55.45 30.42 172.17
Gly87 8.57 106.22 43.37 172.16
Lys88 8.47 120.82 54.78 34.75 175.12
Leu89 8.79 126.62 54.06 46.17 172.91
Asp90 9.52 125.06 55.03 44.85 176.71
Ser91 8.67 111.80 56.97 66.74 173.55
Ile92 9.02 120.14 59.79 42.32 172.69
Ala93 8.96 131.10 50.88 21.53 174.70
Leu94 8.76 120.52 53.67 43.17 176.77
Gly95 8.14 109.12 47.19 171.14
Asp96 8.90 123.18 53.77 45.32 174.06
Thr97 8.28 111.04 64.78 65.17 172.64
Leu98 8.48 128.37 55.29 43.13 176.48
Thr99 9.34 120.89 60.23 72.03 173.64
Gly100 8.35 106.24 45.14 173.40
Gly101 6.75 106.29 43.70 173.78  
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Residue 1HN
15NH
13Cα 13Cβ 13CO
Ala102 8.72 123.54 55.52 19.37 174.43
Ser103 59.93 63.19 175.01
Ser104 7.41 114.79 57.77 63.83 174.48
Gly105 7.93 109.00 45.51 174.16
Gly106 7.67 107.39 44.32 174.38
Tyr107 9.31 121.48 58.77 41.16 175.73
Ala108 8.79 123.96 51.54 22.38 174.62
L109 8.30 119.68 52.91 43.35 176.99
Asp110 9.31 124.74 56.74 41.60 177.49
Ser111 7.74 112.00 55.98 63.13 173.14
Gln112 8.74 126.66 56.67 30.00 175.16
Glu113 8.87 128.70 58.68 30.70 175.28
Val114 7.36 116.81 60.36 37.61 173.65
Ser115 8.61 117.49 56.34 66.08 172.39
Phe116 9.17 122.62 56.19 42.07 174.15
Ser117 9.44 117.86 57.73 65.61 172.83
Asn118 8.28 118.09 53.85 37.18 175.65
Leu119 8.97 115.34 57.32 42.10 178.74
Gly120 8.74 102.57 47.27 174.94
Leu121 7.39 118.52 54.73 42.88 176.22
Asp122 8.54 124.90 53.97 43.71 175.93
Ser123 9.34 122.78 56.26 66.91 172.36
Pro124 61.88 32.67 177.40
Ile125 7.66 125.05 64.75 36.26 176.44
Ala126 7.11 118.93 53.99 19.02 178.98
Gln127 6.83 113.45 56.75 29.46 177.44
Gly128 8.03 107.46 46.39 175.02
Arg129 8.66 123.07 57.17 29.66 174.77
Asp130 7.57 114.80 54.61 41.86 177.01
Gly131 7.76 107.87 45.91 173.13
Thr132 8.62 119.97 67.34 69.08 175.17
Val133 8.75 122.37 69.33 31.31 176.47
His134 8.49 119.86 62.64 31.38 178.35
Lys135 8.57 116.18 61.26 33.14 181.44
Val136 9.02 118.57 66.77 31.83 178.22  
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Residue 1HN
15NH
13Cα 13Cβ 13CO
Val137 8.17 119.10 67.68 32.11 176.86
Tyr138 10.08 122.77 62.56 40.27 179.69
Tyr138' 10.40 121.81 62.59 40.17 179.51
Gly139 8.12 105.76 48.30 176.33
Leu140 7.18 122.71 58.52 41.38 179.13
Met141 7.84 114.69 59.91 33.39 174.96
Ser142 7.15 109.47 56.39 63.69 174.23
Gly143 7.71 111.00 47.05 173.67
Asp144 8.51 119.08 52.51 42.29 175.52
Ser145 9.01 119.68 58.83 64.18 175.19
Ser146 8.77 121.29 62.35 63.42 177.11
Ala147 9.02 127.05 55.63 17.41 180.91
Leu148 8.24 120.33 58.50 41.02 177.82
Gln149 8.99 117.52 60.99 29.16 177.78
Gly150 8.16 104.10 47.32 177.05
Gln151 7.59 119.38 57.56 27.69 178.05
Ile152 8.41 118.78 64.59 36.73 177.24
Asp153 8.46 118.75 59.19 42.84 177.18
Ala154 7.22 117.27 55.39 18.15 181.17
Leu155 7.94 119.51 58.01 42.89 180.16
Leu156 8.56 120.61 58.17 41.42 178.48
Lys157 7.98 118.58 58.69 32.93 178.30
Ala158 7.28 118.41 53.73 18.39 179.37
Val159 7.50 120.03 65.67 31.83 176.62
Asp160 7.79 118.83 52.49 44.22 173.93
Pro161 64.60 32.17 176.80
Ser162 8.92 115.01 60.00 64.09 174.53
Leu163 8.15 124.29 53.97 43.54 174.75
Ser164 8.24 109.81 58.26 67.58 175.01
Ile1165 9.09 114.83 62.38 39.04 174.10
Asn166 8.41 116.63 53.67 39.21 174.79
Ser167 7.92 119.41 60.33 64.41 173.17
Thr168 8.40 111.25 60.01 71.51 176.88
Phe169 8.01 118.94 64.32 36.12 177.70  
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Residue 1HN
15NH
13Cα 13Cβ 13CO
Asp170 8.50 116.71 57.63 41.23 180.09
Gln171 8.09 121.58 59.21 28.10 180.18
Leu172 8.32 120.59 57.52 41.51 179.40
Ala173 8.92 126.59 54.84 18.64 182.15
Ala174 8.07 123.95 54.90 17.66 178.93
Ala175 7.35 117.16 52.27 20.41 177.61
Gly176 7.85 105.44 45.72 174.47
Val177 7.60 113.80 62.16 33.13 173.52
Ala178 6.90 119.64 48.81 24.40 175.20
His179 8.67 116.34 55.35 32.32 172.53
Ala180 8.45 127.73 50.72 19.53 178.57
Thr181 8.56 117.69 59.24 69.32 172.37
Pro182 63.16 32.27 176.70
Ala183 8.26 125.71 52.42 19.50 174.60
Ala184 7.81 129.34 52.39 19.50 176.25
Ala185 8.29 123.97 52.36 19.66 177.24
Ala186 8.22 123.65 52.83 19.44 177.27
Ala187 8.20 123.30 52.57 19.53 177.61
Glu188 8.32 120.34 56.57 30.47 176.34
Val189 8.14 121.16 62.68 32.84 176.56
Gly190 8.42 112.25 45.35 173.69
Val191 7.98 119.90 62.49 33.10 175.30
Val192 8.00 119.57 62.67 32.91 176.41
Gly193 8.44 112.84 45.43 173.70
Val194 7.98 119.90 62.46 32.90 176.07
Gln195 8.46 124.19 55.86 29.86 175.43
Glu196 8.40 122.97 56.60 30.70 175.82
Leu197 8.04 122.05 53.17 43.02 176.54
Pro198 63.23 32.22 178.20
His199 8.32 119.63 56.44 30.70 174.82
Asp200 8.28 120.73 54.54 41.15 175.87
Leu201 8.13 122.79 55.67 42.46 176.11
Ala202 8.21 124.11 52.78 19.09 177.47
Leu203 7.95 120.84 55.26 42.68 176.80
Ala204 8.10 125.38 52.59 19.61 175.90
Ala205 8.34 125.16 54.06 19.68 175.12  
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Appendix 3. Backbone Assignment of Holo Truncated HasAp 
 
 
Residue 1HN
15NH
13Cα 13Cβ 13CO
Met1
Ser2 57.41 64.18 171.30
Ile3 8.61 122.19 61.42 38.61 171.96
Ser4 8.08 118.78 56.35 65.07 174.26
Ile5 8.61 127.30 59.91 42.78 174.97
Ser6 8.82 124.44 56.30 65.18 172.68
Tyr7 7.95 120.15 54.72 41.23 172.54
Ser8 8.13 115.73 56.87 63.85 177.41
Thr9 8.46 118.74 65.38 68.27 176.18
Thr10 7.67 119.92 65.57 69.52 174.75
Tyr11 7.87 117.70 58.54 38.07 175.12
Ser12 7.66 115.79 63.08 64.14 175.30
Gly13 7.99 105.38 46.12 175.09
Trp14 8.64 122.89 56.97 29.13 176.26
Thr15 8.82 109.40 59.93 70.72 175.61
Val16 7.32 120.77 66.43 30.71 178.47
Ala17 8.49 119.91 55.47 18.77 179.58
Asp18 8.21 118.37 57.43 39.64 180.10
Tyr19 8.84 121.46 63.33 39.14 176.89
Leu20 8.77 118.73 58.10 41.69 179.53
Ala21 8.44 122.51 55.35 18.35 180.42
Asp22 7.92 120.73 57.75 42.73 178.38
Trp23 9.11 122.12 63.22 28.61 178.70
Ser24 8.61 113.34 62.80 64.49 177.01
Ala25 7.45 124.25 54.35 18.05 178.90
Tyr26 7.42 120.36 58.41 38.30 177.99
Phe27 8.50 123.33 61.29 38.87 176.81
Gly28 8.27 108.24 44.78 176.81
Asp29 7.27 116.34 51.50 42.75 178.10
Asp29' 7.21 116.20 51.32 42.65 177.86
Val30 7.98 118.58 61.24 30.98 176.41
Asn31 8.93 123.82 53.00 35.77 172.60
His32
Arg33
Pro34 65.80 32.45 177.52  
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Residue 1HN
15NH
13Cα 13Cβ 13CO
Gly35 9.59 113.91 45.88 175.03
Gln36 8.23 116.73 53.97 30.68 175.21
Val37 7.84 122.30 58.41 33.54 173.90
Val38 8.59 131.02 65.40 29.45 176.66
Asp39 7.79 118.31 52.21 41.81 177.21
Gly40 8.10 112.33 45.76 173.89
Ser41 8.04 115.05 58.83 63.27 174.17
Asn42 7.48 114.77 51.00 36.16 176.40
Thr43 6.83 105.68 59.99 71.93 175.63
Gly44 8.42 111.86 45.77 173.65
Gly45 8.16 107.33 45.88 170.48
Phe46 9.45 117.53 57.21 44.19 176.16
Asn47 8.95 116.32 48.99 42.83 175.20
Asn47' 9.01 116.08 48.93 42.53 175.20
Pro48 65.43 34.47 179.77
Gly49 8.02 105.74 46.25 176.30
Pro50 64.59 34.24 177.73
Phe51 8.89 117.21 56.63 40.58 170.93
Asp52 6.64 113.58 51.76 45.84 174.87
Gly53 8.67 106.81 47.24 171.37
Ser54 8.90 114.06 58.02 64.04 176.84
Gln55 8.10 117.12 54.47 37.21 175.26
Tyr56 9.46 122.79 57.19 42.34 172.17
Ala57 8.17 129.09 49.28 23.90 174.35
Leu58 7.08 120.99 54.05 45.11 172.63
Lys59 7.82 124.93 53.80 34.68 174.46
Ser60 8.21 117.51 57.78 63.34 174.89
Thr61 7.61 114.50 61.97 68.45 174.77
Ala62 8.39 125.95 52.42 21.04 176.64
Ser63 7.80 116.01 56.73 66.23 172.45
Asp64 7.99 114.88 54.44 41.24 175.89
Ala65 7.63 124.12 52.71 19.76 175.26
Ala66 9.25 120.55 51.99 19.63 174.23
Phe67 8.22 112.87 55.05 44.11 172.94
Ile68 8.67 114.98 60.64 42.24 176.35  
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Residue 1HN
15NH
13Cα 13Cβ 13CO
Ala69 10.42 135.58 50.22 20.80 175.20
Gly70 9.49 110.90 43.51 173.83
Gly71 8.67 111.19 46.45 171.68
Asp72 9.58 129.57 54.29 41.52 173.74
Leu73 8.50 123.33 54.31 46.98 176.15
His74 8.16 118.41 54.74 31.57 173.71
Tyr75 8.42 125.06 52.39 34.50
Tyr75' 8.43 124.44 52.59 34.50
Thr76 68.39 176.31
Leu77 7.31 122.94 58.17 41.41 179.14
Leu77' 7.32 122.24 58.48 41.52 179.14
Phe78 6.50 120.65 56.83 38.34 175.30
Ser79 7.04 118.61 57.68 62.91 170.57
Asn80 7.69 118.02 51.38 39.24 173.70
Asn80' 7.58 117.91 51.22 39.04 173.70
Pro81 61.40 32.31 176.51
Ser82 8.18 124.75 58.13 63.37 174.80
His83 57.70 28.88 174.87
Thr84 7.57 113.90 62.03 68.39
Leu85 10.42 133.40 53.99 45.50 174.31
Trp86 9.56 125.83 55.21 30.31 172.23
Gly87 8.56 106.24 43.20 172.22
Lys88 8.47 120.79 54.58 34.59 175.17
Leu89 8.78 126.61 53.78 46.10 172.93
Asp90 9.51 125.05 54.84 44.74 176.80
Ser91 8.66 111.78 56.74 66.65 173.59
Ile92 9.02 120.14 59.56 42.12 172.76
Ala93 8.95 131.10 50.71 21.44 174.79
Leu94 8.75 120.52 53.51 43.21 176.83
Gly95 8.14 109.10 46.98 171.18
Asp96 8.89 123.15 53.58 45.19 174.11
Thr97 8.29 111.05 64.49 65.30 172.56
Leu98 8.46 128.36 55.16 43.11 176.54
Thr99 9.33 120.84 60.01 71.96 173.67
Gly100 8.34 106.24 44.98 173.37
Gly101 6.74 106.28 43.52 173.82  
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Residue 1HN
15NH
13Cα 13Cβ 13CO
Val137 8.16 119.08 67.59 31.58 176.94
Tyr138 10.07 122.74 62.14 39.91 179.78
Tyr138' 10.38 121.80 62.31 179.78
Gly139 8.10 105.75 48.21 176.38
Leu140 7.18 122.68 58.22 41.27 179.24
Met141 7.84 114.72 59.62 33.42 175.03
Ser142 7.14 109.44 56.11 63.63 174.32
Gly143 7.70 110.98 46.92 173.77
Asp144 8.50 119.07 52.24 42.15 175.52
Ser145 9.01 119.68 58.61 64.06 175.19
Ser146 8.76 121.26 62.13 63.23 177.21
Ala147 9.01 127.03 55.52 17.37 181.05
Leu148 8.23 120.30 58.22 40.94 177.92
Gln149 8.99 117.51 60.73 28.73 177.83
Gly150 8.16 104.10 47.14 177.11
Gln151 7.58 119.36 47.17 27.46 178.15
Ile152 8.41 118.76 64.52 36.68 177.29
Asp153 8.46 118.74 58.98 42.76 177.24
Ala154 7.22 117.27 55.10 18.12 181.26
Leu155 7.94 119.51 57.83 42.98 180.27
Leu156 8.56 120.63 57.86 41.28 178.55
Lys157 7.98 118.58 58.47 32.78 178.43
Ala158 7.28 118.39 53.51 18.25 179.51
Val159 7.50 120.01 65.36 31.71 176.69
Asp160 7.79 118.81 52.17 43.95 173.90
Pro161 64.45 32.05 176.85
Ser162 8.91 115.00 59.81 63.91 174.57
Leu163 8.14 124.26 53.75 43.44 174.87
Ser164 8.23 109.82 58.02 67.53 175.13
Ile1165 9.09 114.82 62.09 39.05 174.17
Asn166 8.41 116.64 53.43 39.07 174.81
Ser167 7.91 119.41 60.19 64.38 173.25
Thr168 8.39 111.24 59.76 71.41 176.96
Phe169 8.01 118.91 64.17 36.01 177.77  
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Residue 1HN
15NH
13Cα 13Cβ 13CO
Asp170 8.49 116.68 57.40 41.01 180.21
Gln171 8.09 121.59 59.11 27.99 180.33
Leu172 8.32 120.54 57.30 41.41 179.49
Ala173 8.91 126.64 54.66 18.60 182.28
Ala174 8.07 123.99 54.76 17.64 179.04
Ala175 7.35 117.02 52.09 20.36 177.68
Gly176 7.85 105.38 45.59 174.54
Val177 7.60 113.85 62.09 33.07 173.63
Ala178 6.90 119.61 48.66 24.32 175.35
His179 8.67 116.46 54.99 31.76 172.52
Ala180 8.47 127.89 50.55 19.40 178.68
Thr181 8.55 117.72 59.05 69.08 172.40
Pro182 62.93 32.17 176.76
Ala183 8.26 126.09 52.33 19.42 174.57
Ala184 7.90 129.16 53.70 20.08 176.20  
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Appendix 4. Backbone Assignment of Apo Truncated HasAp 
 
Residue 1HN
15NH
13Cα
Met1
Ser2
Ile3
Ser4
Ile5 8.65 127.18 59.92
Ser6 8.81 124.28 56.29
Tyr7 7.89 120.15 54.66
Ser8
Thr9
Thr10
Tyr11
Ser12
Gly13
Trp14 8.68 122.88 57.03
Thr15 8.76 109.08 60.03
Val16 7.26 120.10 66.35
Ala17 8.49 119.73 55.39
Asp18 8.38 119.56 57.38
Tyr19 8.82 122.74 63.35
Leu20 8.75 119.35 58.31
Ala21 8.16 120.11 55.02
Asp22 7.83 122.32 58.52
Trp23 8.70 119.81 63.57
Ser24 8.76 114.36 63.54
Ala25 7.88 125.69 54.82
Tyr26 8.16 120.89 57.00
Phe27 8.69 122.72 60.93
Gly28 7.35 102.41 46.28
Val30 7.60 128.01 63.83
Asn31 8.04 115.40 54.67
His32 8.28 118.57 59.67
Arg33 7.30 115.31 52.91
Pro34  
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Residue 1HN
15NH
13Cα
Gly35 8.61 111.72 45.43
Gln36 7.88 118.66 55.05
Val37 8.38 117.54 60.16
Val38 8.45 124.92 61.72
Asp39 10.74 131.50 53.99
Gly40 9.69 113.58 46.40
Ser41
Asn42
Thr43 8.40 114.58 61.97
Gly44 7.91 109.17 44.95
Gly45 8.21 108.42 44.21
Phe46 8.72 116.14 58.46
Asn47
Pro48
Gly49 7.90 105.82 46.36
Pro50
Phe51 8.70 116.41 51.00
Asp52 6.56 113.33 52.00
Gly53 8.54 106.79 47.64
Ser54 8.60 114.17 58.15
Gln55 7.97 116.78 54.16
Tyr56 9.12 121.85 57.72
Ala57 7.56 130.70 48.83
Leu58 7.11 120.04 54.76
Lys59 7.20 124.48 53.21
Ser60 8.26 119.34 58.00
Thr61 8.04 113.50 62.60
Ala62 8.55 126.68 52.32
Ser63 7.59 112.18 56.33
Asp64 9.28 116.05 54.18
Ala65 7.36 123.30 53.48
Ala66 9.06 121.55 51.30
Phe67 8.46 114.69 55.31
Ile68 8.97 115.40 61.11  
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Residue 1HN
15NH
13Cα
Ala69 10.09 135.37 50.24
Gly70 9.29 110.80 43.66
Gly71 8.52 111.54 46.56
Asp72 9.43 129.27 54.45
Leu73 8.35 122.94 54.29
His74 8.17 117.28 54.56
Tyr75 8.63 121.88 55.56
Thr76 8.72 117.24 63.09
Leu77 5.86 119.25 57.00
Phe78
Ser79 7.68 120.10 65.61
Asn80 7.77 117.50 58.27
Pro81
Ser82 8.58 123.90 59.30
His83 8.97 119.60 57.94
Thr84 8.01 113.89 62.99
Leu85 11.32 136.10 54.00
Trp86 9.33 122.74 55.45
Gly87 8.28 105.84 43.59
Lys88 8.40 121.06 54.91
Leu89 8.76 126.56 53.65
Asp90 9.30 124.90 55.11
Ser91 8.47 111.28 56.77
Ile92 9.03 120.22 58.95
Ala93 8.98 130.88 50.61
Leu94 8.88 121.33 53.83
Gly95 8.58 108.36 47.65
Asp96 8.89 127.33 54.38
Thr97 8.99 114.94 68.53
Leu98 7.82 126.84 54.22
Thr99 9.04 116.04 59.88
Gly100 8.21 107.22 45.22
Gly101 6.64 106.55 43.62  
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Residue 1HN
15NH
13Cα
Ala102
Ser103
Ser104 7.34 114.79 57.66
Gly105 7.89 109.04 45.37
Gly106 7.59 107.43 43.93
Tyr107 9.37 121.16 59.20
Ala108 8.63 123.75 51.29
Leu109 8.20 120.01 52.87
Asp110 9.18 125.02 57.03
Ser111 7.73 110.24 55.82
Gln112 8.95 127.87 56.44
Glu113 8.63 129.79 58.69
Val114 7.24 115.61 60.32
Ser115 8.65 117.68 56.26
Phe116 9.27 123.25 56.05
Ser117 9.44 118.16 57.62
Asn118 8.22 118.08 53.78
Leu119 8.80 115.18 57.19
Gly120 8.64 102.73 47.41
Leu121 7.27 118.36 54.46
Asp122 8.47 124.40 54.05
Ser123 9.17 122.68 55.82
Pro124
Ile125 7.63 125.10 64.41
Ala126 7.28 119.46 54.11
Gln127 6.97 113.46 56.72
Gly128 8.15 107.05 46.65
Arg129 8.77 123.58 57.15
Asp130 7.56 115.13 54.60
Gly131 7.74 107.86 45.68
Thr132 8.56 120.48 66.88
Val133 8.80 122.07 69.02
His134 8.40 120.82 62.21
Lys135 8.32 115.92 60.85
Val136 8.61 116.83 66.49  
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Residue 1HN
15NH
13Cα
Val137 8.49 119.08 67.14
Tyr138 9.57 121.19 61.42
Gly139 7.42 104.90 48.21
Leu140 7.18 123.04 58.25
Met141 7.81 115.92 59.24
Ser142 7.41 110.61 57.43
Gly143 7.67 112.50 46.28
Asp144 8.05 120.93 52.76
Ser145 8.59 118.63 57.72
Ser146 8.69 121.41 63.08
Ala147 8.64 127.01 55.32
Leu148 8.06 119.86 58.28
Gln149 8.93 118.14 60.64
Gly150 7.81 103.63 47.42
Gln151 7.50 119.51 57.43
Ile152 8.41 118.45 63.88
Asp153 8.19 118.43 58.98
Ala154 7.15 117.17 55.23
Leu155 8.01 119.43 57.88
Leu156 8.51 120.60 58.02
Lys157 7.88 118.34 58.37
Ala158 7.25 118.26 53.63
Val159 7.48 120.03 65.45
Asp160 7.72 118.73 52.34
Pro161
Ser162 8.89 114.95 59.84
Leu163 8.15 124.41 53.89
Ser164 8.21 109.67 58.21
Ile1165 8.92 113.33 62.31
Asn166 8.42 116.53 53.57
Ser167 7.89 119.38 60.17
Thr168 8.37 111.26 59.92
Phe169  
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Residue 1HN
15NH
13Cα
Asp170
Gln171 8.06 121.72 59.12
Leu172 8.33 120.69 57.43
Ala173 8.95 126.47 54.86
Ala174 8.04 123.98 54.84
Ala175 7.37 117.20 52.27
Gly176 7.83 105.34 45.98
Val177 7.61 113.90 62.08
Ala178 6.89 119.57 48.94
His179 8.60 116.22 55.16
Ala180 8.40 127.56 50.79
Thr181 8.50 117.80 59.11
Pro182
Ala183 8.22 125.92 52.46
Ala184 7.84 128.98 53.79  
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Appendix 5. 1H and 15N Chemical Shifts of Residues with Double Peaks 
 
1H 15N 1H 15N
Asp29 7.28 116.33 7.27 116.34
Asp29' 7.21 116.21 7.21 116.20
Gln36 8.22 116.73 8.23 116.73
Gln36' 8.14 116.75 8.12 116.74
Gly45 8.17 107.36 8.16 107.33
Gly45' 8.27 107.39 8.23 107.40
Asn47 8.96 116.31 8.95 116.32
Asn47' 9.02 116.02 9.01 116.08
Phe51 8.89 117.22 8.89 117.21
Phe51' 8.84 116.89 8.82 116.89
Ala62 8.40 125.95 8.39 125.95
Ala62' 8.33 125.78 8.31 125.85
Tyr75 8.41 125.14 8.42 125.06
Tyr75' 8.42 124.60 8.43 124.44
Leu77 7.32 123.00 7.31 122.94
Leu77' 7.34 122.44 7.34 122.43
Ser79 7.03 118.60 7.00 118.57
Ser79' 6.71 118.33 6.68 118.36
Asn80 7.69 117.98 7.69 118.02
Asn80' 7.56 117.91 7.58 117.91
Ser82 8.17 124.71 8.18 124.75
Ser82' 7.99 124.38 7.97 124.41
Gly100 8.35 106.24 8.34 106.24
Gly100' 8.24 106.30 8.24 106.28
Tyr138 10.08 122.77 10.07 122.74
Tyr138' 10.40 121.81 10.38 121.80
Gly139 8.12 105.76 8.10 105.75
Gly139' 8.18 105.89 8.17 105.82
Full-Length Truncated
Residue
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CHAPTER 4 
Chemical Shift Perturbation Mapping of the Protein-Protein 
Interaction of HasAp with  Hemoglobin 
 
INTRODUCTION 
 
Iron is an essential nutrient for almost every living organism including the 
gram-negative bacteria [1-3]. However, free soluble iron is not available under 
biological conditions [4, 5]. Under iron starvation conditions, the gram-negative 
bacteria Pseudomonas aeruginosa uses different iron uptake mechanisms to scavenge 
iron from the host animal [6]. A major source of iron in the host is heme [7] which 
are bound in heme proteins such as hemoglobin, transferrin, and lactoferrin [2, 8-10] 
and approximately 95% of the heme are bound in hemoglobin [11].  The heme 
acquisition system (has) is one of the mechanism by which this bacteria “steal” heme 
from the host animal. The has system involves the secretion of a hemophore, HasAp, 
into the extracellular medium using the type I secretion pathway (TISS) [12-15]. 
HasAp is believed to “steal” heme from hemoglobin and then delivers the heme to the 
cognate receptor, HasR for subsequent deliver into the cytosol. The mechanism of 
heme uptake of HasAp from hemoglobin has not been understood. Létoffé et al. [14, 
16] reported that the hemophore, from Serratia marcescens (HasASM) takes the heme 
from hemoglobin by passive diffusion as determined by analytical ultracentrifugation 
technique. However, we have presented in Chapter 3 using electronic absorbance 
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spectroscopy and stopped-flow analysis that there is a likelihood of protein-protein 
interaction between HasAp and hemoglobin. To further proved this, we attempted to 
determine the proposed HasAp-hemoglobin interaction at the molecular level using a 
combination of X-ray crystallography and NMR spectroscopy to specifically 
determine which regions of HasAp are involved in heme uptake from hemoglobin. 
This study would further give more insights on how hemophores in general scavenge 
heme from hemoglobin. The X-ray crystal structure of holo truncated HasAp and the 
amide backbone assignments of holo full-length and truncated and apo truncated 
HasAp are reported in Chapter 3.  
One of the powerful techniques used to determine weak protein-protein 
interaction in solution at the molecular level is  NMR [17-22].  In comparison to other 
biochemical techniques available, the high sensitivity of the chemical shifts [23] upon 
structural rearrangements and ligand binding makes the chemical shift perturbation 
mapping a practical method to determine protein-protein interaction ([22, 24-27]. In 
brief, the 1H-15N HSQC spectrum of the uniformly 15N-labeled protein is monitored 
as function of added unlabeled protein and the perturbations of the chemical shifts of 
each residue in the protein are recorded [22, 24]. Hence, the resonances which 
undergo environmental or chemical changes as manifested by the perturbation of the 
chemical shifts of the nuclei [22, 24, 28, 29] are mapped onto the three-dimensional 
X-ray crystal structure of the protein to determine the putative binding interface [18].  
Basically, chemical shift mapping can be used to determine the binding interface and 
the kinetics of binding between the two proteins. If the protein-protein interaction is 
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weak, the free and bound proteins are in fast chemical exchange and only one set of 
resonances is observed [30]. If the interaction is strong, two sets of resonances are 
observed which are in slow exchange, one for the free protein and one for the bound-
protein [31, 32]. For the intermediate exchange regime, the resonances becomes 
broad [33] and may disappear in the HSQC spectrum.  
 
 
 
EXPERIMENTAL PROCEDURES 
 
 
General Methods  
 
 The recombinant pET11a plasmid harboring the genes coding for 
wild-type cleaved and uncleaved HasAp were transformed into Escherichia coli 
BL21-GOLD (DE3) expression host cell (Stratagene, La Jolla, CA) for subsequent 
expression.  Gene synthesis, subcloning, site-directed mutagenesis, and bacterial 
transformations were carried out as described in Chapter 3.  
 
Expression and Purification of Uniformly 15N-Labeled HasAp 
 A single colony of freshly transformed E. coli BL21-GOLD (DE3) cells as 
cultured for 12 h in 10 mL of LB-medium containing 100 μg/mL of ampicillin. The 
cells were subsequently subcultured into fresh M9-minimal medium and grown at 37 
°C with continuous shaking at 225 rpm. Once the OD600 reached 0.80 – 0.90, the 
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culture was transferred to centrifuge bottles and centrifuged at 4000 rpm for 10 m. 
The supernatant was discarded, and the cells were resuspended in a small volume of 
M9-minimal ampicillin medium that did not contain ammonium chloride as nitrogen 
source.  After the OD600 reached 1.0, biosynthesis of the polypeptide was induced by 
addition of isopropyl-β-D-thiogalactopyranoside (IPTG) to a final concentration of 1 
mM and 1 g of 15NH4Cl for producing [U-15N]-HasAp.   The cells were then grown 
further for 5 h at 30 °C and harvested by centrifugation at 4000 rpm for 10 min. The 
harvested cells were resuspended and lysed by sonification. Cell lysis, protein 
purification and heme reconstitution of the uniformly 15N-labeled HasAp were carried 
out using the same protocol described in Chapter 3.  
 
Preparation of Apo Truncated HasAp 
 
The extraction of heme was carried out using the cold-acid acetone treatment.  
A 1.5 mL of 2.5 mM holo 15N-labeled truncated HasAp was added drop by drop with 
stirring into a 100 mL acid-acetone solution previously stored in -20 °C. The solution 
contains 0.2 % V/V of 12 M HCl. After addition, the solution turned red with the 
formation of white precipitate. The solution was kept stirring for 10 min after addition 
of the protein and then centrifuged at 2500 rpm for 1 min at 4 ºC.  The procedure was 
repeated again if the precipitate has some reddish color.  The final precipitate was 
dissolved in 100 mL of 100 mM Tris-HCl buffer (pH 7.8) containing 7.0 M urea.  
The solution was then dialyzed against 100 mM Tris-HCl with 100 mM NaCl buffer 
(pH 7.8) (1 x 4 L) and then against phosphate buffer (μ = 0.1, pH 7.0) (3 x 4 L) at 4 
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ºC. After dialysis, the protein was concentrated to 3 mL and loaded into a G50 size 
exclusion column pre-equilibrated with phosphate buffer (μ = 0.1, pH 7.0). Protein 
fractions with > 90% apo protein, as determined by the absence of the Soret peak at 
407 nm, were pooled and concentrated.  
 
Preparation of Hemoglobin Samples 
 
Lyophilized human hemoglobin (Sigma) was dissolved in phosphate buffer  
(μ = 0.10, pH 7.0). The insoluble part was removed by centrifugation. The soluble 
part was purified in Sephacryl S-200 size exclusion column. Protein fractions with 
purity ratio (A280/A406) < 0.25 were pooled and concentrated using Amicon 
ultracentrifuge filter to a final concentration of ~1 mL. Freshly prepared human 
hemoglobin was used in the titration experiments.  The cyanomethemoglobin (HbCN) 
was prepared by adding the appropriate volume of 1 M NaCN stock solution to a 
solution of HasAp to achieve a 20-fold excess concentration of ligand relative to the 
concentration of HasAp in solution.  
 
NMR Sample Preparation 
 
The titration experiments were performed as follows. Uniformly 15N-labeled 
holo full-length and truncated HasAp (2.5 mM) samples were titrated with 
incremental 0.083 molar equivalence of met-hemoglobin with respect to HasAp at a 
time to a final molar ratio of 1:1.25 of 15N-labeled holo HasAp to unlabeled 
hemoglobin. 1H-15N HSQC NMR spectrum was taken before the titration and after 
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each titration. A stock solution of 3.5 mM of hemoglobin was used in the titration 
experiments. Both HasAp and hemoglobin were in the same phosphate buffer            
(μ = 0.1, pH 7.0). The NMR samples contained 5% D2O in sodium phosphate buffer.  
The titration experiment for apo HasAp and HbCN were carried out in the same way 
as described for the holo HasAp, however, incremental addition of 0.25 molar 
equivalence of HbCN was titrated each time to a final molar ratio of 1:0.75 of 15N-
labeled apo-HasAp to unlabeled HbCN.  
 
NMR Spectroscopy 
 
 NMR experiments were performed at 305 K on a Bruker Avance 800 
spectrometer equipped with a 5 mm TXI 1H-13C/15N/D xyz-gradient probe. Fast 1H-
15N-HSQC spectra [34] were collected over a 19.2 kHz (1H) and 3.4 kHz (15N) 
spectral widths; with 32 scans per increment;  2048 (1H) and 256 (15N) complex 
points; 100 ms acquisition time; and 1 s relaxation delay. 1H-15N-HSQC spectra were 
processed using NMRPipe [35] and analyzed with Sparky [36]. The interaction 
between HasAp and hemoglobin were determined using chemical shift perturbation 
analyses [22].  
 
  
 
 
 
RESULTS AND DISCUSSION 
 
The fact that heme from hemoglobin is captured very rapidly by apo-HasAp 
suggest specific interactions amongst the two proteins that lead to facile transfer of 
 196
the heme from one molecule to the other. This fast transfer precludes most 
experimental approaches aimed at mapping the surface of interaction between these 
proteins. To better understand how HasAp takes the heme from hemoglobin, it is 
highly significant to determine protein-protein interaction between HasAp and 
hemoglobin at the molecular level. In addition, it is also important to determine if the 
cleavage of the last 21-amino acid residues in the tail is biologically relevant in terms 
of heme capture from hemoglobin. The protein-protein interaction between the holo 
full-length, holo truncated HasAp, and apo truncated HasAp with hemoglobin were 
carried out using NMR spectroscopy. 1H-15N HSQC spectra were recorded using 
uniformly 15N-labeled HasAp in combination with unlabeled hemoglobin, in this way 
we can only monitor the residues in HasAp that are affected. This entailed assigning 
the amide backbone of HasAp. The assignment of the N-H resonances of HasAp at 32 
°C were carried out using a combination of 2D and 3D NMR experiments and amino 
acid selective labeling techniques described in Chapter 3. 98% of the residues in holo 
full-length and truncated HasAp were assigned, while only 89% of residues in apo 
HasAp were assigned. These assignments were used to determine the protein-protein 
interaction between HasAp and hemoglobin by mapping the chemical shift 
perturbation in the X-ray crystal structure of holo truncated HasAp. Hence, 
interaction is viewed on the HasAp perspective.  
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NMR Spectral Changes Observed Upon Addition of Hemoglobin to Holo HasAp  
 
It has been shown in the proteomics study of Arevalo-Ferro et. al. [37] that  
cleaved HasAp appears to be the physiologically active form based from the 2D gel 
electrophoresis data. In this study, we determined the protein-protein interaction 
between holo full-length and truncated HasAp with hemoglobin. It has been shown in 
Chapter 3 that heme transfer from hemoglobin to HasAp is very fast and to 
circumvent the problem of fast heme transfer, holo HasAp was used in this 
experiment to determine the binding sites of interaction of HasAp with hemoglobin. 
The interaction was monitored by the chemical shift perturbation of the N-H cross-
peaks in the 1H-15N HSQC spectra. Cross-peaks affected by the titration can be 
categorized in three groups: (1) Cross-peaks that do not show appreciable chemical 
shift perturbation (Δδavg), (2) cross-peaks that shift as the titration progresses; the 
perturbations in this category are in fast exchange, i.e., Δδmax < kex, and (3) cross-
peaks that decrease in intensity and disappear as the titration progresses; the 
perturbations in this category are in the intermediate exchange regime, where Δδmax 
~kex. The results of holo full-length and truncated HasAp interaction with hemoglobin 
are summarized in the per-residue plot of average chemical shift perturbations 
depicted in Figure 1A and B, respectively, where residues in categories 1 and 2 are 
represented by positive bars and residues in category 3 by negative bars; absence of a 
bar for a particular residue indicates either a proline residue, lack of assignment, or 
peak overlap that prevent its analysis. From Figure 1, it can be observed that the same 
residues in both full-length and truncated HasAp are perturbed and also the residues 
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which disappeared are also the same. The results suggest that the binding sites for 
both are conserved. Moreover, it can also be observed that the magnitude of the 
chemical shift perturbations in the truncated protein is larger compared to the full-
length form and this indicates that the truncated form is likely to be the 
physiologically relevant form of HasAp. 
The per-residue chemical shift perturbations in category 2 of both full-length  
and truncated HasAp  upon titration with hemoglobin were mapped in the structure of 
HasAp with green indicating Δδavg <  0.02,  white 0.02 > Δδavg < 0.03, yellow 0.03 > 
Δδavg < 0.04, orange 0.04 > Δδavg  < 0.05, and red Δδavg  > 0.05; resonances in 
category 3 were mapped in marine. As shown in Figures 2 and 3, it can be observed 
that indeed the perturbed regions of the protein are the same for both full-length and 
truncated HasAp but the magnitude of perturbation in the truncated protein is larger 
as shown by the color coding schemes.  Significant chemical shift perturbations were 
observed in several areas of HasAp upon binding with hemoglobin. Together, these 
residues comprise an extended surface that has been illustrated in white, yellow, 
orange, and red in Figures 2 and 3. In particular, α2 is the most perturbed region of 
the protein. For both full-length and truncated HasAp, Trp23 in α2 is the most 
perturbed residue and from the surface structure of the protein (Figure 4A and B), 
Trp23 is situated inside a cavity and not on surface of the protein. A π-π stacking 
with another aromatic residue of hemoglobin could have caused this interaction. 
Moreover, hairpin loops in close proximity to α1 are also perturbed. These are the 
hairpin loops connecting α1 and β1,  β6 and β7, and  β3 and β4.   Some  parts  of  α4, 
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Figure 1.  Per-residue chemical shift perturbation plot of holo full-length (A) and 
truncated HasAp (B) upon binding with hemoglobin measured using the weighted 
average 1H and 15N shifts and was calculated with the expression Δδavg = {[Δδ1H)2 + 
(Δδ15N/5)2]/2}½.  
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β1, β2, β4-β8 are also perturbed. In addition, the residues in the tail are also 
perturbed.  The marked difference in the magnitude of the chemical shift perturbation 
in full-length and truncated HasAp is also clearly observed in the titration curves 
(Figure 5). Upon incremental titration of 0.083 molar equivalence of hemoglobin with 
respect to HasAp, the residues in truncated HasAp showed larger perturbation 
compared to the residues in the full-length protein. This is clearly shown in Figure 5 
with 5 residues (Y11, L20, W23 and Y26) as examples.  
The surface structures in Figures 2-3 C and D shows that the bulk of the 
perturbed area of the protein is concentrated on the upper area of the protein. While, 
the bottom part are not affected shown in green. On the other hand, the back part of 
the protein where the α-helices are situated (Figures 2-3 C and D) shows that it is less  
perturbed than the other side. The results suggest that hemoglobin binds on the upper 
part of the protein and the interaction of hemoglobin to both full-length and truncated 
HasAp are the same but it binds more tightly in the truncated form than in the full-
length form. As also observed in Figure 4A and B, the residues in the tail are also 
perturbed which could suggest that these residues interact with hemoglobin. Residues 
A180-A205 in the full-length HasAp were also perturbed but they cannot be mapped 
on the structure of truncated HasAp. A closer inspection of the structure of truncated 
HasAp could suggest that the tail could be speculated to be located somewhere on top 
of α1 and this could prevent the efficient interaction of hemoglobin with HasAp. 
Furthermore, the residues in the tail of the full-length protein is dynamic as reported 
in Chapter 3 and this mobility of the tail could also prevent the interaction with  
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hemoglobin.  The tail may pose as a steric hindrance with hemoglobin interaction. 
Hence, it could be one of the reasons the tail is cleaved in the extracellular medium so 
it can efficiently take heme from hemoglobin.  
As shown in Figures 2-3, the residues in category 3 are concentrated in the 
heme pocket. These residues are found in the long extended loop where the axial 
heme ligand His32 is situated and in the loop where the other axial ligand Tyr75 is 
located and also in α2 at the back of the heme. As has been pointed out above, 
resonances in category 3 do not exhibit  chemical  shift perturbations.  Rather, the 
intensity of these resonances decreases as the titration progresses with most 
resonances disappearing  before the titration  is over.  It is noteworthy that most of the 
 
 
 
 
 
 
 
 
 
 
Figure 5.  Titration curve of residues Y11, L20, W23,  and Y26 obtained upon 
titration of hemoglobin into holo full-length (A) and truncated (B) HasAp.  
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residues highlighted in marine in Figure 2-3 exhibit multiple cross-peaks in HSQC 
spectra acquired with fast pulse repetition and only a weak cross-peak in HSQC 
spectra recorded with standard conditions. This means that resonances from these 
residues are affected by their proximity to the heme-iron (fast relaxation) and by 
conformational disorder (multiple cross-peaks). Although it is clear that 
disappearance of these resonances during the titration is a consequence of exchange 
in the intermediate timescale, the nature of the exchange can be a consequence of at 
least two different phenomena: (a) exchange between hemoglobin-bound and free 
forms of HasAp or (b) exchange between conformers that is brought to the 
intermediate timescale via interactions with hemoglobin. Hence, if line broadening is 
brought about by exchange between hemoglobin-bound and free forms, the surface 
colored in marine may be considered as directly interacting with hemoglobin. 
Alternatively, if resonance broadening is a consequence of changes in rate of 
conformer interconversion, the surface in marine may not interact directly with 
hemoglobin. If this is the case, it is interesting that binding to hemoglobin would 
promote changes in conformational dynamics in loop harboring His32, which is 
closest to the area of interaction in HasAp and in the hairpin containing the other 
axial ligand, Tyr75, which is on the opposite side of the heme. From titration study of 
holo full-length and truncated HasAp with hemoglobin, it can be concluded that there 
is protein-protein interaction between these two proteins. Hence, in the following 
experiment we tried to determine the binding sites of hemoglobin in apo truncated 
HasAp.  
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NMR Spectral Changes Observed Upon Addition of HbCN to Apo-HasAp  
 From the results above, it appears that the truncated form is likely to be 
the biologically relevant form of HasAp. Thus, we attempted to determine the 
protein-protein interaction between truncated apo-HasAp and hemoglobin. To prevent 
the transfer of heme from hemoglobin to apo-HasAp, cyanomethemoglobin was used 
instead of methemoglobin. The titration experiment is similar to the experiment 
described above for holo HasAp and hemoglobin. U-15N labeled apo-HasAp and 
unlabeled cyanomethemoglobin were used in the experiment. 89% of the backbone 
amide of apo-HasAp was assigned as described in Chapter 3. The per-residue plot of 
the chemical shift perturbations of apo-HasAp upon binding with hemoglobin is 
shown in Figure 6. It can be observed that residues Val38 is the most perturbed 
residue in apo-HasAp. In addition, V37 and Asp64 also exhibit large chemical shift 
perturbations. The data in Figure 6 suggests that there are less residues which are 
affected by hemoglobin binding in apo-HasAp than in holo-HasAp, but the magnitude 
of chemical shift perturbation shown by Val38 is two-fold higher than the residue 
which showed the largest perturbation in holo truncated HasAp.  The superimposed 
1H-15N HSQC spectra of apo-HasAp with increasing addition of HbCN illustrating 
the chemical shift perturbations of Val37, Val38 and Asp64 resonances are shown in 
Figure 7. It can be observed that there is a marked movement of the N-H cross-peaks 
of the three residues mentioned as shown by the arrows. The magnitude of the 
chemical shift perturbations of all the residues affected in apo-HasAp upon titration 
with HbCN were mapped in the structure of holo-HasAp (Figure 8) using the same 
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color coding scheme as described above. The residues colored in red (Val37, Val38 
and Asp64) are resonances which exhibit large chemical shift perturbation. Val37 and 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.  Per-residue chemical shift perturbation plot of apo-HasAp upon binding 
with HbCN measured using the weighted average 1H and 15N shifts and was 
calculated with the expression Δδavg = {[Δδ1H)2 + (Δδ15N/5)2]/2}½.  
 
 
Val38 are both located in the extended loop where His32 is located.  While Asp64 is 
located in a hairpin loop connecting β3 and β4 and this is close to α1. The rest of the 
residues which were perturbed are located in the loop where Tyr75 is located, 
carboxyl end of β2, hairpin loop connecting β6 and β7, and in β8. The results of the 
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hemoglobin titration experiments with apo- and holo-HasAp showed that there are 
more residues in the holo form that were perturbed. Moreover, in holo HasAp, α1 is 
the region of the secondary structure where residues which exhibit the large 
perturbations are located, whereas in apo-HasAp, it is in the loop where His32 is 
located. It can be noted that in holo-HasAp Val37 and Val38 disappeared and their 
intensity in the HSQC spectra were very weak to start with. However, both results 
agree that the back part of the protein where the α-helices are located are not involved 
in the interaction. Moreover, in both apo and holo titration experiments, it can be 
noted that the upper part of the protein are perturbed upon hemoglobin binding. This 
could suggest that this is the area which interacts with hemoglobin. Interestingly, as 
shown in Figure 8B and D, Val37 and Val38 are situated on top of the heme 
(magenta).  This also suggests that the heme pocket of apo-HasAp is highly involved 
in heme uptake from hemoglobin. Based from the results it can be speculated that the 
loop where His32 is located interacts with hemoglobin to take the heme with Val37 
and Val38 as the two residues that are directly involved and this leads to a 
conformation change of the structure of the protein with the upper part of the protein 
going to a “closed” conformation upon heme binding.  
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Figure 7.   Superimposed 1H-15N HSQC spectral regions of apo-HasAp upon titration 
with increasing amounts of HbCN. The red, blue, green and yellow cross-peaks 
represent the resonances with 0, 0.25, 0.50 and 0.75 equivalent addition of HbCN.  
The spectral regions shown highlights (A) Val38, (B) Val37 and (C) Asp64 which 
showed large chemical shift perturbation as indicated by the black arrows.  
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CHAPTER 5 
Summary 
 
The gram-negative bacteria, Pseudomonas aeruginosa overcome iron 
starvation conditions by using two known distinct heme uptake mechanisms regulated 
by the Fe uptake regulator (Fur) [1-4]. One of the heme uptake mechanisms is the 
heme acquisition system (has) which constitutes a receptor, HasR and a heme-binding 
protein, HasAp [1]. HasAp is classified as hemophore secreted by Pseudomonas 
aeruginosa in response to iron limitation condition at the early stage of infection.  
Hemophores are secreted to the extracellular medium to scavenge free heme and 
heme from other heme proteins available from the host animal and deliver the heme 
to the specific outer membrane receptor, HasR for internalization into the bacterial 
cell [5, 6]. The mechanistic detail how HasAp takes heme from hemoglobin and its 
subsequent release of heme to the receptor is not fully understood. It is also 
interesting to note that HasAp undergoes C-terminal proteolytic cleavages at five 
different sites in the extracellular medium, whereas, hemophores from other gram-
negative bacteria only undergo a single C-terminal proteolytic cleavage [7-9]. The 
structural and biochemical studies carried out with HasAp was aimed at elucidating 
the structure and function relationship of this protein. The significant difference 
between the full-length and truncated HasAp and the unusual His-Tyr coordination of 
hemophores could give some insights on how this heme scavenging proteins can take 
heme from hemoglobin. Thus, inhibitors can be designed to prevent the transfer of 
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heme from hemoglobin to HasAp and by doing this; infection can be prevented at the 
early stage of infection. In this research, we used a combination of bioanalytical 
techniques in the context of trying to understand the heme uptake mechanism of 
HasAp. The summary and findings that can be drawn based on our experimental 
results are summarized below.  
 
1.  Structure of HasAp suggests heme uptake and release is due to different 
conformation and bonding interactions present in the apo and holo forms. The C-
terminus of the full-length HasAp is highly unstructured.  
The X-ray crystal structure of holo truncated HasAp is similar to HasASM as 
shown in Figure 11 of Chapter 3. The heme in the structure is highly exposed to the 
solvent and the two axial ligands coordinating the heme-iron are located in long 
stretch of loops.   The strategic location of the heme pocket in HasAp could facilitate 
heme acquisition from hemoglobin as well as the release of heme to the cognate 
receptor, HasR. Moreover, as observed in Figure 46 of Chapter 3, the regions that are 
different in conformations between the apo and holo truncated HasAp are located in 
the binding pocket area. This also suggests that this part of the protein is in different 
conformations when heme is present or absent in the protein. The NMR structure of 
apo-HasASM is in open conformation and the loop where His32 is located is displaced 
30 Å [10] compared to the holo form and this agree with our results. This 
conformational difference between the apo and holo forms of HasAp could be 
propose as desirable conformational change so heme can be bound tightly. It can be 
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noted that in the structure of HasAp that Gly35 and Arg129 are forming hydrogen-
bonds to the propionate groups of the heme which could imply that the heme is 
stabilized in the heme pocket by this bonding interactions aside from the axial 
ligands.  
 In addition, the calculated Cα B-factor values of the residues of the protein 
shown Figure 13 of Chapter 3, suggests that residues G100-G106 and 183-184 have 
high B-factor values. From the amino acid alignment of (Figure 3 of Chapter 1), these 
residues correspond to G100-P105 of HasASM, which were identified by Létoffé et. al 
[11] to be involved in the interaction with HasRSM. It can be concluded that the 
flexibility of this loop makes it highly efficient to bind with the receptor. Moreover, 
the last two C-terminal residues of truncated HasAp showed also high B-factor values 
and this could also suggest that this part is dynamic. This is supported by the X-ray 
crystallography results when these residues did not show any diffraction pattern. The 
chemical shift index (CSI) data also supports this postulate. This part of the protein is 
classified as loops. Further, there was no 1H-1H NOE observed in the residues in the 
tail to the rest of the residues in the protein. Hence, the X-ray and NMR data suggest 
that the tail is highly unstructured and disordered part of the protein. In addition, the 
hydrogen-deuterium exchange experiment done on the holo truncated HasAp 
suggests that it is a highly dynamic protein.  
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2.  The breaking and forming of hydrogen-bond between Tyr75 and His83 could 
modulate the heme uptake and release mechanism of HasAp.   
The heme-iron in HasAp is a mixture of high-spin (S = 5/2) and low-spin (S = 
½) species in solution as confirmed using UV-Vis spectroscopy, EPR and NMR. X-
ray and NMR result suggest that there is only one heme orientation in HasAp. The 
heme electronic structure and coordinate state was elucidated using 13C NMR coupled 
with the biosynthetic preparation of labeled heme. It has been reported that the 
chemical shift characteristics of the heme core carbons, most importantly, the carbon-
meso chemical shifts can be used as a straightforward diagnostic tool to determine the 
coordination state of the heme-iron [12, 13]. A method to determine the coordination 
state of high-spin heme proteins is described in detail in Chapter 2.  The 13C NMR 
results of HasAp suggest that it is a mixture of high-spin and low-spin hexacoordinate 
species. At lower temperature, the carbon-mesos are moving upfield which could 
imply that high-spin species are populated and the hexacoordinate complex is 
stronger at higher temperature. Interestingly, comparison of the temperature 
dependence data of the carbon-mesos of HasAp in H2O and in D2O suggests that the 
low-spin carbon-mesos are the same in both solutions, whereas the high-spin carbon-
mesos in H2O are more upfield than in D2O. Clearly, this study suggests that there is 
an isotopic effect responsible for the spin state and coordination state of the heme-
iron. We proposed that a hydrogen-bond between Tyr75 and His83 (Scheme 1) is 
responsible for the high-spin and low-spin equilibrium in HasAp. The hydrogen-bond 
between these two residues strengthen the Tyr-iron coordination and makes Tyr a 
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weaker field ligand. On the other hand, the breaking of this hydrogen-bond makes 
Tyr a stronger field ligand. This proposed breaking and forming of H-bond between 
Tyr75 and His83 could modulate the heme uptake and release mechanism of HasAp. 
The H-bond formation could make the iron-Tyr coordination stronger so it can bind 
heme tightly while the breaking of this H-bond could facilitate the transfer of heme to 
HasR.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.  The proposed breaking and forming of hydrogen-bond between Tyr75 
and His83 which modulates the heme uptake and release mechanism of HasAp 
(hydrogen-bond is shown in dashed line).  
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3. HasAp can only take heme from methemoglobin and there appears to be protein-
protein interaction between the two proteins before heme uptake. The heme 
transfer event from met-Hb to apo-HasAp is a multi-step process.  
The heme transfer experiments in Chapter 3 show that apo-HasAp can only 
take heme from methemoglobin. Thus, it can only scavenge heme from hemoglobin if 
the heme-iron is in the ferric state. For this transfer to occur, the Fe-NHis bond that 
anchors the heme to met-Hb must be cleaved and replaced by the Fe-NHis and Fe-OTyr 
bonds present in holo-HasAp. The weak-aqua ligand that coordinates the iron(III) in 
met-Hb is also essential to the heme transfer process since its substitution with a 
stronger ligand such as cyanide enhibits the heme transfer to HasAp. Considering the 
large number of metal ligand involved, and in analogy with the mechanism of heme 
heme binding to apo-Hb and apo-Mb, there is little doubt that the heme transfer event 
from met-Hb to apo-HasAp is a multi-step process. The heme transfer from 
hemoglobin to apo-HasAp is very fast and occurs in two steps.  The first pseudo first 
order rate constant suggests that heme is taken by apo-HasAp before hemoglobin 
starts to dissociate in solution. Thereby, there appears to be a protein-protein 
interaction between the two proteins. This is supported by the NMR titration 
experiments between HasAp and hemoglobin. The binding sites in holo full-length 
and truncated HasAp are conserved but the perturbations are larger in the truncated 
protein than in the full-length form and this imply that the truncated form is likely to 
be the biologically active form of HasAp. The tail could pose as a steric hindrance for 
the binding interaction between HasAp and hemoglobin. The binding sites of 
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hemoglobin in truncated apo-HasAp are not the same as the holo forms. However, it 
is in the same region as the binding sites in the holo proteins.  
 
 
REFERENCES 
 
1. Poole, K. A. M., G. A., Iron Acquisition and Its Control in Pseudomonas 
aeruginosa: Many Roads Lead to Rome. Front. Biosci., 2003. 8: p. 661-686. 
 
2. Ochsner, U.A., Johnson, Z., and Vasil, M. L., Genetics and Regulation of Two 
Distinct Haem-Uptake Systems, phu and has, in Pseudomonas aeruginosa. 
Microbiology, 2000. 146: p. 185-198. 
 
3. Ochsner, U.A., Vasil, A. I., and Vasil, M. L., Role of the Ferric Uptake 
Regulator of Pseudomonas aeruginosa in the Regulation of Siderophores and 
Exotoxin A Expression: Purification and Activity on Iron-Regulated 
Promoters. J. Bacteriol., 1995. 177: p. 7194-7201. 
 
4. Nouwens, A., Beatson, S. A., Whitchurch, C. B., Nalsh, B. J., Schweizer, H. 
P., Mattick, J. S., and Cordwell, S. J., Proteome Analysis of Extracellular 
Proteins Regulated by las and rhl Quorum Sensing System in Pseudomonas 
PAO1. Microbiology, 2003. 149: p. 1311-1322. 
 
5. Ratliff, M., Zhu, W., Deshmukh, R., Wilks, A., and Stojiljkovic, I., 
Homologues of Neisserial Heme Oxygenase in Gram-Negative Bacteria: 
Degradation of Heme by the Product of the pigA Gene of Pseudomonas 
aeruginosa. J. Bacteriol., 2001. 183: p. 6394-6403. 
 
6. Wandersman, C., and Delepelaire, P., Bacterial Iron Sources: From 
Siderophores to Hemophores. Annu. Rev. Microbiol., 2004. 58: p. 611-647. 
 
7. Arevalo-Ferro, C., Hentzer, M., Reil, G., Gorg, A., Kjelleberg, S., Givskov, 
M., Riedel, K., and Eberl, L., Identification of Quorum-Sensing Regulated 
Proteins in the Opportunistic Pathogen Pseudomonas aeruginosa by 
Proteomics. Envi. Microbiol., 2003. 5: p. 1350-1369. 
 
 222
8. Izadi-Pruneyre, N., Wolff, N., Redeker, V., Wandersman, C., Delepierre, M., 
and Lecroisey, A., NMR Studies of the C-Terminal Secretion Signal of the 
Haem-Binding Protein, HasA. Eur. J. Biochem., 1999. 261: p. 562-568. 
 
9. Létoffé, S., Omori, K., and Wandersman, C., Functional Characterization of 
the HasAPF Hemophore and Its Truncated and Chimeric Variants. 
Determination of a Region Involved in Binding to the Hemophore Receptor. J. 
Bacteriol., 2000. 182: p. 4401-4405. 
 
 
10. Wolff, N., Izadi-Pruneyre, N., Couprie, J., Habeck, M., Linge, J., Riepeng, 
W., Wandersman, C., Nilges, M., Delepierre, M., and Lecroisey, A., 
Comparative Analysis of Structural and Dynamic Properties of the Loaded 
and Unloaded Hemophore HasA: Functional Implications. J. Mol. Biol., 
2008. 376: p. 517-525. 
 
11. Létoffé, S., Debarbieux, L., Izadi, N., Delepelaire, P.,  and Wandersman, C., 
Ligand Delivery by Haem Carrier Proteins: The Binding of Serratia 
marcescens Haemophore to Its Outer Membrane Receptor is Mediated by 
Two Distinct Peptide Regions. Mol. Microbiol., 2003. 50: p. 77-88. 
 
12. Rivera, M., and Caignan, G. A., Recent Developments in the 13C NMR 
Spectroscopic Analysis of Paramagnetic Hemes and Heme Proteins. Anal. 
Bioanal. Chem., 2004. 378: p. 1464-1483. 
 
13. Nakamura, M., Hoshino, A., Ikezaki, A., and Ikeue, T., Chemical Shift of 
Meso-Carbon: A Powerful Probe to Determine the Coordination Structure 
and Electronic Configuration of Ferric Porphyrin Complexes. Chem. 
Commun., 2003: p. 1862-1863. 
 
 
 
